ssy-10q_20220930.htm

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

0001564590-22-037559.txt : 20221114 0001564590-22-037559.hdr.sgml : 20221114 20221114131419 ACCESSION NUMBER: 0001564590-22-037559 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20220930 FILED AS OF DATE: 20221114 DATE AS OF CHANGE: 20221114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SUNLINK HEALTH SYSTEMS INC CENTRAL INDEX KEY: 0000096793 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] IRS NUMBER: 310621189 STATE OF INCORPORATION: OH FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12607 FILM NUMBER: 221383196 BUSINESS ADDRESS: STREET 1: 900 CIRCLE 75 PARKWAY STREET 2: SUITE 690 CITY: ATLANTA STATE: GA ZIP: 30339 BUSINESS PHONE: 7709337000 MAIL ADDRESS: STREET 1: 900 CIRCLE 75 PARKWAY STREET 2: SUITE 690 CITY: ATLANTA STATE: GA ZIP: 30339 FORMER COMPANY: FORMER CONFORMED NAME: KRUG INTERNATIONAL CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: TECHNOLOGY INC DATE OF NAME CHANGE: 19860803 FORMER COMPANY: FORMER CONFORMED NAME: COMANCO INDUSTRIES INC DATE OF NAME CHANGE: 19710719 10-Q 1 ssy-10q_20220930.htm Q1 FY 2023 10Q ssy-10q_20220930.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2022

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-12607

SUNLINK HEALTH SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Ohio

31-0621189

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

900 Circle 75 Parkway, Suite 690, Atlanta, Georgia 30339

(Address of principal executive offices)

(Zip Code)

(770) 933-7000

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered Symbol(s)
Common Shares without par value	SSY	NYSE American
Preferred Share Purchase Rights

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filings requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (of for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

Securities registered pursuant to Section 12(b) of the Act:

The number of Common Shares, without par value, outstanding as of November 14, 2022 was 7,031,603 .

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

	September 30,
	2022		June 30,
	(unaudited)		2022
ASSETS
Current Assets:
Cash and cash equivalents	$	4,951	$	6,794
Receivables - net		4,686		4,624
Inventory		1,842		1,748
Employee retention credits receivable		1,761		1,761
Prepaid expense and other assets		2,166		1,888
Total current assets		15,406		16,815
Property, plant and equipment, at cost		23,859		23,920
Less accumulated depreciation		15,377		15,703
Property, plant and equipment - net		8,482		8,217
Noncurrent Assets:
Intangible assets - net		1,195		1,201
Right of use assets		1,113		1,187
Other noncurrent assets		630		523
Total noncurrent assets		2,938		2,911
TOTAL ASSETS	$	26,826	$	27,943
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	1,831	$	1,347
Current maturities of long-term debt		41		40
Accrued payroll and related taxes		1,344		1,520
Accrued sales tax		2,777		2,600
Unearned CARES Act Funds		469		519
Current operating lease liabilities		354		352
Other accrued expenses		1,347		1,313
Total current liabilities		8,163		7,691
Long-Term Liabilities
Long-term debt		3		14
Noncurrent liability for professional liability risks		87		86
Long-term operating lease liabilities		780		857
Deferred income taxes		69		69
Other noncurrent liabilities		114		106
Total long-term liabilities		1,053		1,132
Commitments and Contingencies
Shareholders’ Equity
Preferred Shares, authorized and unissued, 2,000 shares		0		0
Common Shares, without par value:
Issued and outstanding, 7,032 shares at September 30, 2022 and 6,954 at June 30, 2022		3,516		3,478
Additional paid-in capital		10,746		10,736
Retained earnings		3,242		4,800
Accumulated other comprehensive loss		106		106
Total Shareholders’ Equity		17,610		19,120
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	26,826	$	27,943

See notes to condensed consolidated financial statements.

SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE EARNINGS (LOSS)

(In thousands, except per share amounts)

(Unaudited)

	Three Months Ended
	September 30,
	2022			2021
Net revenues	$	11,037		$	10,525
Costs and Expenses
Cost of goods sold		4,369			4,073
Salaries, wages and benefits		5,330			4,698
Supplies		337			300
Purchased services		1,035			862
Other operating expenses		1,093			1,082
Rent and lease expense		118			170
Depreciation and amortization		368			333
Operating Loss		(1,613	)		(993	)
Other Income (Expense):
Gains on sale of assets		12			5
Forgiveness of PPP loans and accrued interest		0			3,010
Federal stimulus - Provider relief funds		61			0
Interest income (expense), net		(4	)		(14	)
Earnings (Loss) from Continuing Operations before income taxes		(1,544	)		2,008
Income Tax Expense (Benefit)		0			2
Earnings (Loss) from Continuing Operations		(1,544	)		2,006
Loss from Discontinued Operations, net of tax		(14	)		(67	)
Net Earnings (Loss)		(1,558	)		1,939
Other comprehensive income		0			0
Comprehensive Earnings (Loss)	$	(1,558	)	$	1,939
Earnings (Loss) Per Share:
Continuing Operations:
Basic	$	(0.22	)	$	0.29
Diluted	$	(0.22	)	$	0.28
Discontinued Operations:
Basic	$	(0.00	)	$	(0.01	)
Diluted	$	(0.00	)	$	(0.01	)
Net Earnings (Loss):
Basic	$	(0.22	)	$	0.28
Diluted	$	(0.22	)	$	0.27
Weighted-Average Common Shares Outstanding:
Basic		6,983			6,924
Diluted		6,983			7,095

See notes to condensed consolidated financial statements.

SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS SHAREHOLDERS’ EQUITY

(In thousands)

(Unaudited)

	Common Shares				Additional Paid-in Capital		Retained Earnings (Loss)			Accumulated Other Comprehensive Loss			Total Shareholders’ Equity
	Shares		Amount
JUNE 30, 2022		6,954	$	3,478	$	10,736	$	4,800		$	106		$	19,120
Share options exercised		78		38		10								48
Net loss								(1,558	)					(1,558	)
SEPTEMBER 30, 2022		7,032	$	3,516	$	10,746	$	3,242			106		$	17,610



JUNE 30, 2021		6,924	$	3,463	$	10,700	$	6,809		$	(162	)	$	20,810
Net earnings								1,939						1,939
SEPTEMBER 30, 2021		6,924	$	3,463	$	10,700	$	8,748		$	(162	)	$	22,749

See notes to condensed consolidated financial statements.

SUNLINK HEALTH SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

	Three Months Ended
	September 30,
	2022			2021
Net Cash Provided by (Used in) Operating Activities	$	(1,271	)	$	(334	)
Cash Flows Used in Investing Activities:
Expenditures for property, plant and equipment		(624	)		(692	)
Proceeds from share option exercises		49		0
Proceeds from sale of other assets		13			5
Net Cash Used in Investing Activities		(562	)		(687	)
Cash Flows Used in Financing Activities:
Payments on long-term debt		(10	)		(8	)
Net Cash Used in Financing Activities		(10	)		(8	)
Net Decrease in Cash and Cash Equivalents		(1,843	)		(1,029	)
Cash and Cash Equivalents Beginning of Period		6,794			9,962
Cash and Cash Equivalents End of Period	$	4,951		$	8,933
Supplemental Disclosure of Cash Flow Information:
Cash Paid (Received) for:
Interest	$	4		$	(1	)
Income taxes	$	0		$	(293	)
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities	$	7		$	35

See notes to condensed consolidated financial statements.

SUNLINK HEALTH SYSTEMS, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

THREE MONTHS ENDED SEPTEMBER 30, 2022

(all dollar amounts in thousands except per share amounts)

(Unaudited)

Note 1. –Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements as of September 30, 2022 and for the three month periods ended September 30, 2022 and 2021 have been prepared in accordance with Rule 8-03 and Article 8-03 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and, as such, do not include all information required by accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated June 30, 2022 balance sheet included in this interim filing has been derived from the audited consolidated financial statements at that date but does not include all the information and related notes required by GAAP for complete consolidated financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements included in the SunLink Health Systems, Inc. (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”) Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the SEC on September 28, 2022. In the opinion of management, the Condensed Consolidated Financial Statements, which are unaudited, include all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position and results of operations for the periods indicated. The results of operations for the three month periods ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire fiscal year or any other interim period.

Throughout these notes to the condensed consolidated financial statements, SunLink Health Systems, Inc., and its consolidated subsidiaries are referred to on a collective basis as “SunLink”, “we”, “our”, “ours”, “us” or the “Company.” This drafting style is not meant to indicate that SunLink Health Systems, Inc. or any particular subsidiary of the Company owns or operates any particular asset, business or property. Each operation and business described in this filing is owned and operated by a distinct and indirect subsidiary of SunLink Health System, Inc.

Note 2. – Business Operations

Healthcare Services

The Health Services segment includes the following:

•

A subsidiary which owns and operates Trace Regional Medical Center (“Trace”) which is composed of an 49 licensed-bed acute care hospital, located in Houston, Mississippi. Our Medical Center includes an 26-bed geriatric psychology unit (“GPU”) and an attached 66-bed extended care and rehabilitation center. This facility focuses primarily on senior healthcare services.

•

A subsidiary, SunLink Health Systems Technology (“SHS Technology”), which provides information technology (“IT”) services to outside customers and to SunLink subsidiaries.

•

A subsidiary which owns approximately five (5) acres of unimproved land in Houston, Mississippi, and

•

A subsidiary which owns approximately 25 acres of unimproved land in Ellijay, Georgia.

Pharmacy

The Pharmacy segment is composed of three operational areas:

•

Retail pharmacy products and services, consisting of retail pharmacy sales conducted in rural markets at two locations in Louisiana. This also includes non-institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to clients or patients in non-institutional settings, including private residences in Louisiana;

•

Institutional pharmacy services consisting of the provision of specialty and non-specialty pharmaceutical and biological products to institutional clients or to patients in institutional settings, such as extended care and rehabilitation centers, nursing homes, assisted living facilities, behavioral and specialty hospitals, hospice, and correctional facilities; and,

•

Durable medical equipment products and services (“DME”), consisting primarily of the sale and rental of products for institutional clients or to patients in institutional settings and patient-administered home care.

COVID-19 Pandemic and CARES Act Funding

COVID-19 was declared a global pandemic by the World Health Organization on March 11, 2020. We have continued to monitor the impact on our operations of the COVID-19 pandemic and its aftermath and have taken significant steps intended to minimize the risk to our employees and patients. Certain employees have been working remotely, but we believe these remote work arrangements have not materially affected our ability to maintain critical business operations, which are being conducted substantially in accordance with, among other things, our understanding of applicable government health and safety protocols and guidance issued in response to the COVID-19 pandemic, although such protocols and guidance have been subject to changes and at times have been unclear. Nevertheless, as in many healthcare environments, we have experienced disruption of our operations, COVID-19 illness, including deaths, and some employees have tested positive and were placed on leave or in quarantine. We believe the effect of the COVID-19 pandemic and certain public and certain governmental responses to it have negatively affected our last eleven quarter’s results.

In late December 2020, we began receiving allotments of COVID-19 vaccine and have vaccinated patients, providers, employees, and staff in accordance with the protocols and guidelines in the states where we operate. Not all such individuals have been vaccinated to date and some individuals have not consented to vaccination. The Company and its subsidiaries are currently developing and will implement plans to vaccinate employees to the extent required by the final rules of CMS. The Company believes the vaccine mandates have resulted in the loss of staff, including clinical staff, and together with the current state of the labor market, have negatively affected the Company’s ability to maintain the current levels of service.

In our Healthcare Segment business, we have experienced material reductions in demand and net revenues due to the COVID-19 pandemic and its aftermath. There continues to be reduced current demand for certain hospital services and for extended care, rehabilitation center and nursing home admissions and clinic visits. The availability and cost of medical supplies have adversely affected our Healthcare businesses and we continue to monitor supplies and seek additional sources of many supply items. A reduction in the availability of qualified employees accompanied by an increase in the levels of salaries, wages and benefits have occurred, and, despite good faith efforts to do so, we have not yet been able to rehire or fully replace staff reductions which were previously furloughed, laid off or retired.

During the COVID-19 pandemic and its aftermath, our Pharmacy business has experienced reduced sales trends in certain areas, increased costs and reduced staff. Many of our primary physician referral sources have been operating at reduced capacity, and until these referral sources resume operating at full capacity, we believe the COVID-19 pandemic will have continuing to effects on the demand for DME products and Retail and Institutional Pharmacy drugs and products. Reductions in employee hours have been made in response to the lower demand. Extended care facilities and rehabilitation centers, nursing homes and other customers of our Institutional Pharmacy services continue to be adversely affected by the COVID-19 pandemic. Our Institutional Pharmacy services have experienced increased costs and operational inefficiencies due to measures taken to protect our employees and by access controls and other restrictions implemented by our institutional customers. The impact of the COVID-19 pandemic and its aftermath also has and continues to have negatively affected our supply processes and costs generally.

Our Healthcare and Pharmacy segments have received approximately $6,182 in general and targeted Provider Relief Funds ("PRF") during the period April 1, 2020 through September 30, 2022 under the CARES Act, which was enacted in March 2020 in response to the COVID-19 pandemic. The PRF distributions have been accounted for as government grants, and a total of $5,715 have been recognized since April l, 2020 as other income under the gain contingency recognition method.

compliance with conditions specified under the PPP loan program. As of September 30, 2022, all our PPP loans have been forgiven.

The Taxpayer Certainty and Disaster Tax Relief Act of 2020, enacted December 27, 2020, made a number of changes to employer retention tax credits previously made available under the CARES Act, including modifying and extending the Employee Retention Credit ("ERC") for the six calendar months ending June 30, 2021. As a result of such legislation, the Company qualified for ERC for the first and second calendar quarters of 2021 due to the decrease in its gross receipts and has applied for ERC of $3,586 through amended quarterly payroll tax filings for the applicable quarters. Through the date of this filing, the Company has received $1,803 of ERC which we applied for. We continue to monitor compliance with the terms and conditions of the ERC and PPP programs and developing interpretations and enforcement of the ERC and PPP program rules and the regulations.

PRF distributions are subject to Federal audits and Single Audits and not subject to repayment provided we are able to attest to and comply with the terms and conditions of the funding, including demonstrating that the funds received have been used for designated, allowable healthcare-related expenses and capital expenditures attributable to COVID-19 and for "Lost Revenues" as defined by the department of “HHS”. We continue to monitor compliance with the terms and conditions of the PRF and developing interpretations and enforcement of PRF rules and regulations, as well as the impact of the pandemic on our revenues and expenses. If we are unable to attest to or comply with current or future terms and conditions, and there is no assurance we will be able to do so, our ability to retain some or all of the PRF received may be impacted, and we may have to return the unutilized portion of those funds, if any, in the future. The Company filed its Schedule of Grant Income of HHS awards and audit report for the year ended June 30, 2021 with the Health Resources and Services Administration (“HRSA”) agency of HHS on September 30, 2022.

The Company is unable to determine the extent to which the COVID-19 pandemic and its aftermath will continue to affect its assets and operations. Our ability to make estimates of the effect of the COVID-19 pandemic on revenues, expenses or changes in accounting judgments that have had or are reasonably likely to have a material effect on our financial statements is currently limited. The nature and extent of the continuing effect of the COVID-19 pandemic and its aftermath on our balance sheet and results of operations will depend on the severity and length of the pandemic or to evolving strains of COVID-19; any further government actions to address the pandemic's continuing effect; regulatory changes in response to the pandemic, especially those that affect our hospital, extended care, rehabilitation center, nursing home, clinics, and our pharmacy operations; existing and potential government assistance that may be provided; and the requirements of PRF, including our ability to retain such PRF received.

Note 3. – Discontinued Operations

Sold Hospitals and Nursing Home– Subsidiaries of the Company have sold substantially all the assets of five hospitals (“Sold Facilities”) during the period July 2, 2012 to March 17, 2019. The loss before income taxes of the Sold Facilities results primarily from the effects of retained professional liability insurance and claims expenses and settlement of a lawsuit.

Life Sciences and Engineering Segment —SunLink retained a defined benefit retirement plan which covered substantially all the employees of this segment when the segment was sold in fiscal 1998. Effective February 28, 1997, the plan was amended to freeze participant benefits and close the plan to new participants. Pension expense and related tax benefit or expense is reflected in the results of operations for this segment for the three months ended September 30, 2022 and 2021, respectively.

The components of pension expense for the three months ended September 30, 2022 and 2021, respectively, were as follows:

	Three Months Ended
	September 30,
	2022			2021
Interest Cost	$	13		$	11
Expected return on assets		(11	)		(11	)
Amortization of prior service cost		0			11
Net pension expense	$	2		$	11

SunLink contributed $22 to the plan in the three months ended September 30, 2022 and expects to contribute an additional $66 during the last nine months of the fiscal year ending June 30, 2023.

Note 4. – Shareholders’ Equity

Stock-Based Compensation – For the three months ended September 30, 2022 and 2021, the Company recognized no stock-based compensation for options issued to employees and directors of the Company. There were 77,452 shares issued as a result of options exercised during the three months ended September 30, 2022.

Note 5. – Revenue

Revenues by payor were as follows for the three months ended September 30, 2022 and 2021:

	Three Months Ended
	September 30,
	2022		2021
Medicare	$	5,013	$	5,055
Medicaid		2,856		2,368
Retail and Institutional Pharmacy		1,499		1,567
Managed Care & Other Insurance		1,385		1,320
Self-pay		259		184
Other		25		31
Total Net Revenues	$	11,037	$	10,525

No settlements of prior year Medicare and Medicaid cost reports were recorded in the three months ended September 30, 2022 and 2021, respectively.

Note 6. – Intangible Assets

Intangibles consist of the following, net of amortization:

	September 30, 2022			June 30, 2022
Pharmacy Segment Intangibles
Trade Name (non-amortizing)	$	1,180		$	1,180
Customer Relationships		1,089			1,089
Medicare License		623			623
		2,892			2,892
Accumulated Amortization		(1,697	)		(1,691	)
Net Intangibles	$	1,195		$	1,201

Amortization expense was $6 and $7 for the three months ended September 30, 2022 and 2021, respectively.

Note 7. – Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2022			June 30, 2022
Capital Lease	$	44		$	54
Less current maturities		(41	)		(40	)
Long-term Debt	$	3		$	14

CARES Act Paycheck Protection Plan Loans— The CARES Act was enacted by the U.S. government on March 27, 2020. As part of the CARES Act, the PPP loan program was established and administered by the SBA. In April and May 2020, subsidiaries of the Company received approximately $3,234 of PPP loans through its regular bank. Forgiveness of PPP loans was generally available if the loans were used to pay wages, rent, utilities and interest on certain debt during the 24-week period following receipt of the loan proceeds, subject to other federally-established terms and conditions. As of June 30, 2022, all our PPP loans have been forgiven by the SBA. During the quarter ended September 30, 2021, $2,972 of our PPP loans and $ 38 of related accrued interest were forgiven by the SBA and $3,010 was recorded as other income.

Note 8. – Income Taxes

No income tax expense and income tax expense of $2 (all state taxes) was recorded for continuing operations for the three months ended September 30, 2022 and 2021, respectively.

Of the CARES Act provisions, the currently most material income tax considerations related to the Company are related to the amounts for ERC and amounts received as general and targeted PRF. Based on the latest published IRS guidance as of the preparation of the September 30, 2022 financial statements, PRF (to the extent the applicable terms and conditions required to retain the funds are met “Retainable PRF”) are fully includable in taxable income in the Company’s tax returns in the fiscal year received. ERC are included in taxable income in the quarter in which the payroll expenses which the credits offset are deductible. ERC results in qualified wages being disallowed as a deduction for the portion of the wages paid equal to the sum of the payroll tax credit taken in the associated quarter. For amounts received and forgiven under the PPP loans, due to the enactment of the Consolidated Appropriations Act, 2021, on December 27, 2020, Congress specifically allowed the deduction of any expenses associated with forgiven PPP loan proceeds. It is the Company’s assumption at September 30, 2022 that all PPP loan associated expenses will be deductible for income tax.

In accordance with the Financial Accounting Standards Board Accounting Standards Codification (“ASC”) 740, we evaluate our deferred taxes quarterly to determine if adjustments to our valuation allowance are required based on the consideration of available positive and negative evidence using a “more likely than not” standard with respect to whether deferred tax assets will be realized. Our evaluation considers, among other factors, our historical operating results, our expectation of future results of operations, the duration of applicable statuary carryforward periods and conditions of the healthcare industry. The ultimate realization of our deferred tax assets depends primarily on our ability to generate future taxable income during the periods in which the related temporary differences in the financial basis and the tax basis of the assets become deductible. The value of our deferred tax assets will depend on applicable income tax rates.

At September 30, 2022, consistent with the above process, we evaluated the need for a valuation allowance against our deferred tax assets and determined that it was more likely than not that none of our deferred tax assets would be realized. As a result, in accordance with ASC 740, we recognized a valuation allowance of $8,278 against the deferred tax asset so that there is no net long-term deferred income tax asset at September 30, 2022. We conducted our evaluation by considering available positive and negative evidence to determine our ability to realize our deferred tax assets. In our evaluation, we gave more significant weight to evidence that was objective in nature as compared to subjective evidence. Also, more significant weight was given to evidence that directly related to our current financial performance as compared to less current evidence and future performance. A long-term deferred tax liability of $69 is recorded September 30, 2022 to reflect the deferred tax liability for the non-amortizing trade name intangible asset.

The principal negative evidence that led us to determine at September 30, 2022 that all the deferred tax assets should have full valuation allowances was the projected current fiscal year tax loss. For purposes of evaluating our valuations allowances, we have disregarded unusual items associated with the CARES Act discussed above, the Company’s history of losses, as well as the underlying negative business conditions for rural healthcare in which our Healthcare Services operates, and we have recognized none of our federal income tax net operating loss carry-forward of approximately $23,143.

For federal income tax purposes, at September 30, 2022, the Company had approximately $23,143 of estimated net operating loss carry-forwards available for use in future years subject to the limitations of the provisions of Internal Revenue Code Section 382. These net operating loss carryforwards expire primarily in fiscal 2023 through fiscal 2038; however, with the enactment of the Tax Cut and Jobs Act on December 22, 2017, federal net operating loss carryforwards generated in taxable years beginning after December 31, 2017 now have no expiration date. The Company’s returns for the periods prior to the fiscal year ended June 30, 2018 are no longer subject to potential federal and state income tax examination.

Note 9. – Leases

The Company has operating leases and a financing lease relating to its pharmacy operations, medical office buildings, certain medical equipment, and office equipment. All lease agreements generally require the Company to pay maintenance, repairs, property taxes and insurance costs, all of which are variable amounts based on actual costs. Variable lease costs also include escalating rent payments that are not fixed at commencement but are based on an index determined in future periods over the lease term based on changes in the Consumer Price Index or other measure of cost inflation. Some leases include one or more options to renew the lease at the end of the initial term, with renewal terms that generally extend the lease at the then market rental rates. Leases may also include an option to buy the underlying asset at or a short time prior to the termination of the lease. All such options are at the Company’s discretion and are evaluated at the commencement of the lease, with only those that are reasonably certain of exercise included in determining the appropriate lease term. The components of lease cost and rent expense for the three months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended		Three Months Ended
Lease Cost	September 30, 2022		September 30, 2021
Operating lease cost:
Operating lease cost	$	90	$	125
Short-term rent expense		27		44
Variable lease cost		1		1
Total operating lease cost	$	118	$	170

Finance lease cost:
Amortization right-of-use assets	$	9	$	9
Interest on finance lease liabilities		1		1
Total finance lease cost	$	10	$	10

Supplemental balance sheet information relating to leases was as follows:

		As of		As of
		September 30		June 30,
		2022		2022
Operating Leases:	Balance Sheet Classifications
Operating Lease ROU Assets	ROU Assets	$	1,113	$	1,187

Finance Leases:
Finance Lease ROU Assets	Property, plant and equipment		203		203
Accumulated amortization	Accumulated depreciation		108		101
Current finance lease liabilities	Current maturities of long-term debt		41		40
Long-term finance lease liabilities	Long-term debt		3		14

Supplemental cash flow and other information related to leases as of and for the three months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended
Other information	September 30, 2022			September 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	91		$	126
Operating cash flows from finance leases		1			1
Financing cash flow from finance leases		10			9
Right-of-use assets obtained in exchange for new operating lease liabilities		7			35
Weighted-average remaining lease term:
Operating leases	1.16 years			2.16 years
Finance leases	3.27 years			3.95 years
Weighted-average discount rate:
Operating leases		1.01	%		1.35	%
Finance leases		6.54	%		6.54	%

Commitments relating to non-cancellable operating and finance leases as of September 30, 2022 for each of the next five years and thereafter are as follows:

Payments due within	Operating Leases			Finance Leases
1 year	$	359		$	42
2 years		351			3
3 years		327			0
4 years		124			0
5 years		11			0
Over 5 years		0			0
Total minimum future payments		1,172			45
Less: Imputed interest		(38	)		(1	)
Total liabilities		1,134			44
Less: Current portion		(354	)		(41	)
Long-term liabilities	$	780		$	3

Note 10. – Accrued Sales Tax

During the fiscal year ended June 30, 2019, the Pharmacy segment business amended its sales tax position to claim exemption from state and local sales taxes in Louisiana on revenues from the sales of products and services

to beneficiaries of government insurance programs to the extent reimbursed by the administrators of such programs. No such sales taxes for any period subsequent to June 30, 2019 have been paid on the related reimbursement received with respect to sales of such products and services from the government payers’ insurance programs. The Company has filed amended sales tax returns for periods still open under the applicable statutes of limitations claiming refunds of such sales taxes paid. Refunds have been received from two taxing authorities in the amounts claimed on amended returns. Accordingly, amounts claimed and received from these two taxing authorities were recorded as revenues in the fiscal year ended June 30, 2020 in the amount of $359. Refunds from two different taxing authorities totaling approximately $1,500 are under audit. The Company’s position with respect to such refunds claimed from the two other local taxing authorities is still uncertain as these claims are under audit by such local taxing authorities and such claims have not yet been determined probable of collection; therefore, no amount has been recorded as a receivable or in income by the Company at September 30, 2022 in respect of such other local taxing authorities. In addition, the Company has continued to accrue the amounts for sales tax estimates from these two other taxing authorities in amounts it believes would be payable if its amended returns and continuing position is challenged and the Company does not prevail. The unpaid sales tax accrued as a liability at September 30, 2022 was $2,777 compared to $2,600 at June 30, 2022.

Note 11. – Commitments and Contingencies

Contractual obligations, commitments and contingencies related to outstanding debt and interest (excluding leases, see Note 9) in continuing operations at September 30, 2022 were as follows:

Payments due within:	Long-Term Debt		Interest on Outstanding Debt
1 year	$	41	$	1
2 years		3		0
3 years		0		0
4 years		0		0
5 years		0		0
	$	44	$	1

Note 12. – Related Party Transactions

A director of the Company is a member of a law firm which provides services to SunLink. The Company expensed an aggregate of $55 and $50 for legal services to this law firm in the three months ended September 30, 2022 and 2021, respectively. Included in the Company’s condensed consolidated balance sheets at September 30, 2022 and June 30, 2022 is $50 and $15, respectively, of amounts payable to this law firm.

Note 13. – Financial Information by Segment

Under ASC Topic No. 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision-making group is composed of SunLink’s chief executive officer and other members of SunLink’s senior management. Our two reportable operating segments are Healthcare Services and Pharmacy.

We evaluate performance of our operating segments based on revenue and operating profit (loss). Segment information as of September 30, 2022 and 2021 and for the three months then ended is as follows:

	Healthcare Services			Pharmacy			Corporate and Other			Total
As of and for the three months ended September 30, 2022
Net revenues from external customers	$	3,784		$	7,253		$	0		$	11,037
Operating loss		(1,034	)		(219	)		(360	)		(1,613	)
Depreciation and amortization		120			247			1			368
Assets		12,885			8,250			5,691			26,826
Expenditures for property, plant and equipment		354			269			1			624
As of and for the three months ended September 30, 2021
Net revenues from external customers	$	3,498		$	7,027		$	0		$	10,525
Operating profit (loss)		(587	)		12			(418	)		(993	)
Depreciation and amortization		98			235			0			333
Assets		13,549			10,030			9,789			33,368
Expenditures for property, plant and equipment		373			318			1			692

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL

CONDITION AND RESULTS OF OPERATIONS

(Dollars in thousands, except per share and admissions data)

Forward-Looking Statements

This Quarterly Report and the documents that are incorporated by reference in this Quarterly Report contain certain forward-looking statements within the meaning of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that do not relate solely to historical or current facts and may be identified by the use of words such as “may,” “believe,” “will,” “seeks to”, “expect,” “project,” “estimate,” “anticipate,” “plan” or “continue.” These forward-looking statements are based on the current plans and expectations and are subject to a number of risks, uncertainties and other factors which could significantly affect current plans and expectations and our future financial condition and results. Throughout this annual report and the notes to the condensed consolidated financial statements, SunLink Health Systems, Inc., and its consolidated subsidiaries are referred to on a collective basis as “SunLink”, “we”, “our”, “ours”, “us” or the “Company.” This drafting style is not meant to indicate that SunLink Health Systems, Inc. or any particular subsidiary of SunLink Health Systems, Inc. owns or operates any asset, business, or property. Healthcare services, pharmacy operations and other businesses described in this filing are owned and operated by distinct and indirect subsidiaries of SunLink Health System, Inc. These forward-looking statements are based on current plans and expectations and are subject to a number of risks, uncertainties and other factors that could significantly affect current plans and expectations and our future financial condition and results. These factors, which could cause actual results, performance, and achievements to differ materially from those anticipated, include, but are not limited to:

General Business Conditions

•

general economic and business conditions in the U.S., both nationwide and in the states in which we operate;

•

the effects of the coronavirus (“COVID-19”) pandemic, both nationwide and in the states in which we operate, including among other things, on demand for our customary services, the efficiency of such services, availability of staffing, availability of supplies, costs and financial results;

•

the effects of COVID-19 on our ability to provide for customary services including the large number of unvaccinated persons and plateaued or stagnant vaccination and booster rates in Georgia, Louisiana and Mississippi, the primary states in which we conduct healthcare operations. Future COVID-19 or other pandemics of other contagious diseases could result in the unavailability of personnel to provide services, regulatory bans on certain services or admissions, decreased occupancy levels, increase costs, reduce our revenues and otherwise adversely affect our business;

•

increases in uninsured and/or underinsured patients due to COVID-19, unemployment or other conditions, higher deductibles and co-insurance, or other terms of health insurance and drug coverage resulting in higher bad debt amounts;

•

the competitive nature of the U.S. community hospital, extended care and rehabilitation center, nursing home, and pharmacy businesses;

•

demographic characteristics and changes in areas where we operate, including resistance to vaccination for COVID-19;

•

any new variants of the COVID-19 virus and other SARS-COV-2 viruses and other infectious diseases;

•

the availability of cash or borrowings to fund working capital, renovations, replacements, expansions, and capital improvements at existing healthcare and pharmacy facilities and for acquisitions and replacement of such facilities;

•

changes in accounting principles generally accepted in the U.S.;

•

the impact of inflation on our patients, operating costs, ability and feasibility of raising funds, and on our ability to achieve cash flow and profitability, including our inability to cover cost increases because most of our revenue is from government programs whose payments are fixed; and

•

fluctuations in the market value of equity securities including SunLink common shares, including fluctuations based on fears of actual inflation or recession.

Operational Factors

•

the ability or inability to operate profitably in one or more segments of the healthcare business;

•

the availability of, and our ability to attract and retain, sufficient qualified staff physicians, management, nurses, pharmacists, and staff personnel for our operations;

•

timeliness and amount and conditions on of reimbursement payments received under government programs;

•

the lack of availability of future governmental support that may be required to offset the continuing effects of the COVID-19 pandemic and absence of forgiveness features in any such future loans or an inability to meet the usage or forgiveness requirements;

•

the ability to achieve compliance with requirements of the expenditure and retention of Provider Relief Funds (“PRF”);

•

the ability or inability to fund our obligations under capital leases or new or existing obligations and/or any existing or potential defaults under existing indebtedness;

•

restrictions imposed by existing or future contractual obligations including existing or new indebtedness;

•

the cost and availability of insurance coverage including professional liability (e.g., medical malpractice) and general, employment, fiduciary, and other liability insurance;

•

the efforts of governmental authorities, insurers, healthcare providers, and others to contain and reduce healthcare costs;

•

the impact on hospital, clinic, and nursing home services of the treatment of patients in alternative or lower acuity healthcare settings, such as with drug therapy, in surgery centers, and urgent care centers, retirement homes or at home;

•

changes in medical and other technology;

•

changes in estimates of self-insurance claims and reserves;

•

increases in prices of materials and services utilized in our Healthcare Services and Pharmacy segments;

•

increases in wages as a result of inflation or competition for physician, nursing, pharmacy, management, and staff positions;

•

any impairment in our ability to collect accounts receivable, including deductibles and co-pay amounts;

•

the functionality of or costs with respect to our information systems for our Healthcare Services and Pharmacy segments and our corporate office, including both software and hardware;

•

the availability of and competition from alternative drugs or treatments to those provided by our Pharmacy segment;

•

the restrictions, clawbacks, processes, and conditions relating to our Pharmacy segment imposed by pharmacy benefit managers, drug manufacturers, and distributors; and

•

the ability of our Pharmacy segment to sustain its claims for exemption from sales taxes position in Louisiana on any revenue from sales of products and services to beneficiaries of government insurance programs to the extent reimbursed by administrators of such programs.

Liabilities, Claims, Obligations and Other Matters

•

claims under leases, guarantees, disposition agreements, and other obligations relating to asset sales or discontinued operations, including claims from sold or leased facilities and services, retained liabilities or retained subsidiaries;

•

potential adverse consequences of any known and unknown government investigations;

•

claims for medical malpractice product, environmental or other liabilities from continuing and discontinued operations;

•

professional, general, and other claims which may be asserted against us, including claims based on a failure currently unknown to us of our physicians and other personnel to comply with COVID-19 vaccination mandates;

•

potential damages and consequences of natural disasters and weather-related events such as tornados, earthquakes, hurricanes, flooding, snow, ice and wind damage, and population evacuations affecting areas in which we operate; and

•

potential adverse contingencies of terrorist acts, crime or civil unrest.

Regulation and Governmental Activity

•

negative consequences of existing and proposed governmental budgetary constraints or modification or termination of existing government programs or the implementation and related costs and disruptions of new government programs such as environmental, social and governance programs;

•

negative consequences of Federal and state insurance exchanges and their rules relating to reimbursement terms;

•

the continuing decision by Mississippi (where we operate our remaining hospital and nursing home) to not expand Medicaid;

•

the regulatory environment for our businesses, including state certificate of need laws and regulations, pharmacy licensing laws and regulations, rules and judicial cases relating thereto;

•

changes in the levels and terms of government (including Medicare, Medicaid and other programs) and private reimbursement for SunLink’s healthcare services including the payment arrangements and terms of managed care agreements; indigent care and other reimbursements (Medicare Upper Payment Limit “UPL” and Disproportionate Share Hospital “DSH” adjustments) and governmental assessments for such programs;

•

the failure of government and private reimbursement to cover our increasing costs;

•

changes in or failure to comply with federal, state or local laws and regulations and enforcement interpretations of such laws and regulations affecting our Healthcare Services and Pharmacy segments; and

•

the possible enactment of additional federal healthcare reform laws or reform laws in states where our subsidiaries operate hospital and pharmacy facilities (including Medicaid waivers, bundled payments, managed care programs, accountable care and similar organizations, competitive bidding and other reforms).

Dispositions, Acquisition and Renovation Related Matters

•

the ability to dispose of underperforming facilities, underperforming business segments and surplus assets;

•

the availability of cash and the terms of capital to fund acquisitions or replacement facilities, improvements or renovations to existing facilities or both; and

•

competition in the market for acquisitions of hospitals, rehabilitation centers, nursing homes, pharmacy facilities, and other healthcare businesses.

The foregoing are significant factors we think could cause our actual results to differ materially from expected results. However, there could be additional factors besides those listed herein that also could affect SunLink in an adverse manner. You should read this Quarterly Report completely and with the understanding that actual future results may be materially different from what we expect. You are cautioned not to unduly rely on forward-looking statements when evaluating the information presented in this Quarterly Report or our other disclosures because current plans, anticipated actions, and future financial conditions and results may differ from those expressed in any forward-looking statements made by or on behalf of SunLink.

We have not undertaken any obligation to publicly update or revise any forward-looking statements. All of our forward-looking statements speak only as of the date of the document in which they are made or, if a date is specified, as of such date. We disclaim any obligation or undertaking to provide any updates or revisions to any forward-looking statement to reflect any change in our expectations or any changes in events, conditions, circumstances or information on which the forward-looking statement is based, except as required by applicable law. All subsequent written and oral forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the foregoing factors and the other risk factors set forth elsewhere in this report.

Business Strategy: Operations, Dispositions and Acquisitions

The business strategy of SunLink is to focus its efforts on improving its operations and services generally and achieving and maintaining profitability in its existing Healthcare Services and Pharmacy businesses. While the Company intends primarily to pursue its business strategy of improving its operations and services and achieving and maintaining profitability in its existing businesses, subject to available capital and other resources, the Company also intends to pursue growth by selective healthcare and pharmacy acquisitions. We believe; however, the COVID-19 pandemic and its aftermath has resulted in substantial additional uncertainties and risks in our businesses which are not subject to reliable estimation at this time, particularly because the COVID-19 is novel in nature, uncertain in duration, and materially affected by government actions related to the pandemic and its aftermath. In response to the pandemic, the Company has discontinued certain services, laid off or furloughed employees where necessary, reduced cash outlays where practicable, and deferred other strategic activities. Our ability to resume the pursuit of our normal business strategy, including growth initiatives, has been challenging and will depend on the effect of, among other things, the nature, extent and timing of the existing effects of COVID-19 pandemic, the end thereof, potential new COVID-19 or other pandemics, and government actions in response thereto.

The Company expects to use existing cash primarily to sustain it operations in response to the continuing impact of the COVID-19 pandemic, for growth initiatives, including acquisitions, when available and appropriate, and for other general corporate purposes. There is no assurance that any acquisitions or dispositions of assets will be authorized by the Company’s Board of Directors or, if authorized, that any such transactions will be completed. Although the Company believes certain portions of its businesses continue to under-perform, and the Company periodically entertains overtures for the purchase of its businesses, the Company is not currently offering any of its businesses for sale.

COVID-19 Pandemic and CARES Act Funding

government health and safety protocols and guidance issued in response to the COVID-19 pandemic, although such protocols and guidance have been subject to frequent changes and at times have been unclear. Nevertheless, as in many healthcare environments, we have experienced disruption of our operations, COVID-19 illness, including deaths, and some employees have tested positive and were placed on leave or in quarantine. We believe the effect of the COVID-19 pandemic and certain public and certain governmental responses to it have negatively affected our last eleven quarter’s results.

During the COVID-19 pandemic and aftermath, our Pharmacy business has experienced reduced sales trends in certain areas, increased costs and reduced staff. Many of our primary physician referral sources have been operating at reduced capacity, and until these referral sources resume operating at full capacity, we believe the COVID-19 pandemic will have continuing to effects on the demand for DME products and Retail and Institutional Pharmacy drugs and products. Reductions in employee hours have been made in response to the lower demand. Extended care facilities and rehabilitation centers, nursing homes and other customers of our Institutional Pharmacy services continue to be adversely affected by the COVID-19 pandemic. Our Institutional Pharmacy services have experienced increased costs and operational inefficiencies due to measures taken to protect our employees and by access controls and other restrictions implemented by our institutional customers. The impact of the COVID-19 pandemic and its aftermath also has and continues to negatively affected our supply processes and costs generally.

During the quarter ended June 30, 2020, our Healthcare and Pharmacy segments received $3,234 in Paycheck Protection Plan (“PPP”) loans provided under the CARES Act. These loans were forgivable upon compliance with conditions specified under the PPP loan program. As of September 30, 2022, all our PPP loans have been forgiven.

received have been used for designated, allowable healthcare-related expenses and capital expenditures attributable to COVID-19 and for "Lost Revenues" as defined by the department of “HHS”. We continue to monitor compliance with the terms and conditions of the PRF and developing interpretations and enforcement of PRF rules and regulations, as well as the impact of the pandemic on our revenues and expenses. If we are unable to attest to or comply with current or future terms and conditions, and there is no assurance we will be able to do so, our ability to retain some or all of the PRF received may be impacted, and we may have to return the unutilized portion of those funds, if any, in the future. The Company filed its Schedule of Grant Income of HHS awards and audit report for the year ended June 30, 2021 with the Health Resources and Services Administration (“HRSA”) agency of HHS on September 30, 2022.

The Company is unable to determine the extent to which the COVID-19 pandemic and its aftermath will continue to affect its assets and operations. Our ability to make estimates of the effect of the COVID-19 pandemic on revenues, expenses or changes in accounting judgments that have had or are reasonably likely to have a material effect on our financial statements is currently limited. The nature and extent of the continuing effect of the COVID-19 pandemic and its aftermath on our balance sheet and results of operations will depend on the severity and length of the pandemic or to evolving strains of COVID-19; any further government actions to address the pandemic's continuing effect; regulatory changes in response to the pandemic, especially those that affect our hospital, extended care, rehabilitation center, nursing home, clinics, and our pharmacy operations; existing and potential government assistance that may be provided; and the requirements of PRF receipts, including our ability to retain such PRF received.

For additional discussion of the risks presented by continuing effects of the COVID-19 pandemic to our results, see Risk Factors in Part II, Item 1A of this Form 10-Q.

Critical Accounting Estimates

The preparation of financial statements in accordance with U.S. GAAP requires us to make estimates and assumptions that affect reported amounts and related disclosures. We consider an accounting estimate to be critical if it requires assumptions to be made that were uncertain at the time the estimate was made; and changes in the estimate or different estimates that could have been made could have a material impact on our consolidated results of operations or financial condition.

Our critical accounting estimates are more fully described in our 2022 Annual Report on Form 10-K and continue to include the following areas: receivables – net and provision for doubtful accounts; revenue recognition and net patient service revenues; goodwill, intangible assets and accounting for business combinations; professional and general liability claims; and accounting for income taxes. There have been no material changes in our critical accounting estimates for the periods presented other than amounts readily computable from the financial statements included in this form 10-Q.

Financial Summary

The Company’s operations for the three months ended September 30, 2022 continued to be impacted by the effects of the COVID-19 pandemic, including among other factors, difficulty hiring qualified employees, rising labor

costs and supply chain challenges resulting in inability to obtain pharmacy and DME products on a timely, cost effective basis.

The results of continuing operations shown in the financial summary below are for our two business segments, Healthcare Services and Pharmacy.

	Three Months Ended
	September 30,
	2022			2021			% Change
Net Revenues - Healthcare Services	$	3,784		$	3,498			8.2	%
Net Revenues – Pharmacy		7,253			7,027			3.2	%
Total Net Revenues		11,037			10,525			4.9	%
Costs and expenses		(12,650	)		(11,518	)		9.8	%
Operating loss		(1,613	)		(993	)		62.4	%
Interest income (expense) – net		(4	)		(14	)		(71.4	)%
Federal stimulus - Provider relief funds		61			0		NA
Forgiveness of PPP loans and accrued interest		0			3,010		NA
Gain on sale of assets		12			5			140.0	%
Earnings (loss) from continuing operations before income taxes	$	(1,544	)	$	2,008		NA

Results of Operations

Our net revenues are from our two business segments, Healthcare Services and Pharmacy. The Company’s revenues by payor were as follows for the three months ended September 30, 2022 and 2021:

	Three Months Ended
	September 30,
	2022		2021
Medicare	$	5,013	$	5,055
Medicaid		2,856		2,368
Retail and Institutional Pharmacy		1,499		1,567
Managed Care & Other Insurance		1,385		1,320
Self-pay		259		184
Other		25		31
Total Net Revenues	$	11,037	$	10,525

The Healthcare Services segment in the current year is composed of one hospital, one extended care and rehabilitation center and four clinics, a subsidiary which provides information technology services to outside customers and SunLink subsidiaries and two subsidiaries holding undeveloped real estate. Healthcare Services net revenues increased $286, or 8%, for the three months period ended September 30, 2022 compared to the prior year period. Increased revenues from increased hospital and extended care patient days and increased clinic visit resulted in the net revenue increase this year.

Pharmacy segment net revenues for the three months period ended September 30, 2022 increased $226, or 3.2% from the three months period ended September 30, 2021. Institutional pharmacy sales increased 10.7% for the three month period ended September 30, 2022 from the prior year period due to a 4.3% increase in per script net revenues and 8.4% increase in scripts filled. Retail pharmacy sales increased 6.2% for the three month period ended September 30, 2022 from the prior year period due to a 12.8% increase in revenue per script filled. Durable Medical Equipment (“DME”) sales decreased 6.5% for the three month period ended September 30, 2022 from the prior year period primarily due to lower sales orders filled, despite a 1.9% increase in revenue per DME orders filled.

Costs and expenses, including depreciation and amortization, were $12,650 and $11,518 for the three months ended September 30, 2022 and 2021, respectively.

	Cost and Expenses as a % of Net Revenues
	Three Months Ended
	September 30,
	2022			2021
Cost of goods sold		39.6	%		38.7	%
Salaries, wages and benefits		48.3	%		44.6	%
Supplies		3.1	%		2.9	%
Purchased services		9.4	%		8.2	%
Other operating expenses		9.9	%		10.3	%
Rent and lease expense		1.1	%		1.6	%
Depreciation and amortization expense		3.3	%		3.2	%

Cost of goods sold as a percent of net revenues increased 0.9% in the three months ended September 30, 2022 compared to the prior fiscal year due to the higher cost of certain pharmaceuticals and DME products which resulted from supply chain issues. Salaries, wages and benefits expense as a percent of net revenues increased 3.7% this year compared to the prior fiscal quarter due to higher salaries and wages required in connection with current labor markets and operating challenges of labor allocation relating to the pandemic, including the use of contract labor. Purchased services cost increased this year due to increased cost of fuel, outsourcing at our Healthcare Services facility of certain services (due to challenges in hiring labor locally) and increased costs of software support services. Other operating expenses decreased 0.4% of net revenues due to decreased professional liability insurance expense. Depreciation expense also increased as a percentage of net revenue this year due to the $3,190 of capital expenditures last fiscal year.

Operating Loss

The Company reported an operating loss of $1,613 for the three months period ended September 30, 2022 compared to an operating loss of $993 for the three month period ended September 30, 2022. Such operating loss for the three month periods ended September 30, 2022 was primarily a result of higher operating costs not covered by the increased revenues.

Forgiveness of PPP loans and accrued interest

During the three months ended September 30, 2021, $2,972 of our PPP loans and related $38 of accrued interest were forgiven by the SBA and $3,010 was recorded as income relating to PPP loan.

Other Income – Federal Stimulus – Provider relief funds

As part of the CARES Act, two subsidiaries have received PRF payments. The Company recognized $61 and $0 during the three months ended September 30, 2022 and 2021, respectively.

Income Taxes

No income tax expense and income tax expense of $2 (all state taxes) was recorded for continuing operations for the three months ended September 30, 2022 and 2021, respectively.

forgiven PPP loan proceeds. It is the Company’s assumption at September 30, 2022 that all PPP loan associated expenses will be deductible for income tax.

The principal negative evidence that led us to determine at September 30, 2022 that all the deferred tax assets should have full valuation allowances was the projected current fiscal year tax loss. For purposes of evaluating our valuation allowances, we have disregarded unusual items associated with the CARES Act discussed above, the Company’s history of losses, as well as the underlying negative business conditions for rural healthcare businesses in which our Healthcare Services Segment businesses operate and have recognized none of our federal income tax net operating loss carry-forward of approximately $23,143.

Earnings (Loss) from Continuing Operations after Income Taxes

The loss from continuing operations after income tax was $1,544 for the three months ended September 30, 2022 as compared to income from continuing operations after income tax of $2,006 for the three months ended September 30, 2021. The loss from continuing operations this year compared to the prior year income from continuing operations was due to the non-reoccurrence of the PPP loan forgiveness this year.

Loss from Discontinued Operations after Income Taxes

The loss from discontinued operations after income taxes was $14 for the three month period ended September 30, 2022 compared to a loss from discontinued operations after income taxes of $67 for the three months period ended September 30, 2021.

Discontinued Operations

Sold Hospitals and Nursing Homes– Subsidiaries of the Company have sold substantially all the assets of four hospitals and a nursing home (“Sold Facilities”) during the period July 2, 2012 to March 17, 2019. The loss before income taxes on the Sold Facilities results primarily from the effects of retained professional liability insurance and claims expenses and settlement of a lawsuit.

Life Sciences and Engineering Segment —SunLink retained a defined benefit retirement plan which covered substantially all of the employees of this segment when the segment was sold in fiscal 1998. Effective February 28, 1997, the plan was amended to freeze participant benefits and close the plan to new participants. Pension expense and related tax benefit or expense is reflected in the results of operations for this segment for the three months ended September 30, 2022 and 2021, respectively.

Net Earnings (Loss)

Net loss for the three months period ended September 30, 2021 was $1,558 (a loss of $0.22 per fully diluted share) as compared to net income of $1,939 ($0.27 per fully diluted share) for the three months period ended September 30, 2021.

Liquidity and Capital Resources

Overview

Our primary source of liquidity is unrestricted cash on hand, which was $4,951 at September 30, 2022. The Company and its subsidiaries currently are funding working capital needs primarily from cash on hand. From time-to-time, we may, nevertheless, seek to obtain financing for the liquidity needs of the Company or individual subsidiaries based on anticipated need. However, currently, the Company’s ability to raise capital (debt or equity) in the public or private markets on what it considers acceptable terms is uncertain.

CARES Act Funds - The CARES Act was enacted by the U.S. government on March 27, 2020. Among the relief provided to health care providers under the CARES Act are grants under PRF and forgivable loans under PPP. We have received a total of $9,416 under the CARES Act programs consisting of $6,182 in general and targeted PRF and $3,234 of PPP loans. During the first two calendar quarters of 2021, the Company became eligible for, and we applied for $3,586 of ERC through amended quarterly payroll tax filings. Through the date of this filing, we have received $1,803 of ERC for which we filed amended payroll tax returns.

Subject to the effects, risks and uncertainties associated with the COVID-19 pandemic and our ability to retain the CARES funds described above, we believe we have adequate financing and liquidity to support our current level of operations through the next twelve months.

Contractual Obligations, Commitments and Contingencies

Contractual obligations, commitments and contingencies related to outstanding debt, noncancelable operating leases and interest on outstanding debt from continuing operations at September 30, 2022 were as follows:

Payments due within:	Long-Term Debt		Operating Leases		Interest on Outstanding Debt
1 year	$	41	$	359	$	1
2 years		3		351		0
3 years		0		327		0
4 years		0		124		0
5 years		0		11		0
Over 5 years		0		0		0
	$	44	$	1,172	$	1

As of September 30, 2022, we had outstanding debt of $44 of capital lease debt.

The Company expects to purchase approximately $1,000 of capitalizable DME by the Pharmacy segment (to be rented to customers) during the next twelve months. The timing and actual amount which will be expended is difficult to predict due to various factors including varying demand for such equipment as well as its availability given current supply sourcing challenges. Other capital expenditures for replacement and upgrade of current facilities and equipment of the Healthcare Services and Pharmacy segments will be needed during the next twelve months although there is no estimate of those expenditures. The Company anticipates funding such expenditures primarily from cash on hand. The Company has filed for $3,586 of ERC through filing amended payroll tax returns of which we have collected $1,803 through the date of this filing. We expect to collect the remaining $1,783 receivable in the next 12 months. Other cash expenditures for the next 12 months currently are expected to be in-line with expenditures for the quarter ended September 30, 2022, subject to further operating and administrative cost increases, and other settlements of cost reports in the ordinary course of business, and the Company’s ability to retain unrecognized CARES Act grants, PPP funds and ERC funds received or previously received. Other than reported above, there have been no material changes outside the ordinary course of business relating to our upcoming cash obligations which have occurred during the three months ended September 30, 2022. Other than with respect to scheduled cash expenditures (based on current operating levels) for long-term debt, operating leases, and interest on current outstanding debt, the debt, the specific items previously disclosed here, as well as continued uncertainties relating to the continuing impact of the COVID-19 pandemic, the Company is currently unaware of other trends or unusual uncertainties that are likely to cause a material change in its cash expenditures in periods beyond the next twelve months. See Notes 7, 9, 10, and 11 to our financial statements. The Company is also unaware of events that are reasonably likely to cause a material change in the relationship between its costs and revenues (such as known or reasonably likely future increases in costs of labor or

materials, price increases or inventory adjustments, beyond those discussed herein); however, we are unable to predict with any degree of accuracy when, or the extent to which, recent inflationary price trends, labor disruptions and supply chain challenges in 2021 and 2022 will mitigate.

Related Party Transactions

A director of the Company is a member of a law firm which provides services to SunLink. The Company expensed an aggregate of $55 and $50 for legal services to this law firm in the three months ended September 30, 2022 and 2021, respectively. Included in the Company’s condensed consolidated balance sheets at September 30 , 2022 and June 30, 2022 is $50 and $15, respectively, of amounts payable to this law firm.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We have not entered into any transactions using derivative financial instruments or derivative commodity instruments and believe that our exposure to market risk associated with other financial instruments (such as investments and borrowings) and interest rate risk is not material.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

As required by Rule 13a-15 and Rule 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”), as of the end of the period covered by this report, we carried out an evaluation of the effectiveness of the design and operation of our Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) and the changes in our disclosure controls and procedures during the quarter. Under the direction of our chief executive officer and chief financial officer, we evaluated our disclosure controls and procedures and internal control over financial reporting and concluded that our disclosure controls and procedures were effective as of September 30, 2022.

Disclosure controls and procedures and other procedures are designed to ensure that information required to be disclosed in our reports or submitted under the Exchange Act, such as this Quarterly Report on Form 10-Q, is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure.

Based on an evaluation of the effectiveness of disclosure controls and procedures performed in connection with the preparation of this Form 10-Q, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective as of September 30, 2022. The effect, if any, of the COVID-19 pandemic on the effectiveness of current disclosure controls and procedures in future periods is uncertain and we intend to revise the same, if any and to the extent deemed appropriate.

Changes in Internal Control Over Financial Reporting

There were no changes during the quarter ended September 30, 2022 in our internal control over financial reporting that materially affected, or is likely to materially affect, our internal controls over financial reporting. Notwithstanding staff absences and turnover and challenges hiring new and replacement staff, including in our financial departments, to date, we do not believe the COVID-19 pandemic has had any material effect on the effectiveness of our disclosure controls and procedures, however we cannot assure you that our internal controls will not be effected in the case of other pandemics or an intensified COVID-19 pandemic.

PART II. OTHER INFORMATION

Items required under Part II not specifically shown below are not applicable.

ITEM 1. LEGAL PROCEEDINGS

The Company and its subsidiaries are subject to various claims and litigation that arise from time to time in the ordinary course of business, including, among other things, tax, contract, workers compensation and medical malpractice claims and other claims and litigation. Medical malpractice and certain other claims are generally covered by malpractice, general liability or other insurance but are subject to provisions under which the Company retains a portion of the risk, which retention, particularly in the case of claims of medical malpractice, can be material. Based on current knowledge, the Company’s management does not believe that any current pending legal proceedings will have a material adverse effect on the Company’s consolidated financial position or its liquidity. However, in light of the uncertainties involved and indeterminate damages sought in some such legal proceedings, an adverse outcome could be material to our results of operations or cash flows in any reporting period.

ITEM 1A.

RISK FACTORS

Risk Factors Relating to an Investment in SunLink

Information regarding risk factors appears in “MD&A – Forward-Looking Statements,” in Part I – Item 2 of this Form 10-Q and in “MD&A - Risks Factors Relating to an Investment in SunLink” in Part I – Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2022. We believe there have been no material changes from the risk factors previously disclosed in such Annual Report and as set forth herein.

In addition to the matters set forth herein, the reader should carefully consider, in addition to the other information set forth in this report, the risk factors discussed in our Annual Report that could materially affect our business, financial condition or future results. Such risk factors are expressly incorporated herein by reference. The risks described in our Annual Report are not the only risks facing our Company. In addition to risks and uncertainties inherent in forward-looking statements contained in this Report on Form 10-Q, additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results. Whenever we refer to “SunLink,” “Company”, “we,” “our,” or “us” in this Item 1A, we mean SunLink Health Systems, Inc. and its subsidiaries, unless the context suggests otherwise.

ITEM 6.EXHIBITS

Exhibits:

31.1		Chief Executive Officer’s Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

31.2		Chief Financial Officer’s Certification Pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934.

32.1		Chief Executive Officer’s Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2		Chief Financial Officer’s Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		The following materials from the Company’s Quarterly Report on Form 10-Q for the three months ended September 30, 2022, formatted in iXBRL (eXtensible Business Reporting Language): (i) Condensed Consolidated Balance Sheets as of September 30, 2022 (unaudited) and June 30, 2022, (ii) Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) for the three months ended September 30, 2022 and 2021 (unaudited), (iii) Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2022 and 2021 (unaudited), and (iv) Notes to Condensed Consolidated Financial Statements (unaudited), tagged as blocks of text.

104

Cover Page Interactive Data File (formatted as Inline XRBL with the applicable taxonomy extension information in Exhibit 101.)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, SunLink Health Systems, Inc. has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



SunLink Health Systems, Inc.

By:	/s/ Mark J. Stockslager
	Mark J. Stockslager
	Chief Financial Officer

Dated: November 14, 2022

EX-31.1 2 ssy-ex311_9.htm EX-31.1 ssy-ex311_9.htm

Exhibit 31.1

CERTIFICATION

I, Robert M. Thornton, Jr., the Chief Executive Officer of SunLink Health Systems, Inc. (the “registrant”), certify that:

(1) I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended September 30, 2022 (the “report”);

(2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

(3) Based on my knowledge, the financial statements and other financial information included in this report fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

(4) The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of September 30, 2022 (the “Evaluation Date”), based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

(5) The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 14, 2022		/s/ Robert M. Thornton, Jr.
		Robert M. Thornton, Jr.
		SunLink Health Systems, Inc.
		Chief Executive Officer

EX-31.2 3 ssy-ex312_6.htm EX-31.2 ssy-ex312_6.htm

Exhibit 31.2

CERTIFICATION

I, Mark J. Stockslager, the Chief Financial Officer of SunLink Health Systems, Inc. (the “registrant”), certify that:

(1) I have reviewed this quarterly report on Form 10-Q of the registrant for the period ended September 30, 2022 (the “report”);

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

November 14, 2022		/s/ Mark J. Stockslager
		Mark J. Stockslager
		SunLink Health Systems, Inc.
		Chief Financial Officer

EX-32.1 4 ssy-ex321_8.htm EX-32.1 ssy-ex321_8.htm

Exhibit 32.1

SUNLINK HEALTH SYSTEMS, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of SunLink Health Systems, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), I, Robert M. Thornton, Jr., Chief Executive Officer of the Company, do hereby certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


November 14, 2022	By:	/s/ Robert M. Thornton, Jr.
		Robert M. Thornton, Jr.
		Chief Executive Officer

EX-32.2 5 ssy-ex322_7.htm EX-32.2 ssy-ex322_7.htm

Exhibit 32.2

SUNLINK HEALTH SYSTEMS, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of SunLink Health Systems, Inc. (the “Company”) on Form 10-Q for the quarterly period ended September 30, 2022, as filed with the United States Securities and Exchange Commission on the date hereof (the “Report”), I, Mark J. Stockslager, Chief Financial Officer of the Company, do hereby certify, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

November 14, 2022			/s/ Mark J. Stockslager
			Mark J. Stockslager
			SunLink Health Systems, Inc.
			Chief Financial Officer

EX-101.SCH 6 ssy-20220930.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements Shareholders' Equity link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Basis of Presentation link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Business Operations link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Shareholders' Equity link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Revenue link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Intangible Assets link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Long-Term Debt link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Leases link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Accrued Sales Tax link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Related Party Transactions link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Financial Information by Segment link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Basis of Presentation (Policies) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Revenue (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Long-Term Debt (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Leases (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Financial Information by Segment (Tables) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Business Operations - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Discontinued Operations - Components of Pension Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Discontinued Operations - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Shareholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Revenue - Summary of Revenue by Payor (Detail) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Revenue - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Intangible Assets - Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Lease - Components of Lease Cost and Rent Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Lease - Summary of Non-cancellable Operating and Finance Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Lease - Summary of Non-cancellable Operating and Finance Leases (Detail)2 link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Accrued Sales Tax - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Related Party Transactions - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Financial Information by Segment - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Financial Information by Segment - Segment Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 ssy-20220930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 ssy-20220930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 ssy-20220930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Lessee operating lease liability payments due after year four. Finance lease liability payments due after year four. Cover [Abstract] Document Information [Table] Document Information [Table] Class of Stock Statement Class Of Stock [Axis] Class of Stock Class Of Stock [Domain] Common Stock [Member] Common Stock [Member] Preferred Share Purchase Rights. Preferred Share Purchase Rights [Member] Preferred Share Purchase Rights [Member] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Trading Symbol Trading Symbol No Trading Symbol Flag No Trading Symbol Flag Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Entity Filer Category Entity Filer Category Entity Shell Company Entity Shell Company Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Employee retention credits receivable current. Unearned CARES Act funds. Professional liability risks, noncurrent. Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Current Assets: Assets Current [Abstract] Cash and cash equivalents Cash And Cash Equivalents At Carrying Value Receivables - net Receivables Net Current Inventory Inventory Net Employee retention credits receivable Employee Retention Credits Receivable Current Prepaid expense and other assets Prepaid Expense And Other Assets Current Total current assets Assets Current Property, plant and equipment, at cost Property Plant And Equipment Gross Less accumulated depreciation Accumulated Depreciation Depletion And Amortization Property Plant And Equipment Property, plant and equipment - net Property Plant And Equipment Net Noncurrent Assets: Assets Noncurrent [Abstract] Intangible assets - net Intangible Assets Net Excluding Goodwill Right of use assets Operating Lease Right Of Use Asset Other noncurrent assets Other Assets Noncurrent Total noncurrent assets Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment TOTAL ASSETS Assets LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities And Stockholders Equity [Abstract] Current liabilities: Liabilities Current [Abstract] Accounts payable Accounts Payable Current Current maturities of long-term debt Long Term Debt Current Accrued payroll and related taxes Employee Related Liabilities Current Accrued sales tax Sales And Excise Tax Payable Current Unearned CARES Act Funds Unearned C A R E S Act Funds Current operating lease liabilities Operating Lease Liability Current Other accrued expenses Other Liabilities Current Total current liabilities Liabilities Current Long-Term Liabilities Liabilities Noncurrent [Abstract] Long-term debt Long Term Debt Noncurrent Noncurrent liability for professional liability risks Professional Liability Risks Non Current Long-term operating lease liabilities Operating Lease Liability Noncurrent Deferred income taxes Deferred Income Tax Liabilities Net Other noncurrent liabilities Other Liabilities Noncurrent Total long-term liabilities Liabilities Noncurrent Commitments and Contingencies Commitments And Contingencies Shareholders’ Equity Stockholders Equity [Abstract] Preferred Shares, authorized and unissued, 2,000 shares Preferred Stock Value Common Shares, without par value: Issued and outstanding, 7,032 shares at September 30, 2022 and 6,954 at June 30, 2022 Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Retained earnings Retained Earnings Accumulated Deficit Accumulated other comprehensive loss Accumulated Other Comprehensive Income Loss Net Of Tax Total Shareholders’ Equity Stockholders Equity Including Portion Attributable To Noncontrolling Interest TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY Liabilities And Stockholders Equity Preferred shares, authorized Preferred Stock Shares Authorized Preferred shares, unissued Preferred Stock Share Subscriptions Common shares, without par value Common Stock No Par Value Common shares, issued Common Stock Shares Issued Common shares, outstanding Common Stock Shares Outstanding Forgiveness of PPP loans and accrued interest. Federal stimulus provider relief funds. Earnings (loss) per share continuing operations. Earnings (loss) per share discontinued operations. Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Product [Member] Product [Member] Service [Member] Service [Member] Statement [Line Items] Statement [Line Items] Net revenues Revenue From Contract With Customer Excluding Assessed Tax Costs and Expenses Costs And Expenses [Abstract] Cost of goods sold Cost Of Goods And Services Sold Salaries, wages and benefits Labor And Related Expense Supplies Supplies Expense Other operating expenses Other Cost And Expense Operating Rent and lease expense Operating Lease Expense Depreciation and amortization Depreciation And Amortization Operating Loss Operating Income Loss Other Income (Expense): Nonoperating Income Expense [Abstract] Gains on sale of assets Gains Losses On Sales Of Assets Forgiveness of PPP loans and accrued interest Forgiveness Of P P P Loans And Accrued Interest Federal stimulus - Provider relief funds Federal Stimulus Provider Relief Funds Interest income (expense), net Interest Income Expense Net Earnings (Loss) from Continuing Operations before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income Tax Expense (Benefit) Income Tax Expense Benefit Earnings (Loss) from Continuing Operations Income Loss From Continuing Operations Loss from Discontinued Operations, net of tax Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity Net Earnings (Loss) Net Income Loss Other comprehensive income Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent Comprehensive Earnings (Loss) Comprehensive Income Net Of Tax Continuing Operations: Earnings Loss Per Share Continuing Operations [Abstract] Basic Income Loss From Continuing Operations Per Basic Share Diluted Income Loss From Continuing Operations Per Diluted Share Discontinued Operations: Earnings Loss Per Share Discontinued Operations [Abstract] Basic Income Loss From Discontinued Operations Net Of Tax Per Basic Share Diluted Income Loss From Discontinued Operations Net Of Tax Per Diluted Share Net Earnings (Loss): Earnings Per Share [Abstract] Basic Earnings Per Share Basic Diluted Earnings Per Share Diluted Weighted-Average Common Shares Outstanding: Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common shares. Common Shares [Member] Common Shares [Member] Additional Paid-in Capital [Member] Additional Paid In Capital [Member] Retained Earnings (Loss) [Member] Retained Earnings [Member] Accumulated Other Comprehensive Loss [Member] Accumulated Other Comprehensive Loss [Member] Accumulated Other Comprehensive Loss [Member] Beginning Balance Beginning Balance,Shares Share options exercised Stock Issued During Period Value Stock Options Exercised Share options exercised, Shares Stock Issued During Period Shares Stock Options Exercised Net earnings (loss) Ending Balance Ending Balance, Shares Proceeds from share option exercises. Interest paid received net. Right of use asset obtained in exchange for lease liability. Supplemental cash flow information cash paid for received from income taxes and interest. Statement Of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities Net Cash Provided By Used In Operating Activities Cash Flows Used in Investing Activities: Net Cash Provided By Used In Investing Activities [Abstract] Expenditures for property, plant and equipment Payments To Acquire Property Plant And Equipment Proceeds from share option exercises Proceeds From Share Option Exercises Proceeds from sale of other assets Proceeds From Sale Of Other Assets Investing Activities Net Cash Used in Investing Activities Net Cash Provided By Used In Investing Activities Cash Flows Used in Financing Activities: Net Cash Provided By Used In Financing Activities [Abstract] Payments on long-term debt Repayments Of Long Term Debt Net Cash Used in Financing Activities Net Cash Provided By Used In Financing Activities Net Decrease in Cash and Cash Equivalents Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect Cash and Cash Equivalents Beginning of Period Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Cash and Cash Equivalents End of Period Supplemental Disclosure of Cash Flow Information: Supplemental Cash Flow Information [Abstract] Cash Paid (Received) for: Supplemental Cash Flow Information Cash Paid For Received From Income Taxes And Interest [Abstract] Interest Interest Paid Received Net Income taxes Income Taxes Paid Net Non-cash investing and financing activities: Noncash Investing And Financing Items [Abstract] Right-of-use assets obtained in exchange for lease liabilities Right Of Use Asset Obtained In Exchange For Lease Liability Organization Consolidation And Presentation Of Financial Statements [Abstract] Basis of Presentation Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block] Business Operations Nature Of Operations Discontinued Operations And Disposal Groups [Abstract] Discontinued Operations Disposal Groups Including Discontinued Operations Disclosure [Text Block] Federal Home Loan Banks [Abstract] Shareholders' Equity Stockholders Equity Note Disclosure [Text Block] Revenue From Contract With Customer [Abstract] Revenue Revenue From Contract With Customer [Text Block] Goodwill And Intangible Assets Disclosure [Abstract] Intangible Assets Intangible Assets Disclosure [Text Block] Debt Disclosure [Abstract] Long-Term Debt Long Term Debt [Text Block] Income Tax Disclosure [Abstract] Income Taxes Income Tax Disclosure [Text Block] Operating leases and finance leases of lessee disclosure. Leases [Abstract] Leases Operating Leases And Finance Leases Of Lessee Disclosure [Text Block] Sales tax payable. Payables And Accruals [Abstract] Accrued Sales Tax Sales Tax Payable [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Related Party Transactions [Abstract] Related Party Transactions Related Party Transactions Disclosure [Text Block] Segment Reporting [Abstract] Financial Information by Segment Segment Reporting Disclosure [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Pension expense. Components of Pension Expense Pension Expense Table [Text Block] Summary of Revenues by Payor Disaggregation Of Revenue Table [Text Block] Schedule of intangible assets excluding goodwill. Intangible Assets Schedule Of Intangible Assets Excluding Goodwill Table [Text Block] Long term obligations. Summary of Long-Term Debt Long Term Obligations [Text Block] Components of Lease Cost and Rent Expense Lease Cost Table [Text Block] Summary Of Supplemental Balance Sheet Information. Summary of Supplemental Balance Sheet Information Summary Of Supplemental Balance Sheet Information Table [Text Block] Summary Of Supplemental Cash Flow And Other Information Related To Leases. Summary of Supplemental Cash Flow and Other Information Related to Leases Summary Of Supplemental Cash Flow And Other Information Related To Leases Table [Text Block] Summary of non-cancellable operating and finance leases. Summary of Non-cancellable Operating and Finance Leases Summary Of Non Cancellable Operating And Finance Leases Table [Text Block] Schedule of Contractual Obligations, Commitments and Contingencies EX-101.PRE 10 ssy-20220930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT

Document and Entity Information - shares	3 Months Ended
Document and Entity Information - shares	Sep. 30, 2022	Nov. 14, 2022
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2022
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Entity Registrant Name	SUNLINK HEALTH SYSTEMS, INC.
Entity Central Index Key	0000096793
Current Fiscal Year End Date	--06-30
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Common Stock, Shares Outstanding		7,031,603
Entity File Number	1-12607
Entity Incorporation, State or Country Code	OH
Entity Tax Identification Number	31-0621189
Entity Address, Address Line One	900 Circle 75 Parkway
Entity Address, Address Line Two	Suite 690
Entity Address, City or Town	Atlanta
Entity Address, State or Province	GA
Entity Address, Postal Zip Code	30339
City Area Code	770
Local Phone Number	933-7000
Document Quarterly Report	true
Document Transition Report	false
Common Stock [Member]
Document Information [Line Items]
Trading Symbol	SSY
Title of 12(b) Security	Common Shares without par value
Security Exchange Name	NYSEAMER
Preferred Share Purchase Rights [Member]
Document Information [Line Items]
No Trading Symbol Flag	true
Title of 12(b) Security	Preferred Share Purchase Rights
Security Exchange Name	NONE

XML 12 R2.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Current Assets:
Cash and cash equivalents	$ 4,951	$ 6,794
Receivables - net	4,686	4,624
Inventory	1,842	1,748
Employee retention credits receivable	1,761	1,761
Prepaid expense and other assets	2,166	1,888
Total current assets	15,406	16,815
Property, plant and equipment, at cost	23,859	23,920
Less accumulated depreciation	15,377	15,703
Property, plant and equipment - net	8,482	8,217
Noncurrent Assets:
Intangible assets - net	1,195	1,201
Right of use assets	1,113	1,187
Other noncurrent assets	630	523
Total noncurrent assets	2,938	2,911
TOTAL ASSETS	26,826	27,943
Current liabilities:
Accounts payable	1,831	1,347
Current maturities of long-term debt	41	40
Accrued payroll and related taxes	1,344	1,520
Accrued sales tax	2,777	2,600
Unearned CARES Act Funds	469	519
Current operating lease liabilities	354	352
Other accrued expenses	1,347	1,313
Total current liabilities	8,163	7,691
Long-Term Liabilities
Long-term debt	3	14
Noncurrent liability for professional liability risks	87	86
Long-term operating lease liabilities	780	857
Deferred income taxes	69	69
Other noncurrent liabilities	114	106
Total long-term liabilities	1,053	1,132
Commitments and Contingencies
Shareholders’ Equity
Preferred Shares, authorized and unissued, 2,000 shares	0	0
Common Shares, without par value: Issued and outstanding, 7,032 shares at September 30, 2022 and 6,954 at June 30, 2022	3,516	3,478
Additional paid-in capital	10,746	10,736
Retained earnings	3,242	4,800
Accumulated other comprehensive loss	106	106
Total Shareholders’ Equity	17,610	19,120
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 26,826	$ 27,943

XML 13 R3.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Sep. 30, 2022	Jun. 30, 2022
Statement Of Financial Position [Abstract]
Preferred shares, authorized	2,000,000	2,000,000
Preferred shares, unissued	2,000,000	2,000,000
Common shares, without par value
Common shares, issued	7,032,000	6,954,000
Common shares, outstanding	7,032,000	6,954,000

XML 14 R4.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Net revenues	$ 11,037	$ 10,525
Costs and Expenses
Salaries, wages and benefits	5,330	4,698
Supplies	337	300
Other operating expenses	1,093	1,082
Rent and lease expense	118	170
Depreciation and amortization	368	333
Operating Loss	(1,613)	(993)
Other Income (Expense):
Gains on sale of assets	12	5
Forgiveness of PPP loans and accrued interest	0	3,010
Federal stimulus - Provider relief funds	61	0
Interest income (expense), net	(4)	(14)
Earnings (Loss) from Continuing Operations before income taxes	(1,544)	2,008
Income Tax Expense (Benefit)	0	2
Earnings (Loss) from Continuing Operations	(1,544)	2,006
Loss from Discontinued Operations, net of tax	(14)	(67)
Net Earnings (Loss)	(1,558)	1,939
Other comprehensive income	0	0
Comprehensive Earnings (Loss)	$ (1,558)	$ 1,939
Continuing Operations:
Basic	$ (0.22)	$ 0.29
Diluted	(0.22)	0.28
Discontinued Operations:
Basic	0.00	(0.01)
Diluted	0.00	(0.01)
Net Earnings (Loss):
Basic	(0.22)	0.28
Diluted	$ (0.22)	$ 0.27
Weighted-Average Common Shares Outstanding:
Basic	6,983	6,924
Diluted	6,983	7,095
Product [Member]
Costs and Expenses
Cost of goods sold	$ 4,369	$ 4,073
Service [Member]
Costs and Expenses
Cost of goods sold	$ 1,035	$ 862

XML 15 R5.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements Shareholders' Equity - USD ($) $ in Thousands	Total	Common Shares [Member]	Additional Paid-in Capital [Member]	Retained Earnings (Loss) [Member]	Accumulated Other Comprehensive Loss [Member]
Beginning Balance at Jun. 30, 2021	$ 20,810	$ 3,463	$ 10,700	$ 6,809	$ (162)
Beginning Balance,Shares at Jun. 30, 2021		6,924,000
Net earnings (loss)	1,939			1,939
Ending Balance at Sep. 30, 2021	22,749	$ 3,463	10,700	8,748	(162)
Ending Balance, Shares at Sep. 30, 2021		6,924,000
Beginning Balance at Jun. 30, 2022	$ 19,120	$ 3,478	10,736	4,800	106
Beginning Balance,Shares at Jun. 30, 2022	6,954,000	6,954,000
Share options exercised	$ 48	$ 38	10
Share options exercised, Shares	77,452	78,000
Net earnings (loss)	$ (1,558)			(1,558)
Ending Balance at Sep. 30, 2022	$ 17,610	$ 3,516	$ 10,746	$ 3,242	$ 106
Ending Balance, Shares at Sep. 30, 2022	7,032,000	7,032,000

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 24
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 23
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 326
-SubTopic 10
-Section 65
-Paragraph 4
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 105
-SubTopic 10
-Section 65
-Paragraph 6
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 16
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(3)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 45
-Paragraph 5
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793

Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(2)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 848
-SubTopic 10
-Section 65
-Paragraph 2
-Subparagraph (a)(3)(iii)(03)
-URI https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 65
-Paragraph 8
-Subparagraph (d)(3)
-URI https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(2)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 22: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4I
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 40
-Section 65
-Paragraph 2
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 830
-SubTopic 30
-Section 45
-Paragraph 20
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900

Reference 25: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (f)(1)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 65
-Paragraph 15
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333

+ Details

XML 16 R6.htm IDEA: XBRL DOCUMENT

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Statement Of Cash Flows [Abstract]
Net Cash Provided by (Used in) Operating Activities	$ (1,271)	$ (334)
Cash Flows Used in Investing Activities:
Expenditures for property, plant and equipment	(624)	(692)
Proceeds from share option exercises	49	0
Proceeds from sale of other assets	13	5
Net Cash Used in Investing Activities	(562)	(687)
Cash Flows Used in Financing Activities:
Payments on long-term debt	(10)	(8)
Net Cash Used in Financing Activities	(10)	(8)
Net Decrease in Cash and Cash Equivalents	(1,843)	(1,029)
Cash and Cash Equivalents Beginning of Period	6,794	9,962
Cash and Cash Equivalents End of Period	4,951	8,933
Cash Paid (Received) for:
Interest	4	(1)
Income taxes	0	(293)
Non-cash investing and financing activities:
Right-of-use assets obtained in exchange for lease liabilities	$ 7	$ 35

XML 17 R7.htm IDEA: XBRL DOCUMENT

Basis of Presentation

3 Months Ended

Sep. 30, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation

Note 1. –Basis of Presentation

XML 18 R8.htm IDEA: XBRL DOCUMENT

Business Operations

3 Months Ended

Sep. 30, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Business Operations

Note 2. – Business Operations

Healthcare Services

The Health Services segment includes the following:

•

A subsidiary, SunLink Health Systems Technology (“SHS Technology”), which provides information technology (“IT”) services to outside customers and to SunLink subsidiaries.

•

A subsidiary which owns approximately five (5) acres of unimproved land in Houston, Mississippi, and

•

A subsidiary which owns approximately 25 acres of unimproved land in Ellijay, Georgia.

Pharmacy

The Pharmacy segment is composed of three operational areas:

•

COVID-19 Pandemic and CARES Act Funding

compliance with conditions specified under the PPP loan program. As of September 30, 2022, all our PPP loans have been forgiven.

XML 19 R9.htm IDEA: XBRL DOCUMENT

Discontinued Operations

3 Months Ended

Sep. 30, 2022

Discontinued Operations And Disposal Groups [Abstract]

Discontinued Operations

Note 3. – Discontinued Operations

The components of pension expense for the three months ended September 30, 2022 and 2021, respectively, were as follows:

	Three Months Ended
	September 30,
	2022			2021
Interest Cost	$	13		$	11
Expected return on assets		(11	)		(11	)
Amortization of prior service cost		0			11
Net pension expense	$	2		$	11

SunLink contributed $22 to the plan in the three months ended September 30, 2022 and expects to contribute an additional $66 during the last nine months of the fiscal year ending June 30, 2023.

XML 20 R10.htm IDEA: XBRL DOCUMENT

Shareholders' Equity

3 Months Ended

Sep. 30, 2022

Federal Home Loan Banks [Abstract]

Shareholders' Equity

Note 4. – Shareholders’ Equity

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-URI https://asc.fasb.org/topic&trid=2208762

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 14
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 18
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 16
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(e)(1))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008

+ Details

XML 21 R11.htm IDEA: XBRL DOCUMENT

Revenue

3 Months Ended

Sep. 30, 2022

Revenue From Contract With Customer [Abstract]

Revenue

Note 5. – Revenue

Revenues by payor were as follows for the three months ended September 30, 2022 and 2021:

	Three Months Ended
	September 30,
	2022		2021
Medicare	$	5,013	$	5,055
Medicaid		2,856		2,368
Retail and Institutional Pharmacy		1,499		1,567
Managed Care & Other Insurance		1,385		1,320
Self-pay		259		184
Other		25		31
Total Net Revenues	$	11,037	$	10,525

No settlements of prior year Medicare and Medicaid cost reports were recorded in the three months ended September 30, 2022 and 2021, respectively.

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

XML 22 R12.htm IDEA: XBRL DOCUMENT

Intangible Assets

3 Months Ended

Sep. 30, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 6. – Intangible Assets

Intangibles consist of the following, net of amortization:

	September 30, 2022			June 30, 2022
Pharmacy Segment Intangibles
Trade Name (non-amortizing)	$	1,180		$	1,180
Customer Relationships		1,089			1,089
Medicare License		623			623
		2,892			2,892
Accumulated Amortization		(1,697	)		(1,691	)
Net Intangibles	$	1,195		$	1,201

Amortization expense was $6 and $7 for the three months ended September 30, 2022 and 2021, respectively.

XML 23 R13.htm IDEA: XBRL DOCUMENT

Long-Term Debt

3 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Long-Term Debt

Note 7. – Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2022			June 30, 2022
Capital Lease	$	44		$	54
Less current maturities		(41	)		(40	)
Long-term Debt	$	3		$	14

XML 24 R14.htm IDEA: XBRL DOCUMENT

Income Taxes

3 Months Ended

Sep. 30, 2022

Income Tax Disclosure [Abstract]

Income Taxes

Note 8. – Income Taxes

No income tax expense and income tax expense of $2 (all state taxes) was recorded for continuing operations for the three months ended September 30, 2022 and 2021, respectively.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

XML 25 R15.htm IDEA: XBRL DOCUMENT

Leases

3 Months Ended

Sep. 30, 2022

Leases [Abstract]

Leases

Note 9. – Leases

	Three Months Ended		Three Months Ended
Lease Cost	September 30, 2022		September 30, 2021
Operating lease cost:
Operating lease cost	$	90	$	125
Short-term rent expense		27		44
Variable lease cost		1		1
Total operating lease cost	$	118	$	170

Finance lease cost:
Amortization right-of-use assets	$	9	$	9
Interest on finance lease liabilities		1		1
Total finance lease cost	$	10	$	10

Supplemental balance sheet information relating to leases was as follows:

		As of		As of
		September 30		June 30,
		2022		2022
Operating Leases:	Balance Sheet Classifications
Operating Lease ROU Assets	ROU Assets	$	1,113	$	1,187

Finance Leases:
Finance Lease ROU Assets	Property, plant and equipment		203		203
Accumulated amortization	Accumulated depreciation		108		101
Current finance lease liabilities	Current maturities of long-term debt		41		40
Long-term finance lease liabilities	Long-term debt		3		14

Supplemental cash flow and other information related to leases as of and for the three months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended
Other information	September 30, 2022			September 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	91		$	126
Operating cash flows from finance leases		1			1
Financing cash flow from finance leases		10			9
Right-of-use assets obtained in exchange for new operating lease liabilities		7			35
Weighted-average remaining lease term:
Operating leases	1.16 years			2.16 years
Finance leases	3.27 years			3.95 years
Weighted-average discount rate:
Operating leases		1.01	%		1.35	%
Finance leases		6.54	%		6.54	%

Commitments relating to non-cancellable operating and finance leases as of September 30, 2022 for each of the next five years and thereafter are as follows:

Payments due within	Operating Leases			Finance Leases
1 year	$	359		$	42
2 years		351			3
3 years		327			0
4 years		124			0
5 years		11			0
Over 5 years		0			0
Total minimum future payments		1,172			45
Less: Imputed interest		(38	)		(1	)
Total liabilities		1,134			44
Less: Current portion		(354	)		(41	)
Long-term liabilities	$	780		$	3

XML 26 R16.htm IDEA: XBRL DOCUMENT

Accrued Sales Tax

3 Months Ended

Sep. 30, 2022

Payables And Accruals [Abstract]

Accrued Sales Tax

Note 10. – Accrued Sales Tax

XML 27 R17.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies

3 Months Ended

Sep. 30, 2022

Commitments And Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 11. – Commitments and Contingencies

Contractual obligations, commitments and contingencies related to outstanding debt and interest (excluding leases, see Note 9) in continuing operations at September 30, 2022 were as follows:

Payments due within:	Long-Term Debt		Interest on Outstanding Debt
1 year	$	41	$	1
2 years		3		0
3 years		0		0
4 years		0		0
5 years		0		0
	$	44	$	1

XML 28 R18.htm IDEA: XBRL DOCUMENT

Related Party Transactions

3 Months Ended

Sep. 30, 2022

Related Party Transactions

Note 12. – Related Party Transactions

XML 29 R19.htm IDEA: XBRL DOCUMENT

Financial Information by Segment

3 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Financial Information by Segment

Note 13. – Financial Information by Segment

	Healthcare Services			Pharmacy			Corporate and Other			Total
As of and for the three months ended September 30, 2022
Net revenues from external customers	$	3,784		$	7,253		$	0		$	11,037
Operating loss		(1,034	)		(219	)		(360	)		(1,613	)
Depreciation and amortization		120			247			1			368
Assets		12,885			8,250			5,691			26,826
Expenditures for property, plant and equipment		354			269			1			624
As of and for the three months ended September 30, 2021
Net revenues from external customers	$	3,498		$	7,027		$	0		$	10,525
Operating profit (loss)		(587	)		12			(418	)		(993	)
Depreciation and amortization		98			235			0			333
Assets		13,549			10,030			9,789			33,368
Expenditures for property, plant and equipment		373			318			1			692

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

XML 30 R20.htm IDEA: XBRL DOCUMENT

Basis of Presentation (Policies)

3 Months Ended

Sep. 30, 2022

Organization Consolidation And Presentation Of Financial Statements [Abstract]

Basis of Presentation

XML 31 R21.htm IDEA: XBRL DOCUMENT

Discontinued Operations (Tables)

3 Months Ended

Sep. 30, 2022

Discontinued Operations And Disposal Groups [Abstract]

Components of Pension Expense

The components of pension expense for the three months ended September 30, 2022 and 2021, respectively, were as follows:

	Three Months Ended
	September 30,
	2022			2021
Interest Cost	$	13		$	11
Expected return on assets		(11	)		(11	)
Amortization of prior service cost		0			11
Net pension expense	$	2		$	11

XML 32 R22.htm IDEA: XBRL DOCUMENT

Revenue (Tables)

3 Months Ended

Sep. 30, 2022

Revenue From Contract With Customer [Abstract]

Summary of Revenues by Payor

Revenues by payor were as follows for the three months ended September 30, 2022 and 2021:

	Three Months Ended
	September 30,
	2022		2021
Medicare	$	5,013	$	5,055
Medicaid		2,856		2,368
Retail and Institutional Pharmacy		1,499		1,567
Managed Care & Other Insurance		1,385		1,320
Self-pay		259		184
Other		25		31
Total Net Revenues	$	11,037	$	10,525

XML 33 R23.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

3 Months Ended

Sep. 30, 2022

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

Intangibles consist of the following, net of amortization:

	September 30, 2022			June 30, 2022
Pharmacy Segment Intangibles
Trade Name (non-amortizing)	$	1,180		$	1,180
Customer Relationships		1,089			1,089
Medicare License		623			623
		2,892			2,892
Accumulated Amortization		(1,697	)		(1,691	)
Net Intangibles	$	1,195		$	1,201

XML 34 R24.htm IDEA: XBRL DOCUMENT

Long-Term Debt (Tables)

3 Months Ended

Sep. 30, 2022

Debt Disclosure [Abstract]

Summary of Long-Term Debt

Long-term debt consisted of the following:

	September 30, 2022			June 30, 2022
Capital Lease	$	44		$	54
Less current maturities		(41	)		(40	)
Long-term Debt	$	3		$	14

XML 35 R25.htm IDEA: XBRL DOCUMENT

Leases (Tables)

3 Months Ended

Sep. 30, 2022

Leases [Abstract]

Components of Lease Cost and Rent Expense

The components of lease cost and rent expense for the three months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended		Three Months Ended
Lease Cost	September 30, 2022		September 30, 2021
Operating lease cost:
Operating lease cost	$	90	$	125
Short-term rent expense		27		44
Variable lease cost		1		1
Total operating lease cost	$	118	$	170

Finance lease cost:
Amortization right-of-use assets	$	9	$	9
Interest on finance lease liabilities		1		1
Total finance lease cost	$	10	$	10

Summary of Supplemental Balance Sheet Information

Supplemental balance sheet information relating to leases was as follows:

		As of		As of
		September 30		June 30,
		2022		2022
Operating Leases:	Balance Sheet Classifications
Operating Lease ROU Assets	ROU Assets	$	1,113	$	1,187

Finance Leases:
Finance Lease ROU Assets	Property, plant and equipment		203		203
Accumulated amortization	Accumulated depreciation		108		101
Current finance lease liabilities	Current maturities of long-term debt		41		40
Long-term finance lease liabilities	Long-term debt		3		14

Summary of Supplemental Cash Flow and Other Information Related to Leases

Supplemental cash flow and other information related to leases as of and for the three months ended September 30, 2022 and 2021 are as follows:

	Three Months Ended
Other information	September 30, 2022			September 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$	91		$	126
Operating cash flows from finance leases		1			1
Financing cash flow from finance leases		10			9
Right-of-use assets obtained in exchange for new operating lease liabilities		7			35
Weighted-average remaining lease term:
Operating leases	1.16 years			2.16 years
Finance leases	3.27 years			3.95 years
Weighted-average discount rate:
Operating leases		1.01	%		1.35	%
Finance leases		6.54	%		6.54	%

Summary of Non-cancellable Operating and Finance Leases

Commitments relating to non-cancellable operating and finance leases as of September 30, 2022 for each of the next five years and thereafter are as follows:

Payments due within	Operating Leases			Finance Leases
1 year	$	359		$	42
2 years		351			3
3 years		327			0
4 years		124			0
5 years		11			0
Over 5 years		0			0
Total minimum future payments		1,172			45
Less: Imputed interest		(38	)		(1	)
Total liabilities		1,134			44
Less: Current portion		(354	)		(41	)
Long-term liabilities	$	780		$	3

XML 36 R26.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies (Tables)

3 Months Ended

Sep. 30, 2022

Commitments And Contingencies Disclosure [Abstract]

Schedule of Contractual Obligations, Commitments and Contingencies

Contractual obligations, commitments and contingencies related to outstanding debt and interest (excluding leases, see Note 9) in continuing operations at September 30, 2022 were as follows:

Payments due within:	Long-Term Debt		Interest on Outstanding Debt
1 year	$	41	$	1
2 years		3		0
3 years		0		0
4 years		0		0
5 years		0		0
	$	44	$	1

XML 37 R27.htm IDEA: XBRL DOCUMENT

Financial Information by Segment (Tables)

3 Months Ended

Sep. 30, 2022

Segment Reporting [Abstract]

Segment Information

Segment information as of September 30, 2022 and 2021 and for the three months then ended is as follows:

	Healthcare Services			Pharmacy			Corporate and Other			Total
As of and for the three months ended September 30, 2022
Net revenues from external customers	$	3,784		$	7,253		$	0		$	11,037
Operating loss		(1,034	)		(219	)		(360	)		(1,613	)
Depreciation and amortization		120			247			1			368
Assets		12,885			8,250			5,691			26,826
Expenditures for property, plant and equipment		354			269			1			624
As of and for the three months ended September 30, 2021
Net revenues from external customers	$	3,498		$	7,027		$	0		$	10,525
Operating profit (loss)		(587	)		12			(418	)		(993	)
Depreciation and amortization		98			235			0			333
Assets		13,549			10,030			9,789			33,368
Expenditures for property, plant and equipment		373			318			1			692

XML 38 R28.htm IDEA: XBRL DOCUMENT

Business Operations - Additional Information (Detail) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended	30 Months Ended
	Nov. 14, 2022 USD ($)	Sep. 30, 2022 USD ($) Bed a Area	Jun. 30, 2020 USD ($)	Dec. 31, 2021 USD ($)	Sep. 30, 2022 USD ($)
Business And Organization [Line Items]
Employee retention credit amending quarterly payroll tax filing amount				$ 3,586
Subsequent Event
Business And Organization [Line Items]
Proceeds from employee retention credit	$ 1,803
Provider Relief Fund Distributions CARES Act [Member]
Business And Organization [Line Items]
Recognized amount related to provide relief fund as other income		$ 5,715
Healthcare Services Segment [Member] \| Mississippi [Member]
Business And Organization [Line Items]
Area of unimproved land owned by subsidiary \| a		5
Healthcare Services Segment [Member] \| Georgia [Member]
Business And Organization [Line Items]
Area of unimproved land owned by subsidiary \| a		25
Healthcare Services Segment [Member] \| Acute Care Hospital [Member] \| Mississippi [Member]
Business And Organization [Line Items]
Number of licensed-bed owned and operated by a subsidiary \| Bed		49
Number of bed in extended care and rehabilitation center owned and operated by subsidiary \| Bed		66
Number of bed in geriatric psychology unit owned and operated by subsidiary \| Bed		26
Pharmacy Segment [Member] \| Louisiana [Member]
Business And Organization [Line Items]
Number of operational areas \| Area		3
Healthcare and Pharmacy segments [Member] \| Provider Relief Fund Distributions CARES Act [Member]
Business And Organization [Line Items]
Proceeds under relief fund distributions					$ 6,182
Healthcare and Pharmacy segments [Member] \| Paycheck Protection Program, CARES Act [Member]
Business And Organization [Line Items]
Proceeds from long-term debt			$ 3,234

XML 39 R29.htm IDEA: XBRL DOCUMENT

Discontinued Operations - Components of Pension Expense (Detail) - Life Sciences and Engineering [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Defined Benefit Plan Disclosure [Line Items]
Defined Benefit Plan, Type [Extensible List]	us-gaap:PensionPlansDefinedBenefitMember	us-gaap:PensionPlansDefinedBenefitMember
Interest Cost	$ 13	$ 11
Expected return on assets	(11)	(11)
Amortization of prior service cost	0	11
Net pension expense	$ 2	$ 11

- Definition

Indicates type of defined benefit plan. Includes, but is not limited to, pension plan, other postretirement plan and special and contractual termination benefits payable upon retirement.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(01)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (g)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(6)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(5)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(6)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(5)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(4)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(8)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(7)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(7)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(3)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(5)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(7)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(02)(B)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(4)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(02)(A)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (j)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(5)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(02)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(7)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(4)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)(6)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(ii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (n)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 36: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 37: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 38: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)(3)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 39: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 712
-SubTopic 10
-Section 15
-Paragraph 4
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664

Reference 40: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (k)(4)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 41: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 712
-SubTopic 10
-Section 15
-Paragraph 4
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664

Reference 43: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 44: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(02)(C)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 45: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 46: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 47: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 48: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(3)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 49: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(9)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 50: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(6)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 51: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)(10)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 52: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 53: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(3)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 54: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 55: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 56: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 57: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (h)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 58: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(4)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 59: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

Reference 60: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (b)(8)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 61: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 6
-Subparagraph (a)(3)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920

+ Details

XML 40 R30.htm IDEA: XBRL DOCUMENT

Discontinued Operations - Additional Information (Detail) - Life Sciences and Engineering [Member] $ in Thousands	3 Months Ended
	Sep. 30, 2022 USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Contribution to pension plan	$ 22
Expected contribution to pension plan during the remaining fiscal year	$ 66

XML 41 R31.htm IDEA: XBRL DOCUMENT

Shareholders' Equity - Additional Information (Detail) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-based compensation, amount recognized	$ 0	$ 0
Options exercised	77,452

XML 42 R32.htm IDEA: XBRL DOCUMENT

Revenue - Summary of Revenue by Payor (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	$ 11,037	$ 10,525
Medicare [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	5,013	5,055
Medicaid [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	2,856	2,368
Retail and Institutional Pharmacy [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	1,499	1,567
Managed Care & Other Insurance [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	1,385	1,320
Self-Pay [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	259	184
Other [Member]
Segment Reporting Revenue Reconciling Item [Line Items]
Net Revenues	$ 25	$ 31

- Definition

Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 4
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 924
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB Topic 11.L)
-URI https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856

+ Details

XML 43 R33.htm IDEA: XBRL DOCUMENT

Revenue - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Revenue From Contract With Customer [Abstract]
Net revenues for positive settlements and filings of prior year Medicare and Medicaid cost reports	$ 0	$ 0

XML 44 R34.htm IDEA: XBRL DOCUMENT

Intangible Assets - Intangible Assets (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Indefinite-lived Intangible Assets [Line Items]
Total	$ 1,195	$ 1,201
Specialty Pharmacy Segment [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite and Indefinite-Lived Intangible Assets, Gross	2,892	2,892
Accumulated Amortization	(1,697)	(1,691)
Total	1,195	1,201
Trade Name [Member] \| Specialty Pharmacy Segment [Member]
Indefinite-lived Intangible Assets [Line Items]
Indefinite-Lived Intangible Assets	1,180	1,180
Customer Relationships [Member] \| Specialty Pharmacy Segment [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	1,089	1,089
Medicare License [Member] \| Specialty Pharmacy Segment [Member]
Indefinite-lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Gross	$ 623	$ 623

XML 45 R35.htm IDEA: XBRL DOCUMENT

Intangible Assets - Additional Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Goodwill And Intangible Assets Disclosure [Abstract]
Amortization expense	$ 6	$ 7

XML 46 R36.htm IDEA: XBRL DOCUMENT

Long-Term Debt - Summary of Long-Term Debt (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Debt Disclosure [Abstract]
Capital Lease	$ 44	$ 54
Less current maturities	(41)	(40)
Long-term Debt	$ 3	$ 14

XML 47 R37.htm IDEA: XBRL DOCUMENT

Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail) - CARES Act Paycheck Protection Plan Loans [Member] - USD ($) $ in Thousands	2 Months Ended	3 Months Ended
	May 31, 2020	Sep. 30, 2021
Debt Instrument [Line Items]
PPP loans from bank	$ 3,234
Debt instrument forgiveness amount		$ 2,972
Debt forgiveness income related to loan		3,010
Debt forgiveness accrued interest		$ 38

XML 48 R38.htm IDEA: XBRL DOCUMENT

Income Taxes - Additional Information (Detail) - USD ($)	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income tax expense (benefit)	$ 0	$ 2,000
State tax expense (benefit)	0	$ 2,000
Deferred income tax valuation allowance	8,278,000
Net long-term deferred income tax asset or liability	0
Long-term deferred tax liability	69,000
Net operating loss carry-forward	$ 23,143,000
Net operating loss carryforward expiration year	2023 through fiscal 2038

- Definition

Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.

+ References + Details

XML 49 R39.htm IDEA: XBRL DOCUMENT

Lease - Components of Lease Cost and Rent Expense (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Operating lease cost:
Operating lease cost	$ 90	$ 125
Short-term rent expense	27	44
Variable lease cost	1	1
Total operating lease cost	118	170
Finance lease cost:
Amortization right-of-use assets	9	9
Interest on finance lease liabilities	1	1
Total finance lease cost	$ 10	$ 10

XML 50 R40.htm IDEA: XBRL DOCUMENT

Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Operating Leases:
Right of use assets	$ 1,113	$ 1,187
Finance Leases:
Finance Lease ROU Assets	$ 203	$ 203
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Property, plant and equipment, at cost	Property, plant and equipment, at cost
Accumulated amortization	$ 108	$ 101
Current finance lease liabilities	$ 41	$ 40
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Current maturities of long-term debt	Current maturities of long-term debt
Long-term finance lease liabilities	$ 3	$ 14
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Long-term debt	Long-term debt

XML 51 R41.htm IDEA: XBRL DOCUMENT

Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	$ 91	$ 126
Operating cash flows from finance leases	1	1
Financing cash flow from finance leases	10	9
Right-of-use assets obtained in exchange for new operating lease liabilities	$ 7	$ 35
Weighted-average remaining lease term:
Operating leases	1 year 1 month 28 days	2 years 1 month 28 days
Finance leases	3 years 3 months 7 days	3 years 11 months 12 days
Weighted-average discount rate:
Operating leases	1.01%	1.35%
Finance leases	6.54%	6.54%

XML 52 R42.htm IDEA: XBRL DOCUMENT

Lease - Summary of Non-cancellable Operating and Finance Leases (Detail) - USD ($) $ in Thousands	Sep. 30, 2022	Jun. 30, 2022
Leases [Abstract]
1 year	$ 359
2 years	351
3 years	327
4 years	124
5 years	11
Over 5 years	0
Total minimum future payments	1,172
Less: Imputed interest	(38)
Total liabilities	1,134
Less: Current portion	(354)	$ (352)
Long-term operating lease liabilities	780	857
1 year	42
2 years	3
3 years	0
4 years	0
5 years	0
Over 5 years	0
Total minimum future payments	45
Less: Imputed interest	(1)
Total liabilities	44
Less: Current portion	(41)	(40)
Long-term finance lease liabilities	$ 3	$ 14

XML 53 R43.htm IDEA: XBRL DOCUMENT

Accrued Sales Tax - Additional Information (Details) $ in Thousands	3 Months Ended
	Sep. 30, 2022 USD ($) Authority	Jun. 30, 2022 USD ($)	Jun. 30, 2020 USD ($)
Payables And Accruals [Abstract]
Number of taxing authorities \| Authority	2
Amounts claimed and received	$ 1,500		$ 359
Unpaid sales tax liability	$ 2,777	$ 2,600

XML 54 R44.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail) $ in Thousands	Sep. 30, 2022 USD ($)
Long-Term Debt [Member]
Commitment And Contingencies [Line Items]
Payments due within 1 year	$ 41
Payments due within 2 years	3
Payments due within in 3 years	0
Payments due within 4 years	0
Payments due within 5years	0
Contractual obligations, commitments and contingencies	44
Interest on Outstanding Debt [Member]
Commitment And Contingencies [Line Items]
Payments due within 1 year	1
Payments due within 2 years	0
Payments due within in 3 years	0
Payments due within 4 years	0
Payments due within 5years	0
Contractual obligations, commitments and contingencies	$ 1

XML 55 R45.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Detail) - Management [Member] - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Related Party Transaction [Line Items]
Legal services to these law firms	$ 55	$ 50
Amount payable to law firms	$ 50		$ 15

XML 56 R46.htm IDEA: XBRL DOCUMENT

Financial Information by Segment - Additional Information (Detail)	3 Months Ended
	Sep. 30, 2022 Segment
Segment Reporting [Abstract]
Number of segments	2

XML 57 R47.htm IDEA: XBRL DOCUMENT

Financial Information by Segment - Segment Information (Detail) - USD ($) $ in Thousands	3 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Jun. 30, 2022
Segment Reporting Information [Line Items]
Net revenues from external customers	$ 11,037	$ 10,525
Operating profit (loss)	(1,613)	(993)
Depreciation and amortization	368	333
Assets	26,826	33,368	$ 27,943
Expenditures for property, plant and equipment	624	692
Operating Segments [Member] \| Healthcare Services Segment [Member]
Segment Reporting Information [Line Items]
Net revenues from external customers	3,784	3,498
Operating profit (loss)	(1,034)	(587)
Depreciation and amortization	120	98
Assets	12,885	13,549
Expenditures for property, plant and equipment	354	373
Operating Segments [Member] \| Pharmacy Segment [Member]
Segment Reporting Information [Line Items]
Net revenues from external customers	7,253	7,027
Operating profit (loss)	(219)	12
Depreciation and amortization	247	235
Assets	8,250	10,030
Expenditures for property, plant and equipment	269	318
Corporate and Other [Member]
Segment Reporting Information [Line Items]
Net revenues from external customers	0	0
Operating profit (loss)	(360)	(418)
Depreciation and amortization	1	0
Assets	5,691	9,789
Expenditures for property, plant and equipment	$ 1	$ 1

XML 58 ssy-10q_20220930_htm.xml IDEA: XBRL DOCUMENT 0000096793 2022-07-01 2022-09-30 0000096793 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0000096793 ssy:PreferredSharePurchaseRightsMember 2022-07-01 2022-09-30 0000096793 2022-11-14 0000096793 2022-09-30 0000096793 2022-06-30 0000096793 2021-07-01 2021-09-30 0000096793 us-gaap:ProductMember 2022-07-01 2022-09-30 0000096793 us-gaap:ProductMember 2021-07-01 2021-09-30 0000096793 us-gaap:ServiceMember 2022-07-01 2022-09-30 0000096793 us-gaap:ServiceMember 2021-07-01 2021-09-30 0000096793 ssy:CommonSharesMember 2022-06-30 0000096793 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0000096793 us-gaap:RetainedEarningsMember 2022-06-30 0000096793 ssy:AccumulatedOtherComprehensiveLossMember 2022-06-30 0000096793 ssy:CommonSharesMember 2022-07-01 2022-09-30 0000096793 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0000096793 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0000096793 ssy:CommonSharesMember 2022-09-30 0000096793 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0000096793 us-gaap:RetainedEarningsMember 2022-09-30 0000096793 ssy:AccumulatedOtherComprehensiveLossMember 2022-09-30 0000096793 ssy:CommonSharesMember 2021-06-30 0000096793 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0000096793 us-gaap:RetainedEarningsMember 2021-06-30 0000096793 ssy:AccumulatedOtherComprehensiveLossMember 2021-06-30 0000096793 2021-06-30 0000096793 us-gaap:RetainedEarningsMember 2021-07-01 2021-09-30 0000096793 ssy:CommonSharesMember 2021-09-30 0000096793 us-gaap:AdditionalPaidInCapitalMember 2021-09-30 0000096793 us-gaap:RetainedEarningsMember 2021-09-30 0000096793 ssy:AccumulatedOtherComprehensiveLossMember 2021-09-30 0000096793 2021-09-30 0000096793 stpr:MS ssy:AcuteCareHospitalMember ssy:HealthcareServicesSegmentMember 2022-07-01 2022-09-30 0000096793 stpr:MS ssy:HealthcareServicesSegmentMember 2022-07-01 2022-09-30 0000096793 stpr:GA ssy:HealthcareServicesSegmentMember 2022-07-01 2022-09-30 0000096793 stpr:LA ssy:PharmacySegmentMember 2022-07-01 2022-09-30 0000096793 ssy:ProviderReliefFundDistributionsCARESActMember ssy:HealthcareAndPharmacySegmentsMember 2020-04-01 2022-09-30 0000096793 ssy:ProviderReliefFundDistributionsCARESActMember 2022-07-01 2022-09-30 0000096793 ssy:PaycheckProtectionProgramCARESActMember ssy:HealthcareAndPharmacySegmentsMember 2020-04-01 2020-06-30 0000096793 2021-07-01 2021-12-31 0000096793 us-gaap:SubsequentEventMember 2022-10-01 2022-11-14 0000096793 ssy:LifeSciencesAndEngineeringSegmentMember 2022-07-01 2022-09-30 0000096793 ssy:LifeSciencesAndEngineeringSegmentMember 2021-07-01 2021-09-30 0000096793 ssy:LifeSciencesAndEngineeringSegmentMember 2022-09-30 0000096793 ssy:MedicareMember 2022-07-01 2022-09-30 0000096793 ssy:MedicareMember 2021-07-01 2021-09-30 0000096793 ssy:MedicaidMember 2022-07-01 2022-09-30 0000096793 ssy:MedicaidMember 2021-07-01 2021-09-30 0000096793 ssy:RetailAndInstitutionalPharmacyMember 2022-07-01 2022-09-30 0000096793 ssy:RetailAndInstitutionalPharmacyMember 2021-07-01 2021-09-30 0000096793 ssy:ManagedCareAndOtherInsurersMember 2022-07-01 2022-09-30 0000096793 ssy:ManagedCareAndOtherInsurersMember 2021-07-01 2021-09-30 0000096793 ssy:SelfPayorMember 2022-07-01 2022-09-30 0000096793 ssy:SelfPayorMember 2021-07-01 2021-09-30 0000096793 ssy:OtherMember 2022-07-01 2022-09-30 0000096793 ssy:OtherMember 2021-07-01 2021-09-30 0000096793 us-gaap:TradeNamesMember ssy:SpecialtyPharmacySegmentMember 2022-09-30 0000096793 us-gaap:TradeNamesMember ssy:SpecialtyPharmacySegmentMember 2022-06-30 0000096793 us-gaap:CustomerRelationshipsMember ssy:SpecialtyPharmacySegmentMember 2022-09-30 0000096793 us-gaap:CustomerRelationshipsMember ssy:SpecialtyPharmacySegmentMember 2022-06-30 0000096793 ssy:MedicareLicenseMember ssy:SpecialtyPharmacySegmentMember 2022-09-30 0000096793 ssy:MedicareLicenseMember ssy:SpecialtyPharmacySegmentMember 2022-06-30 0000096793 ssy:SpecialtyPharmacySegmentMember 2022-09-30 0000096793 ssy:SpecialtyPharmacySegmentMember 2022-06-30 0000096793 ssy:CARESActPaycheckProtectionProgramMember 2020-04-01 2020-05-31 0000096793 ssy:CARESActPaycheckProtectionProgramMember 2021-07-01 2021-09-30 0000096793 ssy:CARESActPaycheckProtectionProgramMember 2021-09-30 0000096793 2020-06-30 0000096793 us-gaap:LongTermDebtMember 2022-09-30 0000096793 ssy:InterestOnOutstandingDebtMember 2022-09-30 0000096793 srt:ManagementMember 2022-07-01 2022-09-30 0000096793 srt:ManagementMember 2021-07-01 2021-09-30 0000096793 srt:ManagementMember 2022-09-30 0000096793 srt:ManagementMember 2022-06-30 0000096793 us-gaap:OperatingSegmentsMember ssy:HealthcareServicesSegmentMember 2022-07-01 2022-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:PharmacySegmentMember 2022-07-01 2022-09-30 0000096793 us-gaap:CorporateNonSegmentMember 2022-07-01 2022-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:HealthcareServicesSegmentMember 2022-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:PharmacySegmentMember 2022-09-30 0000096793 us-gaap:CorporateNonSegmentMember 2022-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:HealthcareServicesSegmentMember 2021-07-01 2021-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:PharmacySegmentMember 2021-07-01 2021-09-30 0000096793 us-gaap:CorporateNonSegmentMember 2021-07-01 2021-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:HealthcareServicesSegmentMember 2021-09-30 0000096793 us-gaap:OperatingSegmentsMember ssy:PharmacySegmentMember 2021-09-30 0000096793 us-gaap:CorporateNonSegmentMember 2021-09-30 shares iso4217:USD iso4217:USD shares ssy:Bed utr:acre ssy:Area pure ssy:Authority ssy:Segment false 2022 Q1 true 0000096793 --06-30 NONE 2022

http://fasb.org/us-gaap/2022#PensionPlansDefinedBenefitMember

http://fasb.org/us-gaap/2022#PropertyPlantAndEquipmentGross

http://fasb.org/us-gaap/2022#LongTermDebtCurrent

http://fasb.org/us-gaap/2022#LongTermDebtNoncurrent

10-Q true 2022-09-30 false 1-12607 SUNLINK HEALTH SYSTEMS, INC. OH 31-0621189 900 Circle 75 Parkway Suite 690 Atlanta GA 30339 770 933-7000 Common Shares without par value SSY NYSEAMER Preferred Share Purchase Rights Yes Yes Non-accelerated Filer true false false 7031603

4951000

6794000

4686000

4624000

1842000

1748000

1761000 1761000

2166000

1888000

15406000

16815000

23859000

23920000

15377000

15703000

8482000

8217000

1195000

1201000

1113000

1187000

630000

523000

2938000

2911000

26826000

27943000

1831000

1347000

41000

40000

1344000

1520000

2777000

2600000

469000 519000

354000

352000

1347000

1313000

8163000

7691000

3000

14000

87000 86000

780000

857000

69000

114000

106000

1053000

1132000

2000000

7032000

6954000

3516000

3478000

10746000

10736000

3242000

4800000

106000

17610000

19120000

26826000

27943000

11037000

10525000

4369000

4073000

5330000

4698000

337000

300000

1035000

862000

1093000

1082000

118000

170000

368000

333000

-1613000

-993000

12000

5000

0 3010000 61000 0

-4000

-14000

-1544000

2008000

2000

-1544000

2006000

-14000

-67000

-1558000

1939000

-1558000

1939000

-0.22

0.29

-0.22

0.28

0.00

-0.01

0.00

-0.01

-0.22

0.28

-0.22

0.27

6983000

6924000

6983000

7095000

6954000

3478000

10736000

4800000

106000

19120000

78000

38000

10000

48000

-1558000

7032000

3516000

10746000

3242000

106000

17610000

6924000

3463000

10700000

6809000

-162000

20810000

1939000

6924000

3463000

10700000

8748000

-162000

22749000

-1271000

-334000

624000

692000

49000 0

13000

5000

-562000

-687000

10000

8000

-10000

-8000

-1843000

-1029000

6794000

9962000

4951000

8933000

4000 -1000

-293000

7000 35000

The accompanying unaudited Condensed Consolidated Financial Statements as of September 30, 2022 and for the three month periods ended September 30, 2022 and 2021 have been prepared in accordance with Rule 8-03 and Article 8-03 of Regulation S-X of the Securities and Exchange Commission (“SEC”) and, as such, do not include all information required by accounting principles generally accepted in the United States of America (“GAAP”). The condensed consolidated June 30, 2022 balance sheet included in this interim filing has been derived from the audited consolidated financial statements at that date but does not include all the information and related notes required by GAAP for complete consolidated financial statements. These Condensed Consolidated Financial Statements should be read in conjunction with the audited consolidated financial statements included in the SunLink Health Systems, Inc. (“SunLink”, “we”, “our”, “ours”, “us” or the “Company”) Annual Report on Form 10-K for the fiscal year ended June 30, 2022, filed with the SEC on September 28, 2022. In the opinion of management, the Condensed Consolidated Financial Statements, which are unaudited, include all adjustments, consisting only of normal recurring adjustments, necessary to present fairly the financial position and results of operations for the periods indicated. The results of operations for the three month periods ended September 30, 2022 are not necessarily indicative of the results that may be expected for the entire fiscal year or any other interim period. <p style="text-align:justify;Background-color:#FFFFFF;margin-bottom:0pt;margin-top:6pt;text-indent:4.24%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Throughout these notes to the condensed consolidated financial statements, SunLink Health Systems, Inc., and its consolidated subsidiaries are referred to on a collective basis as “SunLink”, “we”, “our”, “ours”, “us” or the “Company.” This drafting style is not meant to indicate that SunLink Health Systems, Inc. or any particular subsidiary of the Company owns or operates any particular asset, business or property. Each operation and business described in this filing is owned and operated by a distinct and indirect subsidiary of SunLink Health System, Inc.

49 26 66 5 25 3 6182000 5715000

3234000

3586000 1803000

Note 3. – Discontinued Operations Sold Hospitals and Nursing Home– Subsidiaries of the Company have sold substantially all the assets of five hospitals (“Sold Facilities”) during the period July 2, 2012 to March 17, 2019. The loss before income taxes of the Sold Facilities results primarily from the effects of retained professional liability insurance and claims expenses and settlement of a lawsuit. Life Sciences and Engineering Segment —SunLink retained a defined benefit retirement plan which covered substantially all the employees of this segment when the segment was sold in fiscal 1998. Effective February 28, 1997, the plan was amended to freeze participant benefits and close the plan to new participants. Pension expense and related tax benefit or expense is reflected in the results of operations for this segment for the three months ended September 30, 2022 and 2021, respectively. The components of pension expense for the three months ended September 30, 2022 and 2021, respectively, were as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest Cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected return on assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of prior service cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net pension expense</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> SunLink contributed $22 to the plan in the three months ended September 30, 2022 and expects to contribute an additional $66 during the last nine months of the fiscal year ending June 30, 2023.

The components of pension expense for the three months ended September 30, 2022 and 2021, respectively, were as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest Cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expected return on assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization of prior service cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net pension expense</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

13000

11000

2000

11000

22000

66000

Note 4. – Shareholders’ Equity Stock-Based Compensation – For the three months ended September 30, 2022 and 2021, the Company recognized no stock-based compensation for options issued to employees and directors of the Company. There were 77,452 shares issued as a result of options exercised during the three months ended September 30, 2022.

77452

Note 5. – Revenue Revenues by payor were as follows for the three months ended September 30, 2022 and 2021: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicare</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,013</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,055</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicaid</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,856</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,368</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Retail and Institutional Pharmacy</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,499</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Managed Care & Other Insurance</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,385</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,320</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Self-pay</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">259</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Net Revenues</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,037</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,525</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> No settlements of prior year Medicare and Medicaid cost reports were recorded in the three months ended September 30, 2022 and 2021, respectively.

Revenues by payor were as follows for the three months ended September 30, 2022 and 2021: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:29.98%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.64%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicare</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,013</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,055</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicaid</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,856</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,368</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Retail and Institutional Pharmacy</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,499</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,567</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Managed Care & Other Insurance</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,385</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,320</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:65.66%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Self-pay</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">259</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">184</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.66%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">25</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:65.66%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total Net Revenues</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,037</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.64%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,525</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.66%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

5013000

5055000

2856000

2368000

1499000

1567000

1385000

1320000

259000

184000

25000

31000

11037000

10525000

0 0

Note 6. – Intangible Assets Intangibles consist of the following, net of amortization: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy Segment Intangibles</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade Name (non-amortizing)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,180</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,180</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer Relationships</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,089</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,089</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicare License</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,892</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,892</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,697</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,691</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net Intangibles</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,201</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> Amortization expense was $6 and $7 for the three months ended September 30, 2022 and 2021, respectively.

Intangibles consist of the following, net of amortization: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.46%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.44%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy Segment Intangibles</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Trade Name (non-amortizing)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,180</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,180</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Customer Relationships</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,089</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,089</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Medicare License</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">623</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.76%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,892</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,892</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated Amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,697</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,691</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.76%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net Intangibles</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.46%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,195</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,201</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

1180000

1089000

623000

2892000

1697000

1691000

1195000

1201000

6000

7000

Long-term debt consisted of the following: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:70%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.94%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Calibri;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.24%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.48%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64.94%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Capital Lease</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.48%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">54</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.94%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less current maturities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(40</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64.94%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term Debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.24%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.48%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> 44000 54000

41000

40000

3000

14000

3234000

2972000 38000 3010000

2000

8278000

69000

23143000

2023 through fiscal 2038 Note 9. – Leases The Company has operating leases and a financing lease relating to its pharmacy operations, medical office buildings, certain medical equipment, and office equipment. All lease agreements generally require the Company to pay maintenance, repairs, property taxes and insurance costs, all of which are variable amounts based on actual costs. Variable lease costs also include escalating rent payments that are not fixed at commencement but are based on an index determined in future periods over the lease term based on changes in the Consumer Price Index or other measure of cost inflation. Some leases include one or more options to renew the lease at the end of the initial term, with renewal terms that generally extend the lease at the then market rental rates. Leases may also include an option to buy the underlying asset at or a short time prior to the termination of the lease. All such options are at the Company’s discretion and are evaluated at the commencement of the lease, with only those that are reasonably certain of exercise included in determining the appropriate lease term. The components of lease cost and rent expense for the three months ended September 30, 2022 and 2021 are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lease Cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term rent expense</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease cost:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization right-of-use assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on finance lease liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information relating to leases was as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Classifications</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease ROU Assets</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU Assets</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,113</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,187</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance Lease ROU Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated amortization</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current finance lease liabilities</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current maturities of long-term debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term finance lease liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term debt</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow and other information related to leases as of and for the three months ended September 30, 2022 and 2021 are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.76%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other information</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows from operating leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows from finance leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flow from finance leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets obtained in exchange for new operating lease liabilities</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.16 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.16 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.27 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.95 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.35</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.54</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.54</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table></div> <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments relating to non-cancellable operating and finance leases as of September 30, 2022 for each of the next five years and thereafter are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payments due within</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 year</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">359</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">351</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">327</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 5 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum future payments</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,172</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Imputed interest</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,134</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(354</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">780</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

The components of lease cost and rent expense for the three months ended September 30, 2022 and 2021 are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.34%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.84%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Lease Cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:19.34%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.84%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">90</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Short-term rent expense</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Variable lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating lease cost</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">118</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">170</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance lease cost:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:55.68%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amortization right-of-use assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.18%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest on finance lease liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:55.68%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total finance lease cost</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:18.34%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.18%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.84%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

90000

125000

27000 44000 1000 1000

118000

170000

9000

1000

10000 10000 <p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental balance sheet information relating to leases was as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:35.88%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.62%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.2%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:33.42%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Classifications</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.62%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:11.2%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating Lease ROU Assets</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU Assets</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,113</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,187</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance Lease ROU Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">203</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated amortization</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accumulated depreciation</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">108</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">101</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current finance lease liabilities</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current maturities of long-term debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.42%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term finance lease liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:35.88%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term debt</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.62%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.2%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

1113000

1187000

203000

108000

101000

41000

40000

3000

14000

<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Supplemental cash flow and other information related to leases as of and for the three months ended September 30, 2022 and 2021 are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:100%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="6" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.76%;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Other information</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:2.96%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows from operating leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">126</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flows from finance leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing cash flow from finance leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right-of-use assets obtained in exchange for new operating lease liabilities</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">35</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term:</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.16 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.16 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.27 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.9%;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3.95 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating leases</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.01</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1.35</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.54</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.96%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.9%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.54</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</td> </tr> </table></div>

91000

126000

1000 1000

10000

9000

7000

35000

P1Y1M28D

P2Y1M28D

P3Y3M7D

P3Y11M12D

0.0101

0.0135

0.0654

<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:4.24%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Commitments relating to non-cancellable operating and finance leases as of September 30, 2022 for each of the next five years and thereafter are as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payments due within</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.3%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.86%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Finance Leases</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 year</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">359</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">42</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">351</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">327</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">124</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Over 5 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total minimum future payments</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,172</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%; border-top:solid 0.75pt #000000;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">45</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Imputed interest</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(38</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:64%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,134</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.9%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Less: Current portion</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(354</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:64%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term liabilities</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.3%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">780</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.9%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.86%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

359000

42000

351000

3000

327000

124000

11000

0 0

1172000

45000

38000

1000

1134000

44000

354000

41000

780000

3000

Note 10. – Accrued Sales Tax During the fiscal year ended June 30, 2019, the Pharmacy segment business amended its sales tax position to claim exemption from state and local sales taxes in Louisiana on revenues from the sales of products and services to beneficiaries of government insurance programs to the extent reimbursed by the administrators of such programs. No such sales taxes for any period subsequent to June 30, 2019 have been paid on the related reimbursement received with respect to sales of such products and services from the government payers’ insurance programs. The Company has filed amended sales tax returns for periods still open under the applicable statutes of limitations claiming refunds of such sales taxes paid. Refunds have been received from two taxing authorities in the amounts claimed on amended returns. Accordingly, amounts claimed and received from these two taxing authorities were recorded as revenues in the fiscal year ended June 30, 2020 in the amount of $359. Refunds from two different taxing authorities totaling approximately $1,500 are under audit. The Company’s position with respect to such refunds claimed from the two other local taxing authorities is still uncertain as these claims are under audit by such local taxing authorities and such claims have not yet been determined probable of collection; therefore, no amount has been recorded as a receivable or in income by the Company at September 30, 2022 in respect of such other local taxing authorities. In addition, the Company has continued to accrue the amounts for sales tax estimates from these two other taxing authorities in amounts it believes would be payable if its amended returns and continuing position is challenged and the Company does not prevail. The unpaid sales tax accrued as a liability at September 30, 2022 was $2,777 compared to $2,600 at June 30, 2022. 2

359000

1500000

2777000

2600000

Note 11. – Commitments and Contingencies Contractual obligations, commitments and contingencies related to outstanding debt and interest (excluding leases, see Note 9) in continuing operations at September 30, 2022 were as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payments due within:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Term <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Interest on <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 year</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

Contractual obligations, commitments and contingencies related to outstanding debt and interest (excluding leases, see Note 9) in continuing operations at September 30, 2022 were as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:90%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Payments due within:</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Long-Term <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Interest on <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Outstanding <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Debt</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1 year</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">41</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.72%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4 years</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.6%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.9%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.58%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.84%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:solid 0.75pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5 years</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-bottom:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.72%; border-bottom:double 2.5pt transparent;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.6%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">44</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.9%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.58%; border-bottom:double 2.5pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.38%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.8%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.84%; border-bottom:double 2.5pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

41000

1000

3000

44000

1000

Note 12. – Related Party Transactions A director of the Company is a member of a law firm which provides services to SunLink. The Company expensed an aggregate of $55 and $50 for legal services to this law firm in the three months ended September 30, 2022 and 2021, respectively. Included in the Company’s condensed consolidated balance sheets at September 30, 2022 and June 30, 2022 is $50 and $15, respectively, of amounts payable to this law firm.

55000

50000

15000

Note 13. – Financial Information by Segment Under ASC Topic No. 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker, or decision-making group, in deciding how to allocate resources and in assessing performance. Our chief operating decision-making group is composed of SunLink’s chief executive officer and other members of SunLink’s senior management. Our two reportable operating segments are Healthcare Services and Pharmacy. We evaluate performance of our operating segments based on revenue and operating profit (loss). Segment information as of September 30, 2022 and 2021 and for the three months then ended is as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Healthcare <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Services</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Corporate <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">and Other</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of and for the three months ended September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenues from external customers</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,784</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,253</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,037</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,034</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(219</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(360</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,613</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,885</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,250</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,691</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,826</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">354</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">269</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">624</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of and for the three months ended September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenues from external customers</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,498</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,027</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,525</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating profit (loss)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(587</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(418</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(993</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,549</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,030</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,789</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,368</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">373</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">692</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

Segment information as of September 30, 2022 and 2021 and for the three months then ended is as follows: <div> <table border="0" cellpadding="0" cellspacing="0" style="margin:auto;border-collapse:collapse; width:80%;"> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.14%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Healthcare <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Services</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pharmacy</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Corporate <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">and Other</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td colspan="2" style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.18%; border-bottom:solid 0.75pt #000000;" valign="bottom"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Total</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of and for the three months ended September 30, 2022</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%; border-top:solid 0.75pt #000000;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenues from external customers</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,784</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,253</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,037</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating loss</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,034</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(219</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(360</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(1,613</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">120</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">247</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">368</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12,885</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,250</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,691</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,826</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">354</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">269</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">624</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of and for the three months ended September 30, 2021</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net revenues from external customers</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,498</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,027</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,525</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating profit (loss)</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(587</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">12</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(418</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(993</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Depreciation and amortization</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">0</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">333</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Assets</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,549</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">10,030</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,789</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">33,368</td> <td style="background-color:#CFF0FC;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> <tr> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.14%;" valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Expenditures for property, plant and equipment</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">373</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">318</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.18%;white-space:nowrap;" valign="bottom"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">692</td> <td style="background-color:#FFFFFF;padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;" valign="bottom"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </td> </tr> </table></div>

3784000

7253000

11037000

-1034000

-219000

-360000

-1613000

120000

247000

1000

368000

12885000

8250000

5691000

26826000

354000

269000

1000

624000

3498000

7027000

10525000

-587000

12000

-418000

-993000

98000

235000

333000

13549000

10030000

9789000

33368000

373000

318000

1000

692000

EXCEL 59 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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
&PO=V]R:W-H965T&UL4$L! A0#% M @ QVEN58IK2OD] P TPH !D ("!.+, 'AL+W=O&PO=V]R:W-H965TP, '(, 9 " @0ZZ !X M;"]W;W)K&UL4$L! A0#% @ QVEN57U H5[! M P 9PT !D ("!P+T 'AL+W=O&PO=V]R:W-H965T&UL4$L! A0#% @ QVEN57>($C@E P 8 P !D M ("!,LD 'AL+W=O&PO=V]R M:W-H965T&UL M4$L! A0#% @ QVEN560HJR2,!0 6B$ !D ("!W-$ M 'AL+W=O&PO#: !?&PO7W)E;',O=V]R:V)O;VLN>&UL M+G)E;'-02P$"% ,4 " #':6Y59>&9M; XML 60 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 61 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 62 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 87 224 1 false 35 0 false 9 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss) Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements Shareholders' Equity Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity Condensed Consolidated Statements Shareholders' Equity Statements 5 false false R6.htm 100050 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 100060 - Disclosure - Basis of Presentation Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentation Basis of Presentation Notes 7 false false R8.htm 100070 - Disclosure - Business Operations Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperations Business Operations Notes 8 false false R9.htm 100080 - Disclosure - Discontinued Operations Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperations Discontinued Operations Notes 9 false false R10.htm 100090 - Disclosure - Shareholders' Equity Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquity Shareholders' Equity Notes 10 false false R11.htm 100100 - Disclosure - Revenue Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenue Revenue Notes 11 false false R12.htm 100110 - Disclosure - Intangible Assets Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssets Intangible Assets Notes 12 false false R13.htm 100120 - Disclosure - Long-Term Debt Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebt Long-Term Debt Notes 13 false false R14.htm 100130 - Disclosure - Income Taxes Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxes Income Taxes Notes 14 false false R15.htm 100140 - Disclosure - Leases Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeases Leases Notes 15 false false R16.htm 100150 - Disclosure - Accrued Sales Tax Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTax Accrued Sales Tax Notes 16 false false R17.htm 100160 - Disclosure - Commitments and Contingencies Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 17 false false R18.htm 100170 - Disclosure - Related Party Transactions Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactions Related Party Transactions Notes 18 false false R19.htm 100180 - Disclosure - Financial Information by Segment Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegment Financial Information by Segment Notes 19 false false R20.htm 100190 - Disclosure - Basis of Presentation (Policies) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentationPolicies Basis of Presentation (Policies) Policies 20 false false R21.htm 100200 - Disclosure - Discontinued Operations (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperations 21 false false R22.htm 100210 - Disclosure - Revenue (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueTables Revenue (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenue 22 false false R23.htm 100220 - Disclosure - Intangible Assets (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssets 23 false false R24.htm 100230 - Disclosure - Long-Term Debt (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtTables Long-Term Debt (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebt 24 false false R25.htm 100240 - Disclosure - Leases (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables Leases (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeases 25 false false R26.htm 100250 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies 26 false false R27.htm 100260 - Disclosure - Financial Information by Segment (Tables) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentTables Financial Information by Segment (Tables) Tables http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegment 27 false false R28.htm 100270 - Disclosure - Business Operations - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail Business Operations - Additional Information (Detail) Details 28 false false R29.htm 100280 - Disclosure - Discontinued Operations - Components of Pension Expense (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail Discontinued Operations - Components of Pension Expense (Detail) Details 29 false false R30.htm 100290 - Disclosure - Discontinued Operations - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail Discontinued Operations - Additional Information (Detail) Details 30 false false R31.htm 100300 - Disclosure - Shareholders' Equity - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetail Shareholders' Equity - Additional Information (Detail) Details 31 false false R32.htm 100310 - Disclosure - Revenue - Summary of Revenue by Payor (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail Revenue - Summary of Revenue by Payor (Detail) Details 32 false false R33.htm 100320 - Disclosure - Revenue - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueAdditionalInformationDetail Revenue - Additional Information (Detail) Details 33 false false R34.htm 100330 - Disclosure - Intangible Assets - Intangible Assets (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail Intangible Assets - Intangible Assets (Detail) Details 34 false false R35.htm 100340 - Disclosure - Intangible Assets - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail Intangible Assets - Additional Information (Detail) Details 35 false false R36.htm 100350 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail Long-Term Debt - Summary of Long-Term Debt (Detail) Details 36 false false R37.htm 100360 - Disclosure - Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail) Details http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtTables 37 false false R38.htm 100370 - Disclosure - Income Taxes - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail Income Taxes - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Lease - Components of Lease Cost and Rent Expense (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail Lease - Components of Lease Cost and Rent Expense (Detail) Details 39 false false R40.htm 100390 - Disclosure - Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail) Details 40 false false R41.htm 100400 - Disclosure - Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail) Details 41 false false R42.htm 100410 - Disclosure - Lease - Summary of Non-cancellable Operating and Finance Leases (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail Lease - Summary of Non-cancellable Operating and Finance Leases (Detail) Details 42 false false R43.htm 100430 - Disclosure - Accrued Sales Tax - Additional Information (Details) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTaxAdditionalInformationDetails Accrued Sales Tax - Additional Information (Details) Details 43 false false R44.htm 100440 - Disclosure - Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail) Details 44 false false R45.htm 100450 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 45 false false R46.htm 100460 - Disclosure - Financial Information by Segment - Additional Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentAdditionalInformationDetail Financial Information by Segment - Additional Information (Detail) Details 46 false false R47.htm 100470 - Disclosure - Financial Information by Segment - Segment Information (Detail) Sheet http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail Financial Information by Segment - Segment Information (Detail) Details 47 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: dei:SecurityExchangeName - ssy-10q_20220930.htm 24 [ix-0514-Hidden-Fact-Not-Referenced] WARN: 8 fact(s) appearing in ix:hidden were not referenced by any -sec-ix-hidden style property: us-gaap:DefinedBenefitPlanTypeExtensibleList, us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList, us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList, us-gaap:FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList - ssy-10q_20220930.htm 28, 29, 30, 31, 32, 33, 34, 35 ssy-10q_20220930.htm ssy-20220930.xsd ssy-20220930_cal.xml ssy-20220930_def.xml ssy-20220930_lab.xml ssy-20220930_pre.xml ssy-ex311_9.htm ssy-ex312_6.htm ssy-ex321_8.htm ssy-ex322_7.htm http://fasb.org/srt/2022 http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 65 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "ssy-10q_20220930.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 87, "dts": { "calculationLink": { "local": [ "ssy-20220930_cal.xml" ] }, "definitionLink": { "local": [ "ssy-20220930_def.xml" ] }, "inline": { "local": [ "ssy-10q_20220930.htm" ] }, "labelLink": { "local": [ "ssy-20220930_lab.xml" ] }, "presentationLink": { "local": [ "ssy-20220930_pre.xml" ] }, "schema": { "local": [ "ssy-20220930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 362, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 12, "http://xbrl.sec.gov/dei/2022": 8, "total": 20 }, "keyCustom": 38, "keyStandard": 186, "memberCustom": 20, "memberStandard": 15, "nsprefix": "ssy", "nsuri": "http://www.sunlinkhealth.com/20220930", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "100000 - Document - Document and Entity Information", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation", "shortName": "Document and Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100090 - Disclosure - Shareholders' Equity", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100100 - Disclosure - Revenue", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenue", "shortName": "Revenue", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100110 - Disclosure - Intangible Assets", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssets", "shortName": "Intangible Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100120 - Disclosure - Long-Term Debt", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebt", "shortName": "Long-Term Debt", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LongTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100130 - Disclosure - Income Taxes", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100140 - Disclosure - Leases", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeases", "shortName": "Leases", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:SalesTaxPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100150 - Disclosure - Accrued Sales Tax", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTax", "shortName": "Accrued Sales Tax", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:SalesTaxPayableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100160 - Disclosure - Commitments and Contingencies", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100170 - Disclosure - Related Party Transactions", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100180 - Disclosure - Financial Information by Segment", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegment", "shortName": "Financial Information by Segment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100010 - Statement - Condensed Consolidated Balance Sheets", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "shortName": "Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100190 - Disclosure - Basis of Presentation (Policies)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentationPolicies", "shortName": "Basis of Presentation (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:PensionExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100200 - Disclosure - Discontinued Operations (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:PensionExpenseTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100210 - Disclosure - Revenue (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueTables", "shortName": "Revenue (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100220 - Disclosure - Intangible Assets (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsTables", "shortName": "Intangible Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:LongTermObligationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100230 - Disclosure - Long-Term Debt (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtTables", "shortName": "Long-Term Debt (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "ssy:LongTermObligationsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "span", "p", "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100240 - Disclosure - Leases (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables", "shortName": "Leases (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "span", "p", "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100250 - Disclosure - Commitments and Contingencies (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables", "shortName": "Commitments and Contingencies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100260 - Disclosure - Financial Information by Segment (Tables)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentTables", "shortName": "Financial Information by Segment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20210701_20211231", "decimals": "-3", "first": true, "lang": null, "name": "ssy:EmployeeRetentionCreditAmendingQuarterlyPayrollTaxFilingAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100270 - Disclosure - Business Operations - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail", "shortName": "Business Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20210701_20211231", "decimals": "-3", "first": true, "lang": null, "name": "ssy:EmployeeRetentionCreditAmendingQuarterlyPayrollTaxFilingAmount", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ssyLifeSciencesAndEngineeringSegmentMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanInterestCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100280 - Disclosure - Discontinued Operations - Components of Pension Expense (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail", "shortName": "Discontinued Operations - Components of Pension Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ssyLifeSciencesAndEngineeringSegmentMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:DefinedBenefitPlanInterestCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "shortName": "Condensed Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "U_xbrlishares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ssyLifeSciencesAndEngineeringSegmentMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PensionContributions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100290 - Disclosure - Discontinued Operations - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail", "shortName": "Discontinued Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapIncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis_ssyLifeSciencesAndEngineeringSegmentMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:PensionContributions", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "us-gaap:AllocatedShareBasedCompensationExpense", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100300 - Disclosure - Shareholders' Equity - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetail", "shortName": "Shareholders' Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:AllocatedShareBasedCompensationExpense", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:AllocatedShareBasedCompensationExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100310 - Disclosure - Revenue - Summary of Revenue by Payor (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail", "shortName": "Revenue - Summary of Revenue by Payor (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_srtMajorCustomersAxis_ssyMedicareMember_20220701_20220930", "decimals": "-3", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "ssy:HealthCareOrganizationSignificantChangeInEstimates", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100320 - Disclosure - Revenue - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueAdditionalInformationDetail", "shortName": "Revenue - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "ssy:HealthCareOrganizationSignificantChangeInEstimates", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IntangibleAssetsNetExcludingGoodwill", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100330 - Disclosure - Intangible Assets - Intangible Assets (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail", "shortName": "Intangible Assets - Intangible Assets (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapStatementBusinessSegmentsAxis_ssySpecialtyPharmacySegmentMember_20220930", "decimals": "-3", "lang": null, "name": "us-gaap:IntangibleAssetsGrossExcludingGoodwill", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100340 - Disclosure - Intangible Assets - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail", "shortName": "Intangible Assets - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:AmortizationOfIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:LongTermObligationsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "ssy:FinanceLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100350 - Disclosure - Long-Term Debt - Summary of Long-Term Debt (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail", "shortName": "Long-Term Debt - Summary of Long-Term Debt (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:LongTermObligationsTextBlock", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "ssy:FinanceLeaseObligations", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapDebtInstrumentAxis_ssyCARESActPaycheckProtectionProgramMember_20200401_20200531", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLoans", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100360 - Disclosure - Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail", "shortName": "Long-Term Debt (CARES Act Paycheck Protection Plan Loans) - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:LongTermDebtTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapDebtInstrumentAxis_ssyCARESActPaycheckProtectionProgramMember_20200401_20200531", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ProceedsFromLoans", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:IncomeTaxExpenseBenefit", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100370 - Disclosure - Income Taxes - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail", "shortName": "Income Taxes - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxExpenseBenefit", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "lang": null, "name": "us-gaap:CurrentStateAndLocalTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100380 - Disclosure - Lease - Components of Lease Cost and Rent Expense (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail", "shortName": "Lease - Components of Lease Cost and Rent Expense (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ssy:OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100030 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Earnings (Loss)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "lang": null, "name": "us-gaap:LaborAndRelatedExpense", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100390 - Disclosure - Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail", "shortName": "Lease - Summary of Supplemental Balance Sheet Information Relating to Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:SummaryOfSupplementalBalanceSheetInformationTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "lang": null, "name": "us-gaap:FinanceLeaseRightOfUseAsset", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:SummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100400 - Disclosure - Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail", "shortName": "Lease - Summary of Supplemental Cash Flow and Other Information Related to Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:SummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:OperatingLeasePayments", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:SummaryOfNonCancellableOperatingAndFinanceLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100410 - Disclosure - Lease - Summary of Non-cancellable Operating and Finance Leases (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail", "shortName": "Lease - Summary of Non-cancellable Operating and Finance Leases (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ssy:SummaryOfNonCancellableOperatingAndFinanceLeasesTableTextBlock", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "ssy:NumberOfTaxingAuthorities", "reportCount": 1, "unique": true, "unitRef": "U_ssyAuthority", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100430 - Disclosure - Accrued Sales Tax - Additional Information (Details)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTaxAdditionalInformationDetails", "shortName": "Accrued Sales Tax - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "ssy:NumberOfTaxingAuthorities", "reportCount": 1, "unique": true, "unitRef": "U_ssyAuthority", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapExtinguishmentOfDebtAxis_us-gaapLongTermDebtMember_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100440 - Disclosure - Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail", "shortName": "Commitments and Contingencies - Schedule of Contractual Obligations, Commitments and Contingencies (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "srt:ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapExtinguishmentOfDebtAxis_us-gaapLongTermDebtMember_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtManagementMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100450 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_us-gaapRelatedPartyTransactionsByRelatedPartyAxis_srtManagementMember_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_ssySegment", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100460 - Disclosure - Financial Information by Segment - Additional Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentAdditionalInformationDetail", "shortName": "Financial Information by Segment - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "us-gaap:SegmentReportingDisclosureTextBlock", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:NumberOfReportableSegments", "reportCount": 1, "unique": true, "unitRef": "U_ssySegment", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100470 - Disclosure - Financial Information by Segment - Segment Information (Detail)", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "shortName": "Financial Information by Segment - Segment Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20210930", "decimals": "-3", "lang": null, "name": "us-gaap:Assets", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20210630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100040 - Statement - Condensed Consolidated Statements Shareholders' Equity", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity", "shortName": "Condensed Consolidated Statements Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20210630", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "100050 - Statement - Condensed Consolidated Statements of Cash Flows", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows", "shortName": "Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "td", "tr", "table", "div", "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": "-3", "first": true, "lang": null, "name": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "reportCount": 1, "unique": true, "unitRef": "U_iso4217USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100060 - Disclosure - Basis of Presentation", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentation", "shortName": "Basis of Presentation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100070 - Disclosure - Business Operations", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperations", "shortName": "Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "100080 - Disclosure - Discontinued Operations", "role": "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "ssy-10q_20220930.htm", "contextRef": "C_0000096793_20220701_20220930", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 35, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]", "terseLabel": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]", "terseLabel": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r518" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address Address Line1", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address Address Line2", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address City Or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address State Or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r521" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r515" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag", "terseLabel": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "trueItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Security12b Title", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r516" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "tradingSymbolItemType" }, "srt_ConsolidationItemsAxis": { "auth_ref": [ "r101", "r137", "r150", "r151", "r152", "r153", "r155", "r157", "r161", "r212", "r213", "r214", "r215", "r216", "r217", "r219", "r220", "r222", "r224", "r225", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542" ], "lang": { "en-us": { "role": { "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Axis]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "stringItemType" }, "srt_ConsolidationItemsDomain": { "auth_ref": [ "r101", "r137", "r150", "r151", "r152", "r153", "r155", "r157", "r161", "r212", "r213", "r214", "r215", "r216", "r217", "r219", "r220", "r222", "r224", "r225", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542" ], "lang": { "en-us": { "role": { "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments.", "label": "Consolidation Items [Domain]", "terseLabel": "Consolidation Items" } } }, "localname": "ConsolidationItemsDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "domainItemType" }, "srt_ContractualObligationFiscalYearMaturityScheduleTableTextBlock": { "auth_ref": [ "r520" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of contractual obligation by timing of payment due. Includes, but is not limited to, long-term debt obligation, lease obligation, and purchase obligation.", "label": "Contractual Obligation Fiscal Year Maturity Schedule Table [Text Block]", "terseLabel": "Schedule of Contractual Obligations, Commitments and Contingencies" } } }, "localname": "ContractualObligationFiscalYearMaturityScheduleTableTextBlock", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesTables" ], "xbrltype": "textBlockItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r168", "r280", "r284", "r495" ], "lang": { "en-us": { "role": { "documentation": "Information by name or description of a single external customer or a group of external customers.", "label": "Major Customers [Axis]", "terseLabel": "Customer" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "stringItemType" }, "srt_ManagementMember": { "auth_ref": [ "r170", "r434" ], "lang": { "en-us": { "role": { "documentation": "Person or persons designated as part of management.", "label": "Management [Member]", "terseLabel": "Management [Member]" } } }, "localname": "ManagementMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r168", "r280", "r284", "r495" ], "lang": { "en-us": { "role": { "documentation": "Single external customer or group of external customers.", "label": "Name Of Major Customer [Domain]", "terseLabel": "Customer" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r164", "r209", "r210", "r280", "r282", "r442", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Information by product and service, or group of similar products and similar services.", "label": "Product Or Service [Axis]", "terseLabel": "Product and Service" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r164", "r209", "r210", "r280", "r282", "r442", "r492", "r493" ], "lang": { "en-us": { "role": { "documentation": "Product or service, or a group of similar products or similar services.", "label": "Products And Services [Domain]", "terseLabel": "Product and Service" } } }, "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "domainItemType" }, "srt_SegmentGeographicalDomain": { "auth_ref": [ "r165", "r166", "r280", "r283", "r494", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r522", "r524", "r525", "r526", "r527", "r528", "r529", "r530", "r531" ], "lang": { "en-us": { "role": { "documentation": "Geographical area.", "label": "Segment Geographical [Domain]", "terseLabel": "Geographical" } } }, "localname": "SegmentGeographicalDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_StatementGeographicalAxis": { "auth_ref": [ "r165", "r166", "r280", "r283", "r494", "r503", "r505", "r506", "r507", "r508", "r509", "r510", "r511", "r512", "r513", "r522", "r523" ], "lang": { "en-us": { "role": { "documentation": "Information by geographical components.", "label": "Statement Geographical [Axis]", "terseLabel": "Geographical" } } }, "localname": "StatementGeographicalAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "ssy_AccumulatedOtherComprehensiveLossMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Accumulated Other Comprehensive Loss [Member]", "label": "Accumulated Other Comprehensive Loss [Member]", "terseLabel": "Accumulated Other Comprehensive Loss [Member]" } } }, "localname": "AccumulatedOtherComprehensiveLossMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "domainItemType" }, "ssy_AcuteCareHospitalMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Acute care hospital.", "label": "Acute Care Hospital [Member]", "terseLabel": "Acute Care Hospital [Member]" } } }, "localname": "AcuteCareHospitalMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_AreaOfUnimprovedLandOwnedBySubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area of unimproved land owned by subsidiary.", "label": "Area Of Unimproved Land Owned By Subsidiary", "terseLabel": "Area of unimproved land owned by subsidiary" } } }, "localname": "AreaOfUnimprovedLandOwnedBySubsidiary", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "ssy_AssetPurchaseAgreementAndRelatedLicenseAgreementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Asset Purchase Agreement And Related License Agreement [Abstract]", "label": "Asset Purchase Agreement And Related License Agreement [Abstract]" } } }, "localname": "AssetPurchaseAgreementAndRelatedLicenseAgreementAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "xbrltype": "stringItemType" }, "ssy_BusinessAndOrganizationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business And Organization [Line Items]", "label": "Business And Organization [Line Items]", "terseLabel": "Business And Organization [Line Items]" } } }, "localname": "BusinessAndOrganizationLineItems", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "ssy_BusinessAndOrganizationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business And Organization [Table]", "label": "Business And Organization [Table]", "terseLabel": "Business And Organization [Table]" } } }, "localname": "BusinessAndOrganizationTable", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "ssy_CARESActPaycheckProtectionProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CARES Act, Paycheck Protection Program.", "label": "C A R E S Act Paycheck Protection Program [Member]", "terseLabel": "CARES Act Paycheck Protection Plan Loans [Member]" } } }, "localname": "CARESActPaycheckProtectionProgramMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cash paid for amounts included in measurement of lease liabilities.", "label": "Cash Paid For Amounts Included In Measurement Of Lease Liabilities [Abstract]", "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities:" } } }, "localname": "CashPaidForAmountsIncludedInMeasurementOfLeaseLiabilitiesAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "stringItemType" }, "ssy_CommitmentAndContingenciesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Line Items]", "label": "Commitment And Contingencies [Line Items]", "terseLabel": "Commitment And Contingencies [Line Items]" } } }, "localname": "CommitmentAndContingenciesLineItems", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "stringItemType" }, "ssy_CommitmentAndContingenciesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment And Contingencies [Table]", "label": "Commitment And Contingencies [Table]", "terseLabel": "Commitment And Contingencies [Table]" } } }, "localname": "CommitmentAndContingenciesTable", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "stringItemType" }, "ssy_CommitmentContingencyAndRelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commitment, Contingency And Related Party Transactions [Abstract]", "label": "Commitment Contingency And Related Party Transactions [Abstract]" } } }, "localname": "CommitmentContingencyAndRelatedPartyTransactionsAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "xbrltype": "stringItemType" }, "ssy_CommonSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common shares.", "label": "Common Shares [Member]", "terseLabel": "Common Shares [Member]" } } }, "localname": "CommonSharesMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "domainItemType" }, "ssy_DebtForgivenessAccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt forgiveness accrued interest.", "label": "Debt Forgiveness Accrued Interest", "terseLabel": "Debt forgiveness accrued interest" } } }, "localname": "DebtForgivenessAccruedInterest", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_DebtForgivenessIncomeRelatedToLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt forgiveness income related to loan.", "label": "Debt Forgiveness Income Related To Loan", "terseLabel": "Debt forgiveness income related to loan" } } }, "localname": "DebtForgivenessIncomeRelatedToLoan", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_DebtInstrumentForgivenessAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt instrument forgiveness amount.", "label": "Debt Instrument Forgiveness Amount", "terseLabel": "Debt instrument forgiveness amount" } } }, "localname": "DebtInstrumentForgivenessAmount", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_EarningsLossPerShareContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings (loss) per share continuing operations.", "label": "Earnings Loss Per Share Continuing Operations [Abstract]", "terseLabel": "Continuing Operations:" } } }, "localname": "EarningsLossPerShareContinuingOperationsAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "ssy_EarningsLossPerShareDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Earnings (loss) per share discontinued operations.", "label": "Earnings Loss Per Share Discontinued Operations [Abstract]", "terseLabel": "Discontinued Operations:" } } }, "localname": "EarningsLossPerShareDiscontinuedOperationsAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "ssy_EmployeeRetentionCreditAmendingQuarterlyPayrollTaxFilingAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Employee retention credit amending quarterly payroll tax filing amount.", "label": "Employee Retention Credit Amending Quarterly Payroll Tax Filing Amount", "verboseLabel": "Employee retention credit amending quarterly payroll tax filing amount" } } }, "localname": "EmployeeRetentionCreditAmendingQuarterlyPayrollTaxFilingAmount", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_EmployeeRetentionCreditsReceivableCurrent": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10330.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee retention credits receivable current.", "label": "Employee Retention Credits Receivable Current", "terseLabel": "Employee retention credits receivable" } } }, "localname": "EmployeeRetentionCreditsReceivableCurrent", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ssy_FederalStimulusPandemicReliefFunds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Federal stimulus pandemic relief funds.", "label": "Federal Stimulus Pandemic Relief Funds", "terseLabel": "Recognized amount related to provide relief fund as other income" } } }, "localname": "FederalStimulusPandemicReliefFunds", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_FederalStimulusProviderReliefFunds": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10140.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Federal stimulus provider relief funds.", "label": "Federal Stimulus Provider Relief Funds", "verboseLabel": "Federal stimulus - Provider relief funds" } } }, "localname": "FederalStimulusProviderReliefFunds", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "ssy_FinanceLeaseCost": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Finance lease cost.", "label": "Finance Lease Cost", "totalLabel": "Total finance lease cost" } } }, "localname": "FinanceLeaseCost", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "ssy_FinanceLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10080.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance lease liability payments due after year four.", "label": "Finance Lease Liability Payments Due After Year Four", "terseLabel": "Over 5 years" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "ssy_FinanceLeaseObligations": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail": { "order": 10010.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Finance lease obligations.", "label": "Finance Lease Obligations", "terseLabel": "Capital Lease" } } }, "localname": "FinanceLeaseObligations", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "ssy_ForgivenessOfPPPLoansAndAccruedInterest": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10130.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forgiveness of PPP loans and accrued interest.", "label": "Forgiveness Of P P P Loans And Accrued Interest", "terseLabel": "Forgiveness of PPP loans and accrued interest" } } }, "localname": "ForgivenessOfPPPLoansAndAccruedInterest", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "ssy_HealthCareOrganizationSignificantChangeInEstimates": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Health care organization significant change in estimates.", "label": "Health Care Organization Significant Change In Estimates", "terseLabel": "Net revenues for positive settlements and filings of prior year Medicare and Medicaid cost reports" } } }, "localname": "HealthCareOrganizationSignificantChangeInEstimates", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_HealthcareAndPharmacySegmentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare and Pharmacy segments.", "label": "Healthcare And Pharmacy Segments [Member]", "terseLabel": "Healthcare and Pharmacy segments [Member]" } } }, "localname": "HealthcareAndPharmacySegmentsMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_HealthcareServicesSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Healthcare services segment.", "label": "Healthcare Services Segment [Member]", "terseLabel": "Healthcare Services Segment [Member]" } } }, "localname": "HealthcareServicesSegmentMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_IntangibleLiabilityDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible Liability Disclosure [Abstract]", "label": "Intangible Liability Disclosure [Abstract]" } } }, "localname": "IntangibleLiabilityDisclosureAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "xbrltype": "stringItemType" }, "ssy_InterestOnOutstandingDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest on outstanding debt.", "label": "Interest On Outstanding Debt [Member]", "terseLabel": "Interest on Outstanding Debt [Member]" } } }, "localname": "InterestOnOutstandingDebtMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "domainItemType" }, "ssy_InterestPaidReceivedNet": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest paid received net.", "label": "Interest Paid Received Net", "terseLabel": "Interest" } } }, "localname": "InterestPaidReceivedNet", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ssy_LesseeFinanceLeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee finance lease cost.", "label": "Lessee Finance Lease Cost [Abstract]", "terseLabel": "Finance lease cost:" } } }, "localname": "LesseeFinanceLeaseCostAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "stringItemType" }, "ssy_LesseeFinanceLeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee finance leases.", "label": "Lessee Finance Leases [Abstract]", "terseLabel": "Finance Leases:" } } }, "localname": "LesseeFinanceLeasesAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "stringItemType" }, "ssy_LesseeOperatingLeaseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease.", "label": "Lessee Operating Lease [Abstract]", "terseLabel": "Operating Leases:" } } }, "localname": "LesseeOperatingLeaseAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "stringItemType" }, "ssy_LesseeOperatingLeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lessee operating lease cost.", "label": "Lessee Operating Lease Cost [Abstract]", "terseLabel": "Operating lease cost:" } } }, "localname": "LesseeOperatingLeaseCostAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "stringItemType" }, "ssy_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10160.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Lessee operating lease liability payments due after year four.", "label": "Lessee Operating Lease Liability Payments Due After Year Four", "terseLabel": "Over 5 years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFour", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "ssy_LifeSciencesAndEngineeringSegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Life sciences and engineering segment.", "label": "Life Sciences And Engineering Segment [Member]", "terseLabel": "Life Sciences and Engineering [Member]" } } }, "localname": "LifeSciencesAndEngineeringSegmentMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "domainItemType" }, "ssy_LongTermObligationsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long term obligations.", "label": "Long Term Obligations [Text Block]", "terseLabel": "Summary of Long-Term Debt" } } }, "localname": "LongTermObligationsTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtTables" ], "xbrltype": "textBlockItemType" }, "ssy_ManagedCareAndOtherInsurersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Managed care and other insurers.", "label": "Managed Care And Other Insurers [Member]", "terseLabel": "Managed Care & Other Insurance [Member]" } } }, "localname": "ManagedCareAndOtherInsurersMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_MedicaidMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicaid.", "label": "Medicaid [Member]", "terseLabel": "Medicaid [Member]" } } }, "localname": "MedicaidMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_MedicareLicenseMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicare license.", "label": "Medicare License [Member]", "terseLabel": "Medicare License [Member]" } } }, "localname": "MedicareLicenseMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "ssy_MedicareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Medicare.", "label": "Medicare [Member]", "terseLabel": "Medicare [Member]" } } }, "localname": "MedicareMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_NetOperatingLossCarryForwardsExpirePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Net Operating Loss Carry Forwards Expire Period", "label": "Net Operating Loss Carry Forwards Expire Period", "terseLabel": "Net operating loss carryforward expiration year" } } }, "localname": "NetOperatingLossCarryForwardsExpirePeriod", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "ssy_NumberOfBedInExtendedCareAndRehabilitationCenterOwnedAndOperatedBySubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of bed in extended care and rehabilitation center owned and operated by subsidiary.", "label": "Number Of Bed In Extended Care And Rehabilitation Center Owned And Operated By Subsidiary", "terseLabel": "Number of bed in extended care and rehabilitation center owned and operated by subsidiary" } } }, "localname": "NumberOfBedInExtendedCareAndRehabilitationCenterOwnedAndOperatedBySubsidiary", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "ssy_NumberOfBedInGeriatricPsychiatricUnitsOwnedAndOperatedBySubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of bed in geriatric psychiatric units owned and operated by subsidiary.", "label": "Number Of Bed In Geriatric Psychiatric Units Owned And Operated By Subsidiary", "verboseLabel": "Number of bed in geriatric psychology unit owned and operated by subsidiary" } } }, "localname": "NumberOfBedInGeriatricPsychiatricUnitsOwnedAndOperatedBySubsidiary", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "ssy_NumberOfLicensedBedOwnedAndOperatedBySubsidiary": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of licensed-bed owned and operated by subsidiary.", "label": "Number Of Licensed Bed Owned And Operated By Subsidiary", "terseLabel": "Number of licensed-bed owned and operated by a subsidiary" } } }, "localname": "NumberOfLicensedBedOwnedAndOperatedBySubsidiary", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "ssy_NumberOfOperationalAreas": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of operational areas.", "label": "Number Of Operational Areas", "terseLabel": "Number of operational areas" } } }, "localname": "NumberOfOperationalAreas", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "ssy_NumberOfTaxingAuthorities": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of taxing Authorities.", "label": "Number Of Taxing Authorities", "terseLabel": "Number of taxing authorities" } } }, "localname": "NumberOfTaxingAuthorities", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTaxAdditionalInformationDetails" ], "xbrltype": "integerItemType" }, "ssy_OperatingCashFlowsFromFinanceLease": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Operating cash flows from finance lease.", "label": "Operating Cash Flows From Finance Lease", "terseLabel": "Operating cash flows from finance leases" } } }, "localname": "OperatingCashFlowsFromFinanceLease", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "ssy_OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Operating leases and finance leases of lessee disclosure.", "label": "Operating Leases And Finance Leases Of Lessee Disclosure [Text Block]", "terseLabel": "Leases" } } }, "localname": "OperatingLeasesAndFinanceLeasesOfLesseeDisclosureTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeases" ], "xbrltype": "textBlockItemType" }, "ssy_OperatingVariableLeaseCost": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": 10050.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operating variable lease cost.", "label": "Operating Variable Lease Cost", "terseLabel": "Variable lease cost" } } }, "localname": "OperatingVariableLeaseCost", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "ssy_OtherMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other.", "label": "Other [Member]", "terseLabel": "Other [Member]" } } }, "localname": "OtherMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_PaycheckProtectionProgramCARESActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program, CARES Act.", "label": "Paycheck Protection Program C A R E S Act [Member]", "terseLabel": "Paycheck Protection Program, CARES Act [Member]" } } }, "localname": "PaycheckProtectionProgramCARESActMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_PensionExpenseTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pension expense.", "label": "Pension Expense Table [Text Block]", "terseLabel": "Components of Pension Expense" } } }, "localname": "PensionExpenseTableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "ssy_PharmacySegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pharmacy segment.", "label": "Pharmacy Segment [Member]", "terseLabel": "Pharmacy Segment [Member]" } } }, "localname": "PharmacySegmentMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_PreferredSharePurchaseRightsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred Share Purchase Rights.", "label": "Preferred Share Purchase Rights [Member]", "terseLabel": "Preferred Share Purchase Rights [Member]" } } }, "localname": "PreferredSharePurchaseRightsMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "ssy_ProceedsFromEmployeeRetentionCredit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from employee retention credit.", "label": "Proceeds From Employee Retention Credit", "terseLabel": "Proceeds from employee retention credit" } } }, "localname": "ProceedsFromEmployeeRetentionCredit", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_ProceedsFromShareOptionExercises": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10060.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from share option exercises.", "label": "Proceeds From Share Option Exercises", "terseLabel": "Proceeds from share option exercises" } } }, "localname": "ProceedsFromShareOptionExercises", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ssy_ProceedsUnderReliefFundDistributions": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds under relief fund distributions.", "label": "Proceeds Under Relief Fund Distributions", "terseLabel": "Proceeds under relief fund distributions" } } }, "localname": "ProceedsUnderReliefFundDistributions", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "ssy_ProfessionalLiabilityRisksNonCurrent": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10110.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Professional liability risks, noncurrent.", "label": "Professional Liability Risks Non Current", "terseLabel": "Noncurrent liability for professional liability risks" } } }, "localname": "ProfessionalLiabilityRisksNonCurrent", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ssy_ProviderReliefFundDistributionsCARESActMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Provider relief fund distributions CARES Act.", "label": "Provider Relief Fund Distributions C A R E S Act [Member]", "terseLabel": "Provider Relief Fund Distributions CARES Act [Member]" } } }, "localname": "ProviderReliefFundDistributionsCARESActMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "ssy_RetailAndInstitutionalPharmacyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Retail and Institutional Pharmacy.", "label": "Retail And Institutional Pharmacy [Member]", "terseLabel": "Retail and Institutional Pharmacy [Member]" } } }, "localname": "RetailAndInstitutionalPharmacyMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_RightOfUseAssetObtainedInExchangeForLeaseLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Right of use asset obtained in exchange for lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiability", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "ssy_SalesTaxPayableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sales tax payable.", "label": "Sales Tax Payable [Text Block]", "terseLabel": "Accrued Sales Tax" } } }, "localname": "SalesTaxPayableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTax" ], "xbrltype": "textBlockItemType" }, "ssy_ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of intangible assets excluding goodwill.", "label": "Schedule Of Intangible Assets Excluding Goodwill Table [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "ScheduleOfIntangibleAssetsExcludingGoodwillTableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "ssy_SelfPayorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Self payor.", "label": "Self Payor [Member]", "terseLabel": "Self-Pay [Member]" } } }, "localname": "SelfPayorMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "domainItemType" }, "ssy_ShortTermLeaseCostIncome": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": 10040.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Short term lease cost income.", "label": "Short Term Lease Cost Income", "terseLabel": "Short-term rent expense" } } }, "localname": "ShortTermLeaseCostIncome", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "ssy_SpecialtyPharmacySegmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Specialty pharmacy.", "label": "Specialty Pharmacy Segment [Member]", "terseLabel": "Specialty Pharmacy Segment [Member]" } } }, "localname": "SpecialtyPharmacySegmentMember", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "ssy_SummaryOfNonCancellableOperatingAndFinanceLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of non-cancellable operating and finance leases.", "label": "Summary Of Non Cancellable Operating And Finance Leases Table [Text Block]", "terseLabel": "Summary of Non-cancellable Operating and Finance Leases" } } }, "localname": "SummaryOfNonCancellableOperatingAndFinanceLeasesTableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "ssy_SummaryOfSupplementalBalanceSheetInformationTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary Of Supplemental Balance Sheet Information.", "label": "Summary Of Supplemental Balance Sheet Information Table [Text Block]", "terseLabel": "Summary of Supplemental Balance Sheet Information" } } }, "localname": "SummaryOfSupplementalBalanceSheetInformationTableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "ssy_SummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary Of Supplemental Cash Flow And Other Information Related To Leases.", "label": "Summary Of Supplemental Cash Flow And Other Information Related To Leases Table [Text Block]", "terseLabel": "Summary of Supplemental Cash Flow and Other Information Related to Leases" } } }, "localname": "SummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesTableTextBlock", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "ssy_SupplementalCashFlowInformationCashPaidForReceivedFromIncomeTaxesAndInterestAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Supplemental cash flow information cash paid for received from income taxes and interest.", "label": "Supplemental Cash Flow Information Cash Paid For Received From Income Taxes And Interest [Abstract]", "terseLabel": "Cash Paid (Received) for:" } } }, "localname": "SupplementalCashFlowInformationCashPaidForReceivedFromIncomeTaxesAndInterestAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "ssy_UnearnedCARESActFunds": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10190.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Unearned CARES Act funds.", "label": "Unearned C A R E S Act Funds", "terseLabel": "Unearned CARES Act Funds" } } }, "localname": "UnearnedCARESActFunds", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "ssy_WeightedAverageDiscountRateAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Discount Rate.", "label": "Weighted Average Discount Rate [Abstract]", "terseLabel": "Weighted-average discount rate:" } } }, "localname": "WeightedAverageDiscountRateAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "stringItemType" }, "ssy_WeightedAverageLeaseTermAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Lease Term.", "label": "Weighted Average Lease Term [Abstract]", "terseLabel": "Weighted-average remaining lease term:" } } }, "localname": "WeightedAverageLeaseTermAbstract", "nsuri": "http://www.sunlinkhealth.com/20220930", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "stringItemType" }, "stpr_GA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "GEORGIA", "terseLabel": "Georgia [Member]" } } }, "localname": "GA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_LA": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "LOUISIANA", "terseLabel": "Louisiana [Member]" } } }, "localname": "LA", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "stpr_MS": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "MISSISSIPPI", "terseLabel": "Mississippi [Member]" } } }, "localname": "MS", "nsuri": "http://xbrl.sec.gov/stpr/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r50", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10150.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r100", "r432", "r462", "r483" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount for accounts payable to related parties.", "label": "Accounts Payable Related Parties Current And Noncurrent", "terseLabel": "Amount payable to law firms" } } }, "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r32", "r198" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10290.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation Depletion And Amortization Property Plant And Equipment", "terseLabel": "Less accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "auth_ref": [ "r46", "r58", "r59", "r60", "r477", "r500", "r501" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10090.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.", "label": "Accumulated Other Comprehensive Income Loss Net Of Tax", "terseLabel": "Accumulated other comprehensive loss" } } }, "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r44" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10070.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional Paid In Capital Common Stock", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r102", "r103", "r104", "r357", "r358", "r359", "r396" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid In Capital [Member]", "terseLabel": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r356" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Allocated Share Based Compensation Expense", "terseLabel": "Share-based compensation, amount recognized" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r88", "r184", "r191" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization Of Intangible Assets", "terseLabel": "Amortization expense" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r36", "r96", "r145", "r152", "r159", "r171", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r221", "r223", "r225", "r226", "r387", "r390", "r399", "r438", "r440", "r458", "r476" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "terseLabel": "Assets", "totalLabel": "TOTAL ASSETS" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "ASSETS" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r25", "r49", "r96", "r171", "r212", "r213", "r214", "r216", "r217", "r218", "r219", "r221", "r223", "r225", "r226", "r387", "r390", "r399", "r438", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10220.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets Noncurrent [Abstract]", "terseLabel": "Noncurrent Assets:" } } }, "localname": "AssetsNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10240.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets, excluding property, plant, and equipment and other property and investments, that are expected to be realized in cash, sold or consumed after one year or beyond the normal operating cycle, if longer. Alternate captions include Total Deferred Charges and Other Assets.", "label": "Assets Noncurrent Other Than Noncurrent Investments And Property Plant And Equipment", "totalLabel": "Total noncurrent assets" } } }, "localname": "AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis Of Accounting Policy Policy [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentationPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r23", "r30", "r90" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10300.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash And Cash Equivalents At Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r84", "r90", "r92" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents", "periodEndLabel": "Cash and Cash Equivalents End of Period", "periodStartLabel": "Cash and Cash Equivalents Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r84", "r400" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect", "totalLabel": "Net Decrease in Cash and Cash Equivalents" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r41", "r42", "r43", "r93", "r96", "r117", "r118", "r119", "r121", "r123", "r127", "r128", "r129", "r171", "r212", "r217", "r218", "r219", "r225", "r226", "r251", "r252", "r254", "r258", "r264", "r399", "r519" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class Of Stock [Domain]", "terseLabel": "Class of Stock" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r56", "r463", "r482" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10030.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments And Contingencies", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments And Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r206", "r207", "r208", "r211", "r504" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments And Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r102", "r103", "r396" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock No Par Value", "terseLabel": "Common shares, without par value" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r43" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock Shares Issued", "terseLabel": "Common shares, issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r43", "r264" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock Shares Outstanding", "periodEndLabel": "Ending Balance, Shares", "periodStartLabel": "Beginning Balance,Shares", "terseLabel": "Common shares, outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r43", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10060.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock Value", "terseLabel": "Common Shares, without par value: Issued and outstanding, 7,032 shares at September 30, 2022 and 6,954 at June 30, 2022" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomeNetOfTax": { "auth_ref": [ "r63", "r65", "r66", "r74", "r468", "r488" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.", "label": "Comprehensive Income Net Of Tax", "totalLabel": "Comprehensive Earnings (Loss)" } } }, "localname": "ComprehensiveIncomeNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligation": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation, including but not limited to, long-term debt, capital lease obligations, operating lease obligations, purchase obligations, and other commitments.", "label": "Contractual Obligation", "totalLabel": "Contractual obligations, commitments and contingencies" } } }, "localname": "ContractualObligation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInFourthYear": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": 10050.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation Due In Fourth Year", "terseLabel": "Payments due within 5years" } } }, "localname": "ContractualObligationDueInFourthYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInNextTwelveMonths": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": 10020.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation Due In Next Twelve Months", "terseLabel": "Payments due within 2 years" } } }, "localname": "ContractualObligationDueInNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInSecondYear": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": 10030.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation Due In Second Year", "terseLabel": "Payments due within in 3 years" } } }, "localname": "ContractualObligationDueInSecondYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationDueInThirdYear": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": 10040.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Contractual Obligation Due In Third Year", "terseLabel": "Payments due within 4 years" } } }, "localname": "ContractualObligationDueInThirdYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail": { "order": 10010.0, "parentTag": "us-gaap_ContractualObligation", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of contractual obligation to be paid in remainder of current fiscal year.", "label": "Contractual Obligation Future Minimum Payments Due Remainder Of Fiscal Year", "terseLabel": "Payments due within 1 year" } } }, "localname": "ContractualObligationFutureMinimumPaymentsDueRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CorporateNonSegmentMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r155", "r161", "r163" ], "lang": { "en-us": { "role": { "documentation": "Corporate headquarters or functional department that may not earn revenues or may earn revenues that are only incidental to the activities of the entity and is not considered an operating segment.", "label": "Corporate Non Segment [Member]", "terseLabel": "Corporate and Other [Member]" } } }, "localname": "CorporateNonSegmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfGoodsAndServicesSold": { "auth_ref": [ "r78", "r442" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10170.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.", "label": "Cost Of Goods And Services Sold", "terseLabel": "Cost of goods sold" } } }, "localname": "CostOfGoodsAndServicesSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs And Expenses [Abstract]", "terseLabel": "Costs and Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r97", "r369", "r374" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State And Local Tax Expense Benefit", "terseLabel": "State tax expense (benefit)" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r37", "r38", "r39", "r95", "r101", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r410", "r459", "r460", "r475" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]", "terseLabel": "Debt Instrument" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Instrument [Line Items]", "terseLabel": "Debt Instrument [Line Items]" } } }, "localname": "DebtInstrumentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r54", "r95", "r101", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r245", "r246", "r247", "r248", "r410" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.", "label": "Debt Instrument Name [Domain]", "terseLabel": "Debt Instrument, Name" } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentTable": { "auth_ref": [ "r54", "r95", "r101", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r234", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r265", "r266", "r267", "r268", "r408", "r409", "r410", "r411", "r474" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Debt Instrument [Table]", "terseLabel": "Debt Instrument [Table]" } } }, "localname": "DebtInstrumentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r360", "r361" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10130.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred Income Tax Liabilities Net", "terseLabel": "Deferred income taxes" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r366" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets Net", "terseLabel": "Net long-term deferred income tax asset or liability" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r365" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets Valuation Allowance", "terseLabel": "Deferred income tax valuation allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilities": { "auth_ref": [ "r361", "r366" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.", "label": "Deferred Tax Liabilities", "verboseLabel": "Long-term deferred tax liability" } } }, "localname": "DeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanAmortizationOfPriorServiceCostCredit": { "auth_ref": [ "r289", "r327", "r346", "r351", "r352" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail": { "order": 10030.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of prior service cost (credit) recognized in net periodic benefit cost (credit) of defined benefit plan.", "label": "Defined Benefit Plan Amortization Of Prior Service Cost Credit", "terseLabel": "Amortization of prior service cost" } } }, "localname": "DefinedBenefitPlanAmortizationOfPriorServiceCostCredit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanDisclosureLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Defined Benefit Plan Disclosure [Line Items]", "terseLabel": "Defined Benefit Plan Disclosure [Line Items]" } } }, "localname": "DefinedBenefitPlanDisclosureLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear": { "auth_ref": [ "r349", "r352" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of contribution expected to be received by defined benefit plan from employer in remainder of current fiscal year. Excludes contribution previously paid by employer in current fiscal year.", "label": "Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year", "terseLabel": "Expected contribution to pension plan during the remaining fiscal year" } } }, "localname": "DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanExpectedReturnOnPlanAssets": { "auth_ref": [ "r289", "r325", "r344", "r351", "r352" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail": { "order": 10020.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of expected return (loss) recognized in net periodic benefit (cost) credit, calculated based on expected long-term rate of return and market-related value of plan assets of defined benefit plan.", "label": "Defined Benefit Plan Expected Return On Plan Assets", "negatedLabel": "Expected return on assets" } } }, "localname": "DefinedBenefitPlanExpectedReturnOnPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanInterestCost": { "auth_ref": [ "r289", "r293", "r324", "r343", "r351", "r352" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail": { "order": 10010.0, "parentTag": "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost recognized for passage of time related to defined benefit plan.", "label": "Defined Benefit Plan Interest Cost", "terseLabel": "Interest Cost" } } }, "localname": "DefinedBenefitPlanInterestCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanNetPeriodicBenefitCost": { "auth_ref": [ "r322", "r341", "r351", "r352" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of net periodic benefit cost (credit) for defined benefit plan.", "label": "Defined Benefit Plan Net Periodic Benefit Cost", "totalLabel": "Net pension expense" } } }, "localname": "DefinedBenefitPlanNetPeriodicBenefitCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DefinedBenefitPlanTypeExtensibleList": { "auth_ref": [ "r286", "r287", "r288", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r338", "r341", "r342", "r343", "r344", "r345", "r346", "r347", "r348", "r349", "r350" ], "lang": { "en-us": { "role": { "documentation": "Indicates type of defined benefit plan. Includes, but is not limited to, pension plan, other postretirement plan and special and contractual termination benefits payable upon retirement.", "label": "Defined Benefit Plan Type Extensible List", "terseLabel": "Defined Benefit Plan, Type [Extensible List]" } } }, "localname": "DefinedBenefitPlanTypeExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r88", "r196" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10230.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation And Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r280" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "Disaggregation Of Revenue Table [Text Block]", "terseLabel": "Summary of Revenues by Payor" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations And Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r21", "r203" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups Including Discontinued Operations Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "auth_ref": [ "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "Name of disposal group.", "label": "Disposal Groups Including Discontinued Operations Name [Domain]", "terseLabel": "Disposal Group Name" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "domainItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Net Earnings (Loss):" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r75", "r107", "r108", "r109", "r110", "r111", "r115", "r117", "r121", "r122", "r123", "r124", "r125", "r397", "r398", "r469", "r489" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share Basic", "totalLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r75", "r107", "r108", "r109", "r110", "r111", "r117", "r121", "r122", "r123", "r124", "r125", "r397", "r398", "r469", "r489" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share Diluted", "totalLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10170.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Employee Related Liabilities Current", "terseLabel": "Accrued payroll and related taxes" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r67", "r68", "r69", "r102", "r103", "r104", "r106", "r112", "r114", "r126", "r172", "r264", "r269", "r357", "r358", "r359", "r370", "r371", "r396", "r401", "r402", "r403", "r404", "r405", "r406", "r428", "r496", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]", "terseLabel": "Equity Component" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_ExtinguishmentOfDebtAxis": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Information pertaining to the debt extinguished including the amount of gain (loss), the income tax effect on the gain (loss), and the amount of gain (loss), net or the related income tax, by debt instrument.", "label": "Extinguishment Of Debt [Axis]", "terseLabel": "Extinguishment of Debt" } } }, "localname": "ExtinguishmentOfDebtAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ExtinguishmentOfDebtTypeDomain": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Type of debt extinguished.", "label": "Extinguishment Of Debt Type [Domain]", "terseLabel": "Extinguishment of Debt, Type" } } }, "localname": "ExtinguishmentOfDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FederalHomeLoanBanksAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Federal Home Loan Banks [Abstract]" } } }, "localname": "FederalHomeLoanBanksAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FinanceLeaseInterestExpense": { "auth_ref": [ "r415", "r419", "r427" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": 10020.0, "parentTag": "ssy_FinanceLeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense on finance lease liability.", "label": "Finance Lease Interest Expense", "terseLabel": "Interest on finance lease liabilities" } } }, "localname": "FinanceLeaseInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiability": { "auth_ref": [ "r413", "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": 10020.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.", "label": "Finance Lease Liability", "totalLabel": "Total liabilities" } } }, "localname": "FinanceLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10010.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.", "label": "Finance Lease Liability Current", "negatedLabel": "Less: Current portion", "terseLabel": "Current finance lease liabilities" } } }, "localname": "FinanceLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes current finance lease liability.", "label": "Finance Lease Liability Current Statement Of Financial Position Extensible List", "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10020.0, "parentTag": "us-gaap_FinanceLeaseLiability", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.", "label": "Finance Lease Liability Noncurrent", "terseLabel": "Long-term finance lease liabilities" } } }, "localname": "FinanceLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability.", "label": "Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List", "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDue": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Payments Due", "totalLabel": "Total minimum future payments" } } }, "localname": "FinanceLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10040.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Next Twelve Months", "terseLabel": "2 years" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10070.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Four", "terseLabel": "5 years" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10060.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Three", "terseLabel": "4 years" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10050.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Finance Lease Liability Payments Due Year Two", "terseLabel": "3 years" } } }, "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10030.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in remainder of current fiscal year.", "label": "Finance Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "1 year" } } }, "localname": "FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": 10010.0, "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.", "label": "Finance Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeasePrincipalPayments": { "auth_ref": [ "r417", "r421" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for principal payment on finance lease.", "label": "Finance Lease Principal Payments", "terseLabel": "Financing cash flow from finance leases" } } }, "localname": "FinanceLeasePrincipalPayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAsset": { "auth_ref": [ "r412" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.", "label": "Finance Lease Right Of Use Asset", "terseLabel": "Finance Lease ROU Assets" } } }, "localname": "FinanceLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetAmortization": { "auth_ref": [ "r415", "r419", "r427" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": 10010.0, "parentTag": "ssy_FinanceLeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.", "label": "Finance Lease Right Of Use Asset Amortization", "terseLabel": "Amortization right-of-use assets" } } }, "localname": "FinanceLeaseRightOfUseAssetAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList": { "auth_ref": [ "r414" ], "lang": { "en-us": { "role": { "documentation": "Indicates line item in statement of financial position that includes finance lease right-of-use asset.", "label": "Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List", "terseLabel": "Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]" } } }, "localname": "FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "enumerationSetItemType" }, "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r424", "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for finance lease calculated at point in time.", "label": "Finance Lease Weighted Average Discount Rate Percent", "terseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r423", "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Finance Lease Weighted Average Remaining Lease Term1", "terseLabel": "Finance leases" } } }, "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r34", "r190" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail": { "order": 10020.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Accumulated Amortization", "negatedLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r185", "r187", "r190", "r193", "r443", "r444" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Finite-Lived Intangible Assets by Major Class" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r190", "r444" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail": { "order": 10040.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite Lived Intangible Assets Gross", "terseLabel": "Finite-Lived Intangible Assets, Gross" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r185", "r189" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Finite-Lived Intangible Assets, Major Class Name" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_GainsLossesOnSalesOfAssets": { "auth_ref": [], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10120.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets utilized in financial service operations.", "label": "Gains Losses On Sales Of Assets", "terseLabel": "Gains on sale of assets" } } }, "localname": "GainsLossesOnSalesOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill And Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r77", "r89", "r107", "r108", "r109", "r110", "r120", "r123", "r384" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10070.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income Loss From Continuing Operations", "totalLabel": "Earnings (Loss) from Continuing Operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r71", "r145", "r151", "r155", "r158", "r161", "r457", "r465", "r472", "r490" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10090.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest", "totalLabel": "Earnings (Loss) from Continuing Operations before income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r70", "r75", "r105", "r107", "r108", "r109", "r110", "r117", "r121", "r122", "r398", "r464", "r466", "r469", "r484" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10030.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income Loss From Continuing Operations Per Basic Share", "terseLabel": "Basic" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r70", "r75", "r105", "r107", "r108", "r109", "r110", "r117", "r121", "r122", "r123", "r398", "r469", "r484", "r487", "r489" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10010.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income Loss From Continuing Operations Per Diluted Share", "terseLabel": "Diluted" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r3", "r4", "r5", "r6", "r7", "r15", "r17", "r385" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10080.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity", "terseLabel": "Loss from Discontinued Operations, net of tax" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r72", "r75", "r118", "r121", "r122", "r469", "r485", "r487", "r489" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10040.0, "parentTag": "us-gaap_EarningsPerShareBasic", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income Loss From Discontinued Operations Net Of Tax Per Basic Share", "terseLabel": "Basic" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare": { "auth_ref": [ "r118", "r121", "r122", "r393" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10020.0, "parentTag": "us-gaap_EarningsPerShareDiluted", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Income Loss From Discontinued Operations Net Of Tax Per Diluted Share", "terseLabel": "Diluted" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "auth_ref": [ "r353", "r354" ], "lang": { "en-us": { "role": { "documentation": "Information by name of disposal group.", "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis]", "terseLabel": "Disposal Group Name" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]", "terseLabel": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r2", "r9", "r10", "r11", "r12", "r13", "r14", "r16", "r18", "r19", "r20", "r201", "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]", "terseLabel": "Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r98", "r363", "r364", "r367", "r372", "r375", "r377", "r378", "r379" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the additional liability or refund received or expected based on a final settlement with a taxing authority.", "label": "Income Tax Examination Liability Refund Adjustment From Settlement With Taxing Authority", "terseLabel": "Amounts claimed and received" } } }, "localname": "IncomeTaxExaminationLiabilityRefundAdjustmentFromSettlementWithTaxingAuthority", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTaxAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r99", "r113", "r114", "r143", "r362", "r373", "r376", "r491" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10100.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Income Tax Expense Benefit", "terseLabel": "Income Tax Expense (Benefit)", "verboseLabel": "Income tax expense (benefit)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r91" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid Net", "terseLabel": "Income taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r186", "r192" ], "lang": { "en-us": { "role": { "documentation": "Information by type or class of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets By Major Class [Axis]", "terseLabel": "Indefinite-Lived Intangible Assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Indefinite Lived Intangible Assets By Major Class [Line Items]", "terseLabel": "Indefinite-lived Intangible Assets [Line Items]" } } }, "localname": "IndefiniteLivedIntangibleAssetsByMajorClassLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "auth_ref": [ "r192" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail": { "order": 10030.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.", "label": "Indefinite Lived Intangible Assets Excluding Goodwill", "terseLabel": "Indefinite-Lived Intangible Assets" } } }, "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IndefiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r186", "r192" ], "lang": { "en-us": { "role": { "documentation": "The major class of indefinite-lived intangible asset (for example, trade names, etc. but not all-inclusive), excluding goodwill. A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of the company.", "label": "Indefinite Lived Intangible Assets Major Class Name [Domain]", "terseLabel": "Indefinite-Lived Intangible Assets, Major Class Name" } } }, "localname": "IndefiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r195" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r33" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail": { "order": 10010.0, "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets Gross Excluding Goodwill", "totalLabel": "Finite and Indefinite-Lived Intangible Assets, Gross" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r183", "r188" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10250.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets Net Excluding Goodwill", "terseLabel": "Intangible assets - net", "totalLabel": "Total" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r470" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10150.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest Income Expense Net", "terseLabel": "Interest income (expense), net" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r24", "r48", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10320.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory Net", "terseLabel": "Inventory" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r76" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10180.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Labor And Related Expense", "terseLabel": "Salaries, wages and benefits" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lease Cost [Abstract]", "terseLabel": "Lease Cost" } } }, "localname": "LeaseCostAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r425" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "Lease Cost Table [Text Block]", "terseLabel": "Components of Lease Cost and Rent Expense" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeasesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LeasesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Leases [Abstract]" } } }, "localname": "LeasesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Lessee Disclosure [Abstract]" } } }, "localname": "LesseeDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee Operating Lease Liability Payments Due", "totalLabel": "Total minimum future payments" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10120.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Next Twelve Months", "terseLabel": "2 years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10150.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Four", "terseLabel": "5 years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10140.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Three", "terseLabel": "4 years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10130.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee Operating Lease Liability Payments Due Year Two", "terseLabel": "3 years" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10110.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.", "label": "Lessee Operating Lease Liability Payments Remainder Of Fiscal Year", "terseLabel": "1 year" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r426" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": 10030.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee Operating Lease Liability Undiscounted Excess Amount", "negatedLabel": "Less: Imputed interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r47", "r96", "r171", "r399", "r440", "r461", "r479" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities And Stockholders Equity", "totalLabel": "TOTAL LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities And Stockholders Equity [Abstract]", "terseLabel": "LIABILITIES AND SHAREHOLDERS\u2019 EQUITY" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r26", "r53", "r96", "r171", "r212", "r213", "r214", "r217", "r218", "r219", "r221", "r223", "r225", "r226", "r388", "r390", "r391", "r399", "r438", "r439", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10010.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesNoncurrent": { "auth_ref": [ "r27", "r28", "r29", "r39", "r40", "r96", "r171", "r212", "r213", "r214", "r217", "r218", "r219", "r221", "r223", "r225", "r226", "r388", "r390", "r391", "r399", "r438", "r439" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10020.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer.", "label": "Liabilities Noncurrent", "totalLabel": "Total long-term liabilities" } } }, "localname": "LiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesNoncurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities Noncurrent [Abstract]", "terseLabel": "Long-Term Liabilities" } } }, "localname": "LiabilitiesNoncurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by US and non-US government sponsored enterprise, authority, agency and program guarantees for government insured loans.", "label": "Loans Insured Or Guaranteed By Government Authorities [Axis]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Guarantee by US and non-US government sponsored enterprises, authorities, agencies and programs for government insured loans.", "label": "Loans Insured Or Guaranteed By Government Authorities [Domain]", "terseLabel": "Loans Insured or Guaranteed by Government Authorities" } } }, "localname": "LoansInsuredOrGuaranteedByGovernmentAuthoritiesDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligations": { "auth_ref": [ "r39" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as noncurrent.", "label": "Long Term Debt And Capital Lease Obligations", "totalLabel": "Long-term Debt" } } }, "localname": "LongTermDebtAndCapitalLeaseObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtAndCapitalLeaseObligationsCurrent": { "auth_ref": [ "r52" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail": { "order": 10020.0, "parentTag": "us-gaap_LongTermDebtAndCapitalLeaseObligations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt and lease obligation, classified as current.", "label": "Long Term Debt And Capital Lease Obligations Current", "negatedLabel": "Less current maturities" } } }, "localname": "LongTermDebtAndCapitalLeaseObligationsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtSummaryOfLongTermDebtDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtCurrent": { "auth_ref": [ "r51" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10160.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.", "label": "Long Term Debt Current", "terseLabel": "Current maturities of long-term debt" } } }, "localname": "LongTermDebtCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debt arrangement having an initial term longer than one year or beyond the normal operating cycle, if longer.", "label": "Long Term Debt [Member]", "terseLabel": "Long-Term Debt [Member]" } } }, "localname": "LongTermDebtMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfContractualObligationsCommitmentsAndContingenciesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_LongTermDebtNoncurrent": { "auth_ref": [ "r39" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10100.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation.", "label": "Long Term Debt Noncurrent", "terseLabel": "Long-term debt" } } }, "localname": "LongTermDebtNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermDebtTextBlock": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-term debt.", "label": "Long Term Debt [Text Block]", "terseLabel": "Long-Term Debt" } } }, "localname": "LongTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebt" ], "xbrltype": "textBlockItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r130", "r131" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature Of Operations", "terseLabel": "Business Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10030.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided By Used In Financing Activities", "totalLabel": "Net Cash Used in Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Financing Activities [Abstract]", "terseLabel": "Cash Flows Used in Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r84" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10020.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided By Used In Investing Activities", "totalLabel": "Net Cash Used in Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided By Used In Investing Activities [Abstract]", "terseLabel": "Cash Flows Used in Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r84", "r87", "r89" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10010.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided By Used In Operating Activities", "terseLabel": "Net Cash Provided by (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r20", "r61", "r64", "r69", "r73", "r89", "r96", "r105", "r107", "r108", "r109", "r110", "r113", "r114", "r120", "r145", "r151", "r155", "r158", "r161", "r171", "r212", "r213", "r214", "r217", "r218", "r219", "r221", "r223", "r225", "r226", "r398", "r399", "r467", "r486" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10050.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income Loss", "terseLabel": "Net earnings (loss)", "totalLabel": "Net Earnings (Loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing And Financing Items [Abstract]", "terseLabel": "Non-cash investing and financing activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nonoperating Income Expense [Abstract]", "terseLabel": "Other Income (Expense):" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "us-gaap_NumberOfReportableSegments": { "auth_ref": [ "r133" ], "lang": { "en-us": { "role": { "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.", "label": "Number Of Reportable Segments", "terseLabel": "Number of segments" } } }, "localname": "NumberOfReportableSegments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentAdditionalInformationDetail" ], "xbrltype": "integerItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r145", "r151", "r155", "r158", "r161" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10110.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income Loss", "terseLabel": "Operating profit (loss)", "totalLabel": "Operating Loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r420", "r427" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": 10030.0, "parentTag": "us-gaap_OperatingLeaseExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating Lease Cost", "terseLabel": "Operating lease cost" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r416" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10220.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease Expense", "terseLabel": "Rent and lease expense", "totalLabel": "Total operating lease cost" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseComponentsOfLeaseCostAndRentExpenseDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r413" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail2": { "order": 10040.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease Liability", "totalLabel": "Total liabilities" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10090.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10200.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease Liability Current", "negatedLabel": "Less: Current portion", "terseLabel": "Current operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r413" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail": { "order": 10100.0, "parentTag": "us-gaap_OperatingLeaseLiability", "weight": 1.0 }, "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10120.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Operating Lease Liability Noncurrent", "terseLabel": "Long-term operating lease liabilities" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfNonCancellableOperatingAndFinanceLeasesDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeasePayments": { "auth_ref": [ "r418", "r421" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.", "label": "Operating Lease Payments", "terseLabel": "Operating cash flows from operating leases" } } }, "localname": "OperatingLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r412" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10260.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease Right Of Use Asset", "terseLabel": "Right of use assets" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r424", "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Operating Lease Weighted Average Discount Rate Percent", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r423", "r427" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Operating Lease Weighted Average Remaining Lease Term1", "terseLabel": "Operating leases" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r368" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards", "terseLabel": "Net operating loss carry-forward" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingSegmentsMember": { "auth_ref": [ "r150", "r151", "r152", "r153", "r155", "r161" ], "lang": { "en-us": { "role": { "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Operating Segments [Member]", "terseLabel": "Operating Segments [Member]" } } }, "localname": "OperatingSegmentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization Consolidation And Presentation Of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r22", "r394" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization Consolidation And Presentation Of Financial Statements Disclosure [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBasisOfPresentation" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r35" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10270.0, "parentTag": "us-gaap_AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets Noncurrent", "terseLabel": "Other noncurrent assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "auth_ref": [ "r62", "r65", "r385", "r386", "r389" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10060.0, "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.", "label": "Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent", "terseLabel": "Other comprehensive income" } } }, "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostAndExpenseOperating": { "auth_ref": [ "r79" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10210.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation.", "label": "Other Cost And Expense Operating", "terseLabel": "Other operating expenses" } } }, "localname": "OtherCostAndExpenseOperating", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r52", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10210.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other Liabilities Current", "terseLabel": "Other accrued expenses" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesNoncurrent": { "auth_ref": [ "r55" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10140.0, "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.", "label": "Other Liabilities Noncurrent", "terseLabel": "Other noncurrent liabilities" } } }, "localname": "OtherLiabilitiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables And Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r81" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10050.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments To Acquire Property Plant And Equipment", "negatedLabel": "Expenditures for property, plant and equipment", "terseLabel": "Expenditures for property, plant and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PensionContributions": { "auth_ref": [ "r86" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for pension benefit. Includes, but is not limited to, employer contribution to fund plan asset and payment to retiree. Excludes other postretirement benefit.", "label": "Pension Contributions", "terseLabel": "Contribution to pension plan" } } }, "localname": "PensionContributions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockShareSubscriptions": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The number of nonredeemable preferred stock (shares) (or preferred stock redeemable solely at the option of the issuer) allocated to investors to buy shares of a new issue of preferred stock before they are offered to the public. When stock is sold on a subscription basis, the issuer does not initially receive the total proceeds. In general, the issuer does not issue the shares to the investor until it receives the entire proceeds.", "label": "Preferred Stock Share Subscriptions", "terseLabel": "Preferred shares, unissued" } } }, "localname": "PreferredStockShareSubscriptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r42" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock Shares Authorized", "terseLabel": "Preferred shares, authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r42", "r440" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10050.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock Value", "terseLabel": "Preferred Shares, authorized and unissued, 2,000 shares" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r49" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10340.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid Expense And Other Assets Current", "terseLabel": "Prepaid expense and other assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfLongTermDebt": { "auth_ref": [ "r82" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.", "label": "Proceeds From Issuance Of Long Term Debt", "terseLabel": "Proceeds from long-term debt" } } }, "localname": "ProceedsFromIssuanceOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromLoans": { "auth_ref": [ "r85" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received from principal payments made on loans related to operating activities.", "label": "Proceeds From Loans", "terseLabel": "PPP loans from bank" } } }, "localname": "ProceedsFromLoans", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLongTermDebtCARESActPaycheckProtectionPlanLoansAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherAssetsInvestingActivities": { "auth_ref": [ "r80" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10070.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale of other assets recognized in investing activities.", "label": "Proceeds From Sale Of Other Assets Investing Activities", "terseLabel": "Proceeds from sale of other assets" } } }, "localname": "ProceedsFromSaleOfOtherAssetsInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Article or substance produced by nature, labor or machinery.", "label": "Product [Member]", "terseLabel": "Product [Member]" } } }, "localname": "ProductMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "domainItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r199" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Property Plant And Equipment By Type [Axis]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r31", "r197" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10280.0, "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Gross", "terseLabel": "Property, plant and equipment, at cost" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r199", "r440", "r473", "r481" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10230.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property Plant And Equipment Net", "totalLabel": "Property, plant and equipment - net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentOwnedAccumulatedDepreciation": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of depreciation (related to long-lived, depreciable flight assets owned by the entity and used in the entity's principle business operations and capitalized assets classified as property, plant and equipment that are owned by the entity) that has been recognized in the income statement.", "label": "Property Plant And Equipment Owned Accumulated Depreciation", "terseLabel": "Accumulated amortization" } } }, "localname": "PropertyPlantAndEquipmentOwnedAccumulatedDepreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalBalanceSheetInformationRelatingToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r197" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Property Plant And Equipment Type [Domain]", "terseLabel": "Long-Lived Tangible Asset" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_ReceivablesNetCurrent": { "auth_ref": [ "r440", "r480", "r502" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10310.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount due to the entity within one year of the balance sheet date (or one operating cycle, if longer) from outside sources, including trade accounts receivable, notes and loans receivable, as well as any other types of receivables, net of allowances established for the purpose of reducing such receivables to an amount that approximates their net realizable value.", "label": "Receivables Net Current", "terseLabel": "Receivables - net" } } }, "localname": "ReceivablesNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTable": { "auth_ref": [ "r150", "r155" ], "lang": { "en-us": { "role": { "documentation": "Identification, description, and amounts of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues.", "label": "Reconciliation Of Revenue From Segments To Consolidated [Table]", "terseLabel": "Reconciliation Of Revenue From Segments To Consolidated [Table]" } } }, "localname": "ReconciliationOfRevenueFromSegmentsToConsolidatedTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r335", "r431", "r432" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r431", "r435" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction Amounts Of Transaction", "terseLabel": "Legal services to these law firms" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]", "terseLabel": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r335", "r431", "r435", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r453", "r454", "r455", "r456" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party Transactions By Related Party [Axis]", "terseLabel": "Related Party" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r429", "r430", "r432", "r436", "r437" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfLongTermDebt": { "auth_ref": [ "r83" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows": { "order": 10040.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for debt initially having maturity due after one year or beyond the normal operating cycle, if longer.", "label": "Repayments Of Long Term Debt", "negatedLabel": "Payments on long-term debt" } } }, "localname": "RepaymentsOfLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r45", "r269", "r440", "r478", "r499", "r501" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10080.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings Accumulated Deficit", "terseLabel": "Retained earnings" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r102", "r103", "r104", "r106", "r112", "r114", "r172", "r357", "r358", "r359", "r370", "r371", "r396", "r496", "r498" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Retained Earnings (Loss) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue From Contract With Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r136", "r137", "r150", "r156", "r157", "r164", "r165", "r168", "r279", "r280", "r442" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10160.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenue From Contract With Customer Excluding Assessed Tax", "positiveLabel": "Net Revenues", "positiveTerseLabel": "Net revenues from external customers", "verboseLabel": "Net revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "auth_ref": [ "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r281", "r285" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.", "label": "Revenue From Contract With Customer [Text Block]", "terseLabel": "Revenue" } } }, "localname": "RevenueFromContractWithCustomerTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": { "auth_ref": [ "r422", "r427" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.", "label": "Right Of Use Asset Obtained In Exchange For Operating Lease Liability", "terseLabel": "Right-of-use assets obtained in exchange for new operating lease liabilities" } } }, "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureLeaseSummaryOfSupplementalCashFlowAndOtherInformationRelatedToLeasesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_SalesAndExciseTaxPayableCurrent": { "auth_ref": [ "r50" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10180.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred through that date and payable for statutory sales and use taxes, including value added tax. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Sales And Excise Tax Payable Current", "terseLabel": "Accrued sales tax", "verboseLabel": "Unpaid sales tax liability" } } }, "localname": "SalesAndExciseTaxPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureAccruedSalesTaxAdditionalInformationDetails", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ScheduleOfDefinedBenefitPlansDisclosuresTable": { "auth_ref": [ "r337", "r338", "r339", "r340", "r351" ], "lang": { "en-us": { "role": { "documentation": "Disclosures about an individual defined benefit pension plan or an other postretirement defined benefit plan. It may be appropriate to group certain similar plans. Also includes schedule for fair value of plan assets by major categories of plan assets by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets or liabilities (Level 1), Significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "Schedule Of Defined Benefit Plans Disclosures [Table]", "terseLabel": "Schedule Of Defined Benefit Plans Disclosures [Table]" } } }, "localname": "ScheduleOfDefinedBenefitPlansDisclosuresTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureDiscontinuedOperationsComponentsOfPensionExpenseDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r192", "r194" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity.", "label": "Schedule Of Indefinite Lived Intangible Assets [Table]", "terseLabel": "Schedule Of Indefinite Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r433", "r435" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule Of Related Party Transactions By Related Party [Table]", "terseLabel": "Schedule Of Related Party Transactions By Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "auth_ref": [ "r145", "r148", "r154", "r181" ], "lang": { "en-us": { "role": { "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Table]", "terseLabel": "Schedule Of Segment Reporting Information By Segment [Table]" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "auth_ref": [ "r145", "r148", "r154", "r181" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.", "label": "Schedule Of Segment Reporting Information By Segment [Text Block]", "terseLabel": "Segment Information" } } }, "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentDomain": { "auth_ref": [ "r132", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r161", "r168", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r204", "r205", "r492" ], "lang": { "en-us": { "role": { "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.", "label": "Segment [Domain]", "terseLabel": "Segments" } } }, "localname": "SegmentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SegmentReportingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Segment Reporting [Abstract]" } } }, "localname": "SegmentReportingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingDisclosureTextBlock": { "auth_ref": [ "r132", "r134", "r135", "r145", "r149", "r155", "r159", "r160", "r161", "r162", "r164", "r167", "r168", "r169" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.", "label": "Segment Reporting Disclosure [Text Block]", "terseLabel": "Financial Information by Segment" } } }, "localname": "SegmentReportingDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegment" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Information [Line Items]", "terseLabel": "Segment Reporting Information [Line Items]" } } }, "localname": "SegmentReportingInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SegmentReportingRevenueReconcilingItemLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Segment Reporting Revenue Reconciling Item [Line Items]", "terseLabel": "Segment Reporting Revenue Reconciling Item [Line Items]" } } }, "localname": "SegmentReportingRevenueReconcilingItemLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureRevenueSummaryOfRevenueByPayorDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ServiceMember": { "auth_ref": [ "r282" ], "lang": { "en-us": { "role": { "documentation": "Assistance, including, but not limited to, technology, license and maintenance, license and service, maintenance, oil and gas, and financial service.", "label": "Service [Member]", "terseLabel": "Service [Member]" } } }, "localname": "ServiceMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "domainItemType" }, "us-gaap_StatementBusinessSegmentsAxis": { "auth_ref": [ "r8", "r132", "r136", "r137", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r145", "r146", "r147", "r150", "r151", "r152", "r153", "r155", "r156", "r157", "r158", "r159", "r161", "r168", "r173", "r174", "r175", "r176", "r177", "r178", "r179", "r180", "r181", "r182", "r200", "r204", "r205", "r492" ], "lang": { "en-us": { "role": { "documentation": "Information by business segments.", "label": "Statement Business Segments [Axis]", "terseLabel": "Segments" } } }, "localname": "StatementBusinessSegmentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureFinancialInformationBySegmentSegmentInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r41", "r42", "r43", "r93", "r96", "r117", "r118", "r119", "r121", "r123", "r127", "r128", "r129", "r171", "r212", "r217", "r218", "r219", "r225", "r226", "r251", "r252", "r254", "r258", "r264", "r399", "r519" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Statement Class Of Stock [Axis]", "terseLabel": "Class of Stock" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DocumentDocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r57", "r67", "r68", "r69", "r102", "r103", "r104", "r106", "r112", "r114", "r126", "r172", "r264", "r269", "r357", "r358", "r359", "r370", "r371", "r396", "r401", "r402", "r403", "r404", "r405", "r406", "r428", "r496", "r497", "r498" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Statement Equity Components [Axis]", "terseLabel": "Equity Components" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]", "terseLabel": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement Of Stockholders Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r102", "r103", "r104", "r126", "r442" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]", "terseLabel": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r42", "r43", "r264", "r269", "r355" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Stock Issued During Period Shares Stock Options Exercised", "terseLabel": "Share options exercised, Shares", "verboseLabel": "Options exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquityAdditionalInformationDetail", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r57", "r264", "r269" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period Value Stock Options Exercised", "terseLabel": "Share options exercised" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders Equity [Abstract]", "terseLabel": "Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r68", "r96", "r102", "r103", "r104", "r106", "r112", "r171", "r172", "r269", "r357", "r358", "r359", "r370", "r371", "r382", "r383", "r392", "r396", "r399", "r401", "r402", "r406", "r428", "r497", "r498" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets": { "order": 10040.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders Equity Including Portion Attributable To Noncontrolling Interest", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance", "totalLabel": "Total Shareholders\u2019 Equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedBalanceSheets", "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r94", "r252", "r253", "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r269", "r270", "r395" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r407", "r441" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r407", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r407", "r441" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]", "terseLabel": "Subsequent Event Type" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]", "terseLabel": "Supplemental Disclosure of Cash Flow Information:" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_SuppliesExpense": { "auth_ref": [ "r471" ], "calculation": { "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss": { "order": 10190.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense associated with supplies that were used during the current accounting period.", "label": "Supplies Expense", "terseLabel": "Supplies" } } }, "localname": "SuppliesExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeNamesMember": { "auth_ref": [ "r380" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.", "label": "Trade Names [Member]", "terseLabel": "Trade Name [Member]" } } }, "localname": "TradeNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/DisclosureIntangibleAssetsIntangibleAssetsDetail" ], "xbrltype": "domainItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r116", "r123" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number Of Diluted Shares Outstanding", "terseLabel": "Diluted" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Weighted Average Number Of Shares Outstanding [Abstract]", "terseLabel": "Weighted-Average Common Shares Outstanding:" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "stringItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r115", "r123" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number Of Shares Outstanding Basic", "terseLabel": "Basic" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.sunlinkhealth.com/20220930/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperationsAndComprehensiveEarningsLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 9 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r131": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8672-108599" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(j)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "26", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "34", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8475-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r169": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "280", "URI": "https://asc.fasb.org/topic&trid=2134510" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b),(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275" }, "r195": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r203": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.P.4(d))", "Topic": "420", "URI": "https://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r208": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r21": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r22": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=7516071&loc=d3e13374-112631" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(24))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r270": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(25))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r285": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "606", "URI": "https://asc.fasb.org/topic&trid=49130388" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "15", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "712", "URI": "https://asc.fasb.org/extlink&oid=6410066&loc=d3e79218-111664" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=d3e1703-114919" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123453770&loc=SL108413299-114919" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 201.5-02(26))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(10)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(9)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(8)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(j)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(k)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(q)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2410-114920" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2417-114920" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2439-114920" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(4)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(5)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(6)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(7)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2709-114920" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e2919-114920" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4587-114921" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r379": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569643-111683" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.E)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120398118&loc=d3e355146-122828" }, "r394": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(23))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918631-209977" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(2)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r437": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(5))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(26))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.14)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(22))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r492": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(b)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(ii)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-06(3))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e604059-122996" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column B))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column C))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column D))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column E))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column F))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column G))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column H))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Column I))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r514": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r515": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r516": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r517": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r518": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r519": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "303", "Subparagraph": "(5)" }, "r521": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r522": { "Footnote": "2", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r523": { "Footnote": "4", "Name": "Regulation S-X (SX)", "Number": "210", "Publisher": "SEC", "Section": "12", "Subsection": "29" }, "r524": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column B", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r525": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column C", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r526": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column D", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r527": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column E", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r528": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column F", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r529": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column G", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column H", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r531": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "Column I", "Publisher": "SEC", "Section": "12", "Subsection": "28" }, "r532": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "01" }, "r533": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(i)", "Subsection": "02" }, "r534": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(ii)", "Subsection": "01" }, "r535": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)", "Subsection": "01" }, "r536": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "01" }, "r537": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(A)", "Subsection": "02" }, "r538": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "01" }, "r539": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(B)", "Subsection": "02" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iii)(C)", "Subsection": "02" }, "r541": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "01" }, "r542": { "Name": "Regulation S-X (SX)", "Number": "210", "Paragraph": "(a)", "Publisher": "SEC", "Section": "13", "Subparagraph": "(4)(iv)", "Subsection": "02" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e637-108580" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e681-108580" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "14A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669686-108580" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=d3e557-108580" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(24))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2(a),(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" } }, "version": "2.1" } ZIP 66 0001564590-22-037559-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-22-037559-xbrl.zip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Ư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